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Unlike HIV infection in humans, SIV infection is generally nonpathogenic in natural hosts, such 
as African green monkeys (AGMs), despite high life-long viral replication. Previous research has indicated 
that key events occurring early during SIV infection of natural hosts may influence the pathogenic outcome 
of infection. The main objective of this project was to characterize these early events following mucosal 
transmission in a natural host. To this goal, 29 adult male AGMs were intrarectally infected with 
SIVsab92018 and serially sacrificed at various stage of acute and early chronic SIV infection. In order to 
characterize viral spread and replication, an extensive survey of plasma and tissue viral loads was 
performed. SIV replication and dissemination from the site of inoculation occurred very rapidly, possibly 
even simultaneously, resulting in a very rapid virus seeding of virtually every tissue compartment. 
However, immune activation and inflammation in response to infection were limited and largely transient. 
As control of inflammation is associated with preservation of the integrity of the gut epithelium, which is 
damaged during acute pathogenic HIV/SIV infections by viral replication in the GALT and bystander 
effects, a wide variety of markers for immune activation, apoptosis, fibrosis and epithelial integrity were 
evaluated in the AGM gut. No evidence of disruption of the epithelial barrier in the gut or the translocation 
of highly inflammatory microbial byproducts from the gut lumen was found. Transcriptomic analysis was 
performed to evaluate gene expression in the gut of AGMs versus rhesus macaques (RMs) intrarectally 
inoculated with pathogenic SIVmac251. We identified a unique macrophage-mediated wound healing 
response, which occurred in AGMs and was absent in the RMs which would allow maintenance of the gut 
mucosa through exquisite repair of virally induced damage during early SIV infection. We concluded that 
through a combination of repair and low levels of immune activation, AGMs are able to maintain gut 
 v 
epithelial integrity despite high acute viral replication. As microbial translocation and the resultant chronic 
inflammation are the major drivers of pathogenesis, prevention of these events by preservation of gut 
homeostasis are a crucial component to avoiding disease progression in natural hosts.  
 vi 
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A family of primate lentiviruses, collectively referred to as simian immunodeficiency viruses (SIVs), 
naturally infect a large number of African nonhuman primate (NHP) species. Like other lentiviruses, SIVs 
possess both RNA and DNA forms of their genome at different stages of their lifecycle. As virions and 
during production of new viral genomes within the cell, SIVs have RNA genomes. However, upon entering 
a cell, the RNA is reverse transcribed to DNA, which is then integrated into the host cell DNA (1, 2). 
Currently, over 40 different SIVs are known to be circulating in wild African NHPs. Unlike like humans 
infected with HIV or Asian NPHs, which eventually progress to develop acquired immunodeficiency 
syndrome (AIDS) without treatment, the African NHPs that are natural hosts of SIVs generally do not 
progress to AIDS, despite chronic, highly active viral replication that is in same range as or even greater 
than what is typically reported in HIV+ individuals (2–7). However, there have been some rare cases where 
AIDS or AIDS-like clinical signs have been reported to occur natural hosts, primarily in captive NHPs that 
had outlived their normal lifespan of their species in the wild and had been infected and followed for 
decades (8–11). This clearly indicates that the lack of disease progression in the natural hosts of SIVs is not 
the result of infection by benign viruses, but rather that these species have adapted to avoid progression to 
AIDS. Although relatively sparse compared to the body of data on HIV, the research done on the 
pathogenesis of SIV-infection in natural hosts indicates that the lack of disease progression does not appear 
to be mediated by a more effective immune response by the host, but rather by a better management of the 
deleterious consequences of infection (2). These adaptations are undoubtedly the result of long-term 
coevolution between African hosts and their species-specific SIVs (4, 6, 12–14). 
 2 
1.1 The evolutionary history of SIVs in Natural Hosts 
1.1.1  SIVs naturally infect only wild African NHPs 
Before considering the exact features of SIV infection in African NHPs, it is important to 
understand the long evolutionary relationship that exists between these viruses and their hosts. SIVs have 
so far been found to infect over 45 species of African NHPs, with 40 genetically distinct SIVs known to be 
circulating in the wild (2, 6, 15). While most natural hosts are infected by a single species-specific SIV, 
there are several examples of African NHP species, including mandrills, mustached monkeys, and mantled 
guerezas, which are infected in the wild by multiple SIVs (3). No SIV has been found yet that naturally 
infect any wild Asian or New World NHPs in the wild. Therefore, Asian macaques are non-natural hosts 
of SIV (3, 16, 17). The various SIVmac variants that are used to experimentally infect rhesus macaques 
(RMs), pigtailed macaques, crabeating macaques and stumptailed macaques in captivity actually represent 
accidental cross-species transmissions of SIVs from sooty mangabeys (SM), an African NHP species (18). 
In macaques and other Asian NHPs, SIV infections are pathogenic and lead to the development of AIDS, 
which is why the RM has become the primary animal model for HIV infection. 
From an evolutionary perspective, humans could also be considered to be a non-natural host for 
HIV, as HIV only appeared in human populations within the last century, when the virus was acquired from 
chimpanzees/gorillas and sooty mangabeys. The progression to AIDS reflects the poor evolutionary 
adaptation between HIV and humans. A similar situation exists in chimpanzees, which also acquired 
SIVcpz from various monkey species through cross-species transmissions and recombination events (19), 
and then became the source of the SIVgor that infects gorillas (20–24). Like HIV in humans, progression 
to AIDS has been shown to be a possible outcome of SIVcpz infection in chimpanzees, both in captivity 
and in the wild, though it is as of yet unclear how prevalent progression to AIDS is amongst wild chimps 
(25, 26).  
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1.1.2  African NHPs and SIVs have coexisted for an extremely long period of time 
Various studies incorporating biogeology, phylogeny and molecular clock calculations point to 
very ancient origin of SIV, though the exact estimates vary greatly. Due to the discrepancy with the 
molecular clock data, it these estimates rely on biogeography that can be used to recalibrate the molecular 
clocks (12, 27). Through these recalibration, it generally can be surmised that SIVs have been infecting 
African primates for anywhere between hundreds of thousands to millions of years (12, 28, 29). In fact, it 
is possible that SIVs have been infecting NHPs since the time of primate speciation, given the complete 
absence of SIVs in Asian and New World NHPs (7). 
While the precise age of SIV infections in their natural hosts may be uncertain, the SIVS and their 
natural hosts clearly share a long evolutionary history together. One notable example illustrating this 
relationship can be found in the phylogeny of the various types of SIVagm, which infect different species 
of African green monkeys (AGMs). AGMs are NHPs belonging to the genus Chlorocebus. The genus 
encompasses four species of AGM: sabaeus, grivet, tantalus, and vervet (2, 3), which were shown to each 
be infected with a species-specific virus (30). The AGM subspecies are known to have diverged from their 
common ancestor between 1.5-3 million years ago and then spread out over sub-Saharan Africa, each 
settling into a different region (31). Although there are several regions where two different species overlap, 
the SIVagm diversity in the different AGM species follows the host species rather than the geographical 
location. Furthermore, when different populations of the same species have been separated, the virus 
diversity follows this geographical segregation (for example, the two different vervet populations on the 
two sides of the Drakensberg mountains in South Africa, the two mandrill populations at the North or South 
of the Ogoue River in Gabon), which also indicates long term coevolution between the African NHP hosts 
and their species-specific SIVs (12, 32).  
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1.1.3  SIVs are genetically diverse and readily undergo cross-species transmission and 
recombination 
The extensive evolutionary history of SIVs is also reflected in part by their extreme genetic 
diversity of SIVs and, subsequently, that of the HIVs. Phylogenetic analysis of SIVs has revealed that there 
have been numerous cross-species transmissions and recombination events in the past, with many SIVs 
arising after crossing over between two sympatric species (6). There are also multiple examples of cross-
species transmission subsequently followed by recombination, including: (i) SIVmnd-2 ; (ii) SIVagm ; (iii) 
SIVmus, SIVmon, and SIVgsn, three viruses from three different NHP species (mustached monkeys, mona 
monkeys and greater spot-nosed monkeys) which share genetic and phylogenetic features, suggesting 
recombination (33–35). 
Another notable example is SIVcpz, which shares genetic similarity to both SIVrcm and 
SIVgsn/mon/mus. Chimpanzees regularly hunt other primates for food and the recombination of these two 
viruses almost certainly occurred in chimps (19). SIVcpz emergence is most likely a relatively recent event, 
as is reflected by the reports of 10- to 16- fold increase in mortality and AIDS-like disorders in wild SIVcpz-
infected chimpanzees (26, 36, 37). Additionally, expression levels of the SIV coreceptor CCR5 on the 
surface of chimpanzee CD4+ T cells are intermediate between natural hosts and non-natural hosts. As CCR5 
expression levels are generally considered a marker of host adaptation to SIV (38), and are correlated with 
susceptibility to infection (see 1.3.2) this intermediary CCR5 expression on the CD4+ T cells of chimps 
suggests a relatively recent cross-species transmission and consequently an incomplete adaptation of the 
chimpanzee host to the virus (6). 
The SIV propensity to readily cross over between species is reflected by the fact that both HIV-1 
and HIV-2 originated from multiple cross-species transmissions of SIVs to humans (39). HIV-1 arose from 
cross-species transmissions from two different primate sources, with HIV Groups M and N being the result 
of SIVcpz transmission of from chimpanzees to humans in West-Central Africa (23). Conversely, HIV-1 
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groups O and P emerged in humans as a result of cross-species transmission of SIVgor, which is itself a 
cross-species transmission of SIVcpz from chimps to gorillas (20, 24, 40, 41). HIV-2, on the other hand, 
arose in Western Africa from multiple transmission of SIVsmm directly from SMs in Western Africa to 
humans (22, 39, 42).  
1.2 General features of SIV transmission in natural hosts 
1.2.1  Most features of SIV infection of natural hosts have been derived from studies on a limited 
number of species in captivity 
Virtually all of the data regarding the characteristics of SIV infection of natural hosts have been 
derived from studies on a limited number of three animal models (AGMs, SMs and mandrills) in captivity 
(3, 6). There are several reasons for this. First, most SIVs are only known from their genetic sequences and 
have never been properly isolated or characterized. SIVagm, SIVsmm, and SIVmnd-1/SIVmnd-2 are 
among the minority of SIVs that have been studied in detail. Second, the majority of African NHPs are not 
widely available in primate facilities and importation of NHPs directly from Africa is virtually impossible. 
Third, many NHPs are endangered and field work on wild animals is exceptionally difficult. 
Our lab developed a new model of SIVsab infection in Caribbean AGMs that circumvents most of 
these problems. The difficulty in importation is averted, as AGMs (sabaeus) from the Caribbean are easy 
to import. Since the AGMs were brought from Africa to the Caribbean over 300 years ago during the 17th 
and 18th centuries, they have become well established (43). These animals have been shown to be both free 
of SIVsab, and genetically indistinguishable from the sabaeus found in Africa, making them ideal for 
experimental studies (44–46). Finally, neither African nor Caribbean AGMs are endangered, meaning that 
more invasive methods can be used for the study of SIV pathogenesis in AGMs, including experimental 
infections, blood draws and tissue sampling and serial necropsies. 
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1.2.2  SIVs can be highly prevalent in natural hosts in the wild 
In many African NHP species and subspecies, SIV infections are very prevalent in the wild. Some 
examples include: red colobus, AGMs, SMs, red-capped mangabeys, De Brazza monkeys, and mandrills 
(12, 47–51). The prevalence rates in these species can be uniformly high across the population, as is the 
case in AGMs, where 80-90% of adult females and 50-60% of adult males in the wild test positive for 
SIVagm infection (12, 52, 53). However, the picture is less well defined in some other African NHP species. 
In gorillas and chimpanzees, SIVs tend to be distributed heterogeneously, with high prevalence in certain 
populations and low prevalence or absence of infection in others (39). There are also several species where 
the occurrence of SIV infection is quite low, like the greater spot-nosed monkey or the mustached monkey 
(15). The significance of these features has not yet been established (i.e., it is possible that the low 
prevalence in some species is the result of high viral pathogenicity).  
1.2.3  Horizontal transmission of SIVs in natural hosts is common 
Based on the prevalence of SIV-infection of natural hosts in the wild, it can be inferred that 
horizontal transmission of SIV from one animal to another must be a relatively common event. Horizontal 
transmission in NHPs has been reported to occur in a variety of ways, including: (i) sexual contact; (ii) 
biting; (iii) fighting; and (iv) grooming (12, 25, 26, 32, 50, 53–57). Compared to HIV in humans, where 
urogenital mucosal transmission constitutes the major route of horizontal transmission and oral 
transmission is remarkably infrequent (apart from transmission during breastfeeding), in NHPs SIV 
transmission through oral exposure is fairly common (58–61). Consequently, transmission while grooming 
or cleaning wounds (i.e., oral exposure) most likely represents a significant route of infection in natural 
hosts. There have also been multiple descriptions of SIV transmission through biting in captive NHPs (56, 
62–65). It is important to note that in these cases, whether through grooming or biting, NHPs are being 
exposed to blood, which typically has a significantly higher viral load than breast milk or sexual secretions. 
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This may explain in part why horizontal transmission via the oral mucosa is more frequent in NHPs than 
humans. 
1.2.4  Vertical transmission of SIVs in natural hosts is a rare event 
Unlike horizontal transmission, vertical transmission, also known as mother-to-infant transmission 
(MTIT), is exceedingly rare in natural hosts. In humans and macaques, exposure in utero or through 
breastfeeding represent the major routes of MTIT. The rates of MTIT via these routes can be quite high, 
with 35-40% of infants born to HIV-infected mothers becoming infected, especially if the mothers are 
acutely infected (66); similarly 40-70% of infant RM become infected with SIV when born to SIVmac-
infected dams (67). By comparison, in recent studies of wild vervets in South Africa and Gambia, the rates 
of MTIT were shown to be only 4-7% (12, 52). Studies of natural hosts housed in various Primate Centers 
have also found a very low incidence of vertical transmission, supporting the findings of the surveys of 
animals in the wild (51, 68–71). 
1.3 Horizontal SIV transmission in natural hosts 
1.3.1  Detailed characterization of mucosal transmission has only been performed in non-natural 
hosts 
Studying the events following mucosal transmission through sexual contact in wild natural hosts is 
nearly impossible, for the reasons described above. Much of what is currently known about horizontal SIV 
transmission via the urogenital mucosa originated from studies of intravaginal transmission of SIVmac in 
RMs (61, 72, 73). More recently,  studies also confirmed that the same general events outlined below also 
occur during penile transmission of SIVmac in RMs (74). While some aspects surrounding mucosal 
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transmission have been shown to differ between natural and non-natural hosts, characterization of mucosal 
transmission in RMs should provide a good approximation of the general events (61). 
From the RM studies, it appears that the very first phase of transmission occurs when the virus 
crosses the mucosal epithelium and infects a small ‘founder population’ of target cells. This can occur at 
multiple locations throughout the mucosal site of entry, leading to establishment of foci of early virus 
replication. These foci may appear preferentially where there are higher densities of target cells in the 
epithelium, though this has only been shown in the RM intravaginal model of transmission (75). The 
founder CD4+ T-cell populations frequently exhibit markers indicating that they had been previously 
activated (i.e., still expressing enough CCR5 and transcriptional activators to support SIV infection) but are 
no longer active or proliferating (CD69neg CD25neg Ki67neg), and therefore are referred to as being in a resting 
state (76). 
These resting CD4+ T cells were found to outnumber other resident immune cells types, such as 
dendritic cells (DCs) and macrophages, at a ratio ranging between 4-5:1 (77). However, mathematical 
modeling found that the number of these target cells normally present in the mucosa is not sufficient to 
sustain viral replication alone. In order to expand, the virus needs new target cells to be recruited to the 
early foci of replication by the innate inflammatory immune response stimulated by the virus. Following 
the recruitment of the target cells and viral expansion, the virus disseminates to the draining lymph nodes, 
where there is a high enough concentration of CD4+ T cells to facilitate its rapid expansion. Traveling 
through the lymphatics, the virus is able to enter the bloodstream through the thoracic duct and spread 
systemically (61). One implication of this model is that there may be a window of opportunity for 
intervention prior to recruitment of additional target cells to the site of entry and viral dissemination, when 
the virus is limited to a relatively small number of target cells.  
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1.3.2  Target cell availability is reduced at the mucosal sties in natural hosts, but still correlates with 
the rates of transmission 
While most of the detailed knowledge on mucosal transmission comes from the RM intravaginal 
studies, there has also been significant research done on mucosal sites in natural hosts, particularly at the 
gastrointestinal tract mucosa. A study of a large cohort of AGMs of varying ages demonstrated that the 
numbers of CCR5+ CD4+ cells are very low not only in the blood, but also in the gut and jejunum. A strong 
mathematical correlation was found between increases in levels of gut CCR5+ CD4+ T cells and the rate of 
SIV mucosal transmission in these animals (52). Another experimental study established that a 10-fold 
higher dosage of SIVsab was needed to successfully intrarectally and intravaginally inoculate adult AGMs 
as compared to adult PTMs. This reduced susceptibly was correlated with the number of CCR5+ CD4+ T 
cells in the rectum, which was shown to be 10-fold lower in the AGMs than PTMs (78).  
Considering the extremely high prevalence of SIV infection in the wild, it is apparent that reduction in 
overall target cell availability at the mucosal sites does not coincide with protection of natural hosts from 
either transmission or CD4+ T cell depletion in the gut associated lymphatic tissue (GALT, see 1.4.5), 
though it may render them more resistant to infection (78). Therefore, it can be assumed that there may be 
an alternative effect of this reduction on the course of infection. One possible explanation is that, as CCR5 
is a chemokine receptor, its reduced expression on the surface of CD4+ T cells might decrease homing of 
effector memory cells to the gut in natural hosts, which in turn could reduce immune activation and 
inflammation (6). 
1.3.3  Reduced target cell availability may protect natural hosts from oral transmission 
As natural hosts have reduced availability of CCR5+ CD4+ T cells (i.e., target cells) at the mucosal sites, 
target cell restriction at the oral mucosa has been proposed as a mechanism of protection from MTIT (70). 
This is similar to the case of infant RMs, which initially have low populations of CCR5+ CD4+ T cells at 
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their mucosal sites, yet these levels increase dramatically to nearly the levels seen in adult RMs within the 
first 6 months postpartum (70). This supports the observation that the virus challenge needed to infect 
newborn RM infants was 10-fold higher than the dose needed to infect older infants (79). However, a similar 
an increase in CCR5+ CD4+ T cells could not be observed in AGM infants or juveniles less than 3 years old 
(52, 70). 
A recent study experimentally demonstrated the importance of CCR5+ T cell availability to oral SIV 
transmission in AGMs. Infant AGMs were orally exposed to high concentrations of SIVagm, while juvenile 
and adult AGMs were intrarectally inoculated with the same dosage of virus. Following inoculation, none 
of the infant AGMs became infected, while half of the juveniles and all of the adults were infected. The 
juveniles that did not become infected were found to have lower levels of CCR5+ CD4+ T cells in blood and 
mucosal sites than those that did become infected (78). 
No study has yet been able to measure the presence of CCR5+ CD4+ T cells at the oral mucosa in wild 
natural hosts, given the difficulty of invasive sampling in the field. However, in the recent study of wild 
AGMs in Gambia, the highest frequency of circulating CD4+ T cells expressing CCR5 among the 29 infants 
tested was observed in the blood of the single infant AGM that was also infected with SIVagm (52). 
In the rare instances of MTIT in SMs, the SM infants infected through MTIT exhibited viral loads 2 
logs lower than those seen in adults, suggesting that only a low number of CCR5+ CD4+ T cells support 
viral replication (71). This is in contrast to what has been previously observed in human infants, where viral 
loads are very high, sometimes exceeding those seen in adults (71). Such an age-related difference in the 
levels of viral replication was not observed in AGMs (52). These results strongly suggest that target cell 
restriction at the oral mucosa does act to protect natural hosts from MTIT during breastfeeding and possibly 
until the age of sexual maturity, when the overall counts of mucosal CCR5+ CD4+ cells increase (70). 
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1.3.4  A genetic bottleneck is imposed by the mucosal epithelium on the number of transmitted SIV 
variants 
It has been demonstrated that the mucosal barrier acts as a significant obstacle to both SIV and HIV 
transmission, being difficult for the viruses to cross, particularly in the vagina, where much of the mucosa 
is covered by durable stratified layers of squamous cell. However, a recent RM-based study demonstrated 
that transmission is possible at any location along the female reproductive tract (75). On the other hand, the 
lower intestinal tract mucosa is formed by a simple columnar epithelium shaped into straight tubular crypts, 
being much thinner than vaginal mucosa and making the target cells more accessible to the virus. Due to 
these architectural features, the virus can cross the intestinal mucosa more easily than the vaginal mucosa. 
There is also a stochastic barrier to infection at the mucosa, as the overall number of target cells 
initially available to infect is quite low in RMs and even lower in natural hosts. One consequence of these 
steep impediments to transmission is a ‘mucosal bottleneck’, where only a small number of transmitted 
viruses are actually able to go on to establish infection (38, 61, 70). 
This genetic bottleneck imposed on transmitted viruses has been documented during mucosal 
transmission of HIV and SIVmac (80, 81). The same bottleneck was also reported in AGMs, both in the 
wild and in captivity (52, 78). In a study of AGMs in captivity, following both intravaginal and intrarectal 
inoculations with SIVsab, only 1-2 viruses were found to have established infection in each animal (78). 
This agrees with the finding of a more recent study, which found that only a single transmitted viral variant 
established infection in multiple AGMs in the wild (52). The similarity of the mucosal bottleneck observed 
in both natural and non-natural hosts implies that there is little difference in the way the mucosal epithelium 
restricts viral transmission. 
 12 
1.4 Post-transmission features that may impact SIV pathogenesis in natural hosts 
1.4.1  Natural hosts sustain high levels of viral replication without disease progression 
There are a number of features that distinguish natural, nonpathogenic hosts from non-natural, 
pathogenic hosts, like macaques and humans, as shown in Table 1.  
 
Table 1: Pathogenesis of Lentiviral Infections in Natural versus Pathogenic Hosts 
Feature Natural hosts Asian NHPs Humans 
Progression to AIDS No Yes Yes 
Acute plasma viremia +++ +++ +++ 
Chronic plasma viremia Stable Progressive Progressive 
Virus cytopathy Yes Yes Yes 
Genetic bottleneck of virus Yes Yes Yes (not IV) 
Acute damage to gut epithelium Yes Yes Yes 
Microbial Translocation No Yes Yes 
Chronic inflammation No Yes Yes 
Establishment of acute anti-inflammatory milieu Yes No No 
Hypercoagulability No Yes Yes 
Comorbidities Rare Yes Yes 
Horizontal Transmission Frequent Frequent Frequent 
Vertical Transmission Rare Frequent Frequent 
Breast milk viral loads +++ ++ ++ 
 
Of these, the hallmark characteristic of all natural SIV infections are high levels of SIV replication 
during both the acute and chronic stages of infection (46, 78, 82–95). During the acute infection, the peaks 
of virus replication in natural hosts are comparable to those seen in untreated HIV-1 and SIVmac infections 
(12, 46, 52, 78, 82–90, 96–104). During the chronic infection, viral loads in natural hosts tend to be as high 
as or even slightly higher than the viral loads seen in pathogenic infections (105). Additionally, the chronic 
viral replication in natural hosts is remarkably stable, whereas it tends to vary widely and increase with 
disease progression in humans and macaques, thus being predictive of disease progression (6, 7, 88, 96, 
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97). As viral replication remains virtually unchanged throughout the course of chronic infection in natural 
hosts, it can be assumed that plasma viremia has no correlation with disease progression. However, in the 
rare instances where progression to AIDS has occurred in natural hosts, the levels of chronic viral 
replication were significantly higher (1-2 logs) than normally seen in the majority of naturally SIV-infected 
animals (6, 11). 
Though many studies have examined SIV replication in natural hosts in captivity, very limited 
information is available regarding the levels of viral replication in the wild. The most comprehensive studies 
to date on virus replication in the wild were performed using samples collected from several hundred wild-
caught vervets from South Africa and sabaeus from Gambia (12, 52). In these animals, plasma viremia 
ranged between 104-107 SIVagm RNA copies/mL. Note that these numbers represent an average, as the 
viral loads in bulk of the animals tested were fairly consistent, measuring between 104-105 RNA copies/mL. 
In both AGM species, approximately 10% of animals tested presented with viral loads that were 
significantly higher (106-108 RNA copies/mL plasma). The plasma of these animals also tested seronegative 
for SIV-specific antibodies, suggesting that they were in the Fiebig stage II of acute SIV infection (106), 
particularly since the levels of viral replication were in the same range of the viral loads observed during 
acute infection in captive, experimentally infected AGMs (12). 
Based on the findings of these studies and on data derived from studies of natural hosts in captivity, it 
can be reasonably inferred that there is no significant difference in viral replication between wild and 
captive natural hosts (105). One may argue that the high levels of viral replication observed may be due to 
a low virus turnover and not necessarily to high levels of virus replication. However, previous experimental 
studies have shown that virus turnover is high in SIV-infected AGMs and SMs, higher even than in SIVmac 
infection (88, 107). 
The higher levels of chronic viral replication observed in the wild AGMs compared to HIV-1+ 
individuals (12, 39, 97), may significantly impact viral transmission in the wild. A plasma viremia of around 
1500 RNA copies/mL or higher is associated with significant increase in rates of sexual transmission in 
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humans (108). This is lower than either the average acute or chronic viral loads in natural hosts. Assuming 
that similar virus shedding occurs in the body fluids of humans and NHPs, this would support mucosal 
exposure through sexual contact as the primary route of transmission in the wild (3). 
1.4.2  SIV primarily targets CCR5+ CD4+ T cells during mucosal transmission in natural hosts 
For most SIVs, the primary viral binding receptor is CD4, while chemokine receptors such as CCR5 
serve as coreceptors (109–112). This shared receptor and coreceptor usage indicates that, like HIV, the 
identity of the primary target cells of SIV are CCR5+ CD4+ T cells (7, 38, 109, 111, 113, 114). However, 
while HIV can utilize both CCR5 and CXCR4, most SIVs are limited to only CCR5 as a coreceptor. There 
are some exceptions to this, as several SIV isolates were reported to also use CXCR4, including SIVmnd-
1, several SIVsmm strains and SIVagm (91, 115, 116). Very recently, SIVsmm and SIVagm strains were 
reported to also utilize CXCR6 as a coreceptor (117, 118). It has also been reported that CCR6 and CRK-
L3, a natural isoform of CCR6, can act as a coreceptor for both primary HIV and SIVsmm isolates (119, 
120). This suggests that some SIVs may have an expanded cell tropism besides CCR5+ CD4+ T cells or an 
expanded range of potential target cells (117, 118). 
One of the major exceptions to the usage of CCR5+ as a coreceptor by SIVs is SIVrcm, which uses 
CCR2b as a coreceptor instead of CCR5. This appears to be an evolutionary feature born from necessity, 
as the majority of red-capped mangabeys (RCMs), the natural hosts of SIVrcm, lack CCR5 entirely. This 
is because approximately 83% of RCMs have a 24 deletion that silences transcription of their CCR5 gene, 
making them resistant to viral entry using CCR5 as a coreceptor. This is very similar to the situation in 
humans, where a small number of people exhibit a 32 mutation of their CCR5 gene that renders them 
resistant to HIV infection (121). Consequently, SIVrcm has adapted to use CCR2 or CCR4 to ensure its 
continued dissemination throughout the RCM population or persistence upon cross-species transmission 
(122, 123). The usage of CXCR4, CXCR6 and CCR6 coreceptors by some SIVagm and SIVsmm lineages 
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suggests that there might have been similar adaption by these viruses to overcome the naturally low 
availability of CCR5+ CD4+ target cells in natural hosts (see 1.4.4). 
1.4.3  Natural hosts maintain peripheral T-cell populations and T-cell function 
Despite the high levels of ongoing viral replication during both the acute and chronic infection, another 
defining feature of SIV-infection of natural hosts is the preservation of peripheral CD4+ T-cell populations 
during chronic infection (46, 52, 78, 84, 86, 87, 91, 96, 97, 124–127). This is in contrast to pathogenic 
HIV/SIV infections, where chronic peripheral CD4+ T-cell depletion is associated with disease progression 
and the development of AIDS (128). However, while natural hosts of SIV share the acute CD4+ T cells 
depletion with the pathogenic models of infection, the CD4+ T cells are partially restored in natural hosts 
during the chronic infection, differently from the pathogenic infections, where progressive CD4+ T-cell 
depletion is a hallmark of infection and one of the defining features of AIDS (see 1.4.5) (6, 7, 76, 129–132). 
The fact that natural hosts can undergo even a partial depletion of CD4+ T cells and then maintain 
high levels of viral replication calls into question how they are able to maintain T-cell function. One possible 
explanation was derived from studies in SMs, where CD4 + T-cell depletion can occur down to AIDS-
associated levels without any clinical consequences (84, 96, 101, 133, 134). This preservation of immune 
function was reported to be due to populations of CD4neg CD8neg T cells that perform helper cell-like 
functions following SIV-induced CD4+ T cell depletion (101). These double negative T cells arise through 
down-regulation of CD4 expression by memory T cells as they enter the memory pool. The double negative 
T cells were shown to be able to carry out a variety of CD4+ T-cell associated functions (production of IL-
2 and IL-17, FoxP3 and CD40 ligand expression, MHCII restriction) and are resistant to SIV infection (135, 
136). In HIV+ individuals, CD4neg CD8neg cells can also arise from down-regulation, but remain susceptible 
to infection (137). 
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1.4.4  Natural hosts of SIVs exhibit reduced expression of CCR5 and lower total numbers of CCR5+ 
CD4+ T cells at mucosal sites 
Another defining characteristic of natural hosts of SIV is the low expression levels of the viral 
coreceptor CCR5 on CD4+ T cells, particularly on those residing in the gut. In comparison, non-natural 
hosts have high numbers of CCR5+ CD4+ T cells in the gut and other mucosal sites (38, 70). This down-
regulation of CCR5 expression specifically occurs for CD4+ T cells, as CCR5 expression on CD8+ T cells 
remains in the same range as in pathogenic hosts (38). This low levels of expression of CCR5 by the 
memory CD4+ T- cells occurs even in the absence of SIV-infection in the natural hosts of SIVs (38). 
In addition to low expression levels of CCR5, some natural hosts also exhibit a general reduction 
in the overall CD4+ T-cell counts. While this decrease applies to all tissue compartments, it is even more 
pronounced at mucosal sites, such as the gut (38, 46, 70, 78). This trend only holds true for some species 
of African guenons (tribe Cercopithecini), i.e., AGMs, patas and sun-tailed monkeys (46). SMs and 
mandrills (tribe Papionini) have been reported to have higher CD4+ T-cell counts, similar to those seen in 
RMs (6). 
The observation that natural hosts can have high levels of viral replication, but low levels of CCR5+ 
CD4+ target cells available to support that replication is one of the major paradoxes of SIV infection in 
natural hosts. One possible explanation for this is that the level of CCR5 expression by CD4+ T cells does 
increase in response to infection in natural hosts, but the effect is masked by simultaneous SIV-induced 
depletion (6). Another potential explanation is that there are other target cells in natural hosts apart from 
CCR5+ CD4+ T cells, such as macrophages (6). This is somewhat supported by the observation that SIVagm 
and other SIVs are dual-tropic for CCR5 and CXCR4 (see 1.4.2). The occurrence of giant cell disease in 
the rare cases of AIDS in natural hosts also supports the infection of monocytes/macrophages during natural 
infection (11). However, during acute infection, CD4+ T cells are most depleted in the gut, where they more 
frequently express CCR5. The depletion is more limited in blood and LNs, where a higher fraction of CD4+ 
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T cells express CXCR4. This holds true for infections by both natural (AGMs) and non-natural (RMs and 
PTMs) hosts, as well as for HIV infections (6, 89, 127), strongly suggesting that even in cases where SIVs 
can employ other coreceptors for infection, CD4+ T lymphocytes will be preferentially targeted. However, 
it has been shown that SIVs can employ another coreceptor aside form CCR5 or CXCR4, namely CXCR6. 
It has been hypothesized that usage of CXCR6 as a coreceptor helps to preserve a functional immune 
response in natural hosts by redirecting the virus away from the CCR5+ CD4+ T-cell population (117, 138). 
Apart from their obvious depletion, CD4+ T cells have been implicated as the major cell type 
supporting SIV replication by in situ hybridization studies showing that SIV RNA colocalizes mostly with 
CD3+ cells and infrequently with macrophages (88, 107, 139). Furthermore, when natural hosts 
experimentally receive antiretroviral therapy (ART), the viral decay suggests that the cells predominantly 
supporting viral replication are short lived, implicating lymphocytes as the principal target cell (88, 107, 
139). Additionally, in a study where CD4+ T cells were experimentally depleted in naturally SIVsmm-
infected SMs using humanized anti-CD4 mAb, viral loads decreased sharply in blood, rectal biopsies and 
bronchoalveolar lavages, and returned to baseline levels after the CD4+ populations were replenished (140). 
Conversely, the CD4+ depletion had no effect on macrophages, T regulatory cell or CD8+ T-cell 
populations, indicating that CD4+ T cells were the primary cell type supporting viral replication (140).  
Yet, when CD4+ T cells are depleted or are resistant to the virus (such as cells defective for CCR5 
expression, like in RCMs), SIVs will infect macrophages in both progressive and nonprogressive hosts 
(100, 141–143). This is best demonstrated by the fact that both progressive and natural hosts that develop 
AIDS exhibit giant cell disease, a condition characterized by heavy infiltration of tissues by SIV-infected 
macrophages (9, 11, 144). Macrophage tropism of SIVs is not surprising, since lentiviruses first emerged 
as macrophage-tropic viruses, as is still the case for lentiviruses infecting other mammal species (Maedi-
Visna, equine infectious anemia virus or caprine arthritic encephalitis virus) (7). 
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1.4.5  Following depletion, peripheral but not the mucosal CD4+ T-cell populations are restored to 
near preinfection levels in natural hosts 
Both natural and non-natural hosts undergo a similar massive depletion of mucosal CD4+ T cells 
during the acute stage of infection. The primary site of CD4+ T-cell depletion is the gut, specifically the 
GALT and depletion mainly occurs during the acute stage of infection (76, 84, 89, 129–132, 145, 146). 
Natural hosts experience this depletion in spite of the reduced level of CCR5 expression or lower total 
number of CD4+ cells (see 1.4.4) (38, 70). 
What sets natural and non-natural hosts apart are the immunological events following depletion of 
mucosal CD4+ T cells (Table 2) 
 
Table 2: Immunological Features of Lentiviral Infections in Natural versus Non-natural Hosts 
Feature Natural Hosts Asian NHPs Humans 
Primary Target cell CD4 CD4 CD4 
CD4 T-cell CCR5 expression levels + +++ +++ 
Mucosal CCR5+ CD4+ levels + +++ +++ 
Peripheral CD4+ T-cell depletion Acute only +++ +++ 
Mucosal CD4+ T-cell depletion +++ +++ +++ 
CD4negCD8neg resistance to infection Yes No No 
Tscm depletion No Yes Yes 
CD4+ Th17 cell depletion No Yes Yes 
CD8+ T-cell response Yes Yes Yes 
CD20+ B-cell response Yes Yes Yes 
Treg homeostasis Yes No No 
 T cells anergy No Yes Yes 
Chronic immune activation No Yes Yes 
Interferon response Acute only Yes Yes 
T-cell proliferation Acute only Yes Yes 
Inhibitory breast milk factors Yes Yes Yes 
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In untreated HIV+ individuals and pathogenic SIV infections, the peripheral CD4+ T-cell 
populations will eventually decline without intervention, leading to the development of AIDS. The scenario 
in natural hosts is quite different, with recovery of the peripheral CD4+ T cells population to nearly baseline 
levels by the chronic infection. Additionally, the GALT-associated CD4+ T cells partially recover, despite 
the robust chronic viral replication, though GALT CD4+ T cells populations never recover fully to 
preinfection levels (4, 6, 72, 147). Most of this recovery following acute infection consists of restoration of 
central memory and naïve T cells, while effector memory T cells remain depleted (89). This partial recovery 
is possible in natural hosts because of the control of immune activation and apoptosis (see 1.4.6), which 
prevents excessive depletion of the overall CD4+ T cells population, with the loss due to viral replication 
being compensated by a normal production of cells (6). 
After their restoration, CD4+ central memory T cells are lost in SIVsmm-infected SMs at rates 20 
times slower than those of SIV-infected RMs (148). This translates to a half-life of total CD4+ central 
memory T-cell populations <16 months for RMs, but >17 years for SMs, which is in agreement with the 
rare cases of AIDS in natural hosts in very old animals. Also, SM CD4+ central memory T-cell proliferation 
levels are lower than in RMs and the RM CD4+ central memory T-cell proliferation correlates with viral 
replication (148). Yet, a recent study of mandrills in Gabon found a significant decrease in memory T cells 
populations that was correlated with the duration of infection (149). However, other studies of the same 
mandrill cohort did not find similar features (99). 
Besides central memory T cells, other cell types are also preserved in natural hosts and show 
divergent dynamics between SIV-infected RMs and SMs. Notably, memory CD4+ T cells with stem cell-
like properties undergo depletion and exhibit increased rates of proliferation and high levels of virus 
infection in RMs. Conversely, SMs CD4+ stem memory T-cell populations remained stable, showed no 
marked increase in proliferation, and had very low rates of direct infection. As stem memory T-cell are 
known to be able to differentiate into central, effector and naïve T cells, their homeostasis could be crucial 
to restoration of T-cell populations following depletion in natural hosts (150, 151). 
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1.4.6  Natural hosts control chronic immune activation, proliferation and interferon production 
One of the most striking features of the SIV infection in natural hosts is their ability to control their 
levels of chronic immune cell activation. This is reflected by the expression of HLA-DR and CD69 (both 
markers of immune cell activation) on T cells, predominately CD8+ T cells, in natural hosts, which increase 
slightly during acute infection and returns to baseline levels by chronic infection. In pathogenic infections, 
the expression levels of these activation markers by T cells rise dramatically during the acute infection and 
are never resolved during the chronic infection, when they continue to increase, being correlated with 
disease progression (46, 82, 84, 87–89, 91, 97, 125–127, 133, 152). Also, expression of PD-1, a cell surface 
protein that acts as a negative regulator of the immune activation, was found to be rapidly induced in 
response to SIV-infection in the lymphatic tissue in SMs. This was associated with resolution of acute 
immune activation and the preservation of CD4+ T-cell populations and lymphatic tissue structure (153). 
Resolution of this aberrant, persistent immune activation during the transition from acute-to-chronic 
infection is therefore thought to be the major mechanism by which natural hosts avoid progression to AIDS 
(89, 153–157).  
Similar to immune cell activation, T-cell proliferation increases only during the acute infection in 
natural hosts (84, 89, 90, 133, 158). By the chronic phase of infection, proliferation levels return to near 
their preinfection state (158–160). This can be observed as a transient increase in expression of the 
proliferation marker Ki-67 during the acute infection and early chronic infection in AGMs, with return to 
baseline by the transition to chronic infection (76, 89). Conversely, in pathogenic infections, T-cell 
proliferation continues to increase to the point of excessive cell turnover, likely in an attempt to recover 
from the depletion of CD4+ T cells (161, 162). 
Another point of divergence between natural and non-natural hosts during SIV infection is seen in 
the production of interferons. A strong and sustained Th1-mediated type I (IFN-, IFN-) and type II (IFN-
) interferon response was observed in the LNs of pigtailed macaques (PTMs) infected with SIVsab, which 
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is pathogenic in PTMs. In contrast, only a transient type I interferon response occurred in SIVsab-infected 
AGMs, which was resolved after peak viral replication (163). Furthermore, experimental administration of 
high concentrations of the type I IFN- to acutely infected AGMs had no impact on immune activation 
(164). Taken together, natural hosts seem to possess the ability to maintain homeostasis of their immune 
cell populations and resolve immune activation, proliferation and IFN production after the acute SIV 
infection. 
1.4.7  CD8+ T cells do not contribute significantly to the prevention of disease progression 
The current data indicate that the general CD8+ T-cell populations and their SIV-specific responses 
are comparable in both infected and uninfected AGMs and RMs (165–168). However, the role that CD8+ 
T cells play in different natural host species becomes unclear when looking at the dynamics of viral 
replication following experimental depletion of CD8+ T cells. In chronically SIVmac-infected RMs, 
experimental CD8+ T-cell depletion results in a 1-3 log increase in plasma viremia (169, 170). In contrast, 
CD8+ depletion in chronically SIVsmm-infected SMs seem to have very little impact on viral replication, 
though one study did show an increase in viral loads following CD8+ T-cell depletion (171, 172). Similarly, 
CD8+ T-cell depletion during acute infection did not increase the peak viral loads in AGMs, but it did lead 
to a plateau of viral replication following peak infection until the CD8+ T-cell populations were restored. 
These findings, along with those of other studies on cellular immune responses in natural hosts, indicate 
that CD8+ T cells do play a role in controlling viral replication to some extent (167, 172, 173). However, 
none of the in vivo depletion experiments had any effect on the actual state of disease progression (171, 
174). This is in contrast to CD8+ T-cell depletion in RMs, which results in increased CD4+ T-cell 
proliferation and rapid disease progression (175). Consequently, it remains unclear what impact, if any, 
CD8+ T cells play in preventing disease progression in natural hosts. 
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1.4.8  Natural hosts maintain function of other immune cell populations 
Apart from the changes in CD4+ and CD8+ T-cell populations, natural hosts also maintain normal 
populations and functions of a variety of other immune cell subsets, such as NK cells, Th17 T cells, 
regulatory T cells (Tregs),  T cells and myeloid dendritic cells (mDCs). In contrast, disturbances in these 
cell populations have been described during pathogenic HIV and SIV infections (161, 176–181). 
Preservation of these secondary immune cell populations could impact protection from disease progression 
in natural hosts in a number of ways. For instance, there is evidence to support that maintenance of the Th-
17/Treg ratio may be crucial to preventing SIV disease progression and maintaining the integrity of the 
mucosal barrier during acute infection (177, 178). Moreover, preserving Treg homeostasis might confer 
protection through production of anti-inflammatory cytokines, such as IL-10, or by prevention of excess 
CD4+ T-cell proliferation following the initial CD4+ T-cell depletion in the gut (6). Expression of the Treg 
marker FoxP3 was reported to increase along with anti-inflammatory cytokine production, suggesting that 
Tregs might play an important role in establishing the anti-inflammatory response (127). Tregs are rapidly 
depleted in the intestines of neonatal RMs infected with SIVmac, supporting the role of the loss of Tregs 
in pathogenic models of disease progression (182). 
In addition to maintaining Treg homeostasis, preventing dysfunction of  T cells may play a 
crucial role in averting disease progression in natural hosts, as apart from cytokine production,  T cells 
also perform a variety of other functions, including regulation of tissue healing (183, 184). In HIV infection, 
it has been shown that  T cells become anergic and can no longer migrate in response to proinflammatory  
cytokines (185, 186). In contrast,  T cells remain fully functional in SMs (133, 176). It was also shown 
that  T cells in SMs retain their ability to produce the Th1 cytokines TNF- and INF- postinfection, 
while this capacity was reduced in  T cells from HIV-infected subjects, along with the overall numbers 
of  T cells (184). Given the importance of controlling inflammation during primary infection (see 1.4.10 
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and 1.4.11), preservation of regulatory cell populations like Tregs and  T cells likely plays an important 
role in the prevention of SIV disease progression in natural hosts. 
1.4.9  The humoral response plays little to no role in controlling viral replication following mucosal 
transmission in natural hosts 
The humoral response in SIV-infected natural hosts has been shown to be similar to or lower than 
what has been reported in pathogenic infections (82, 187–189). However, a paucity of SIV Gag-specific 
antibodies is a shared feature of SIV-infected natural hosts. Oddly, the T-cell response to Gag in natural 
hosts is comparable to those seen in pathogenic infections, meaning that the absence of anti-Gag antibodies 
is not due to a lack of Gag-specific T cells (165). Furthermore, some SIVs, like several SIVsmm strains, 
are actually resistant to antibody neutralization, making it unclear what effect antibodies might have on 
SIVs (112). Further complicating the situation, experimental depletion of CD20+ B cells had no effect on 
either viral replication or disease progression in AGMs, even after the depletion was maintained in our 
studies for over 6 months (166, 187). Similarly, in a pair of studies that sought to suppress the adaptive 
immune response through simultaneous depletion of CD8+ T cells and CD20+ B cells during primary SIV 
infection, the depletion caused no alteration in the state of disease progression in AGMs. In contrast, 
SIVsab-infected PTMs rapidly progressed to AIDS when both CD8+ and CD20+ populations were depleted 
(166, 168). In summary, these results strongly suggest that the role of the adaptive immune responses are 
minimally involved in preventing disease progression in natural hosts. 
1.4.10  Natural hosts appear to avoid damage to the gut epithelial that is associated with acute 
pathogenic SIV/HIV infection 
Perhaps one of the most important differences between SIV infection in natural and non-natural 
SIV hosts and the one that might play the key role in preventing persistent immune activation is the lack of 
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chronic damage to the gut epithelium in natural hosts. In non-natural, pathogenic hosts (i.e., humans and 
RMs), this damage is a consequence of early viral replication, which causes disruption of the gut epithelium 
and dysregulation of epithelial cell homeostasis (190). The result is damage to the gut epithelium, which 
allows leakage of microbes and microbial products from the gut lumen into the surrounding tissue, a process 
known as microbial translocation. Once outside the lumen, microbial antigens bind to Toll-like receptors, 
stimulating chronic aberrant immune activation. This, in turn, not only creates more available target cells 
for the virus, but also functionally exhausts the immune system and its capacity for regeneration (84, 89, 
191, 191, 192). 
Natural hosts, on the other hand, appear to avoid this vicious cycle of damage and inflammation 
altogether. This is reflected by the absence of bacterial lipopolysaccharide (LPS) in the plasma during both 
the acute and chronic stages of SIV infection in AGMs (89). The importance of avoiding microbial 
translocation was highlighted by two studies where experimentally administration of LPS to AGMs induced 
general immune activation followed by CD4+ T-cell depletion and an increase in viral loads (though there 
was ultimately no impact on disease progression) (193, 194). In another study, dextran sulphate, a drug that 
is directly toxic to intestinal epithelial cells and is known to impair the integrity of the mucosal barrier, was 
administered to chronically SIVsab-infected AGMs. This resulted in increases in plasma SIV RNA, sCD14 
(see below), CRP and LPS levels, along with loss of mucosal CD4+ T cells (195). Conversely, when acutely 
SIV-infected PTMs were treated with sevelamer, an LPS chelator, in the gut, the treatment resulted in a 
dramatic reduction in both inflammation and immune activation, directly demonstrating the significance of 
microbial translocation on SIV pathogenesis (196). 
As the bulk of data regarding microbial translocation in natural hosts was derived from studies of 
animals in captivity, a recent study sought to examine whether or not natural hosts were able to avoid 
microbial translocation (MT) in the wild. Because direct measurement of mucosal integrity in wild natural 
hosts would have been virtually impossible, the sCD14 protein was used as a surrogate marker for microbial 
translocation. CD14 is a coreceptor for LPS expressed by peripheral blood monocytes and tissue 
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macrophages. After LPS stimulation, CD14+ monocytes/macrophages secrete sCD14 and shed surface 
CD14, which then bind to LPS (192). There was no observable difference in the plasma sCD14 levels 
between wild SIV-positive and SIV-negative vervets and sabaeus (12, 52). These results are in agreement 
with studies of experimentally infected AGMs, where sCD14 levels remained virtually unchanged 
following SIV infection (78, 78, 89, 105). A separate study of semiwild mandrills in Gabon confirmed these 
results by showing that plasma levels of sCD14 remained unchanged following SIVmnd1-infection (149). 
1.4.11  Maintenance of the gut integrity and prevention of MT primarily hinges on control of 
apoptosis and establishment of a rapid anti-inflammatory response 
The precise means by which natural hosts avoid chronic damage to their gut and the associated MT 
is still uncertain. CD4+ T-cell apoptosis levels in natural hosts do not increase significantly during acute or 
chronic infection (89, 126, 197–200). However, transient CD8+ T-cell apoptosis occurs in both natural and 
pathogenic hosts (200). Lack of increased apoptosis of both gut lymphocytes and epithelial cells may 
contribute to the preservation of the integrity of the gut epithelium (6). 
Another important mechanism reported to contribute to the preservation of the integrity of the gut 
epithelium is the establishment of an anti-inflammatory milieu early during infection that represses the 
effects of proinflammatory cytokines. Both natural and non-natural hosts exhibit increased expression 
levels of proinflammatory cytokines (IFN-,TNF-, IL-1, IL-12) following infection, albeit at a somewhat 
lower level in natural hosts. These cytokines are produced by both immune and epithelial cells as part of 
the innate immune response to viral replication following transmission (6, 201–204). However, this increase 
is only transient in natural hosts; following acute infection, expression of proinflammatory cytokines return 
to preinfection levels. In HIV+ individuals and SIVmac-infected RMs, proinflammatory  cytokine 
production persists into chronic infection, stimulating chronic inflammation and, in turn, immune activation 
(127, 133, 152). Resolution of this initial proinflammatory response to the virus seems to depend on 
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establishment of the anti-inflammatory milieu early during infection of the natural host. This is reflected in 
a rapid increase in expression of the anti-inflammatory cytokines TGF- and IL-10 following SIVsab 
infection of AGMs (127). Furthermore, a recent study in RMs established a correlation with internalization 
of the IL-10 receptor (i.e., lowered responsiveness to IL-10) by mucosal lymphocytes in the gut epithelium 




Previous studies of natural hosts by our lab and others have strongly suggested that events occurring 
very early during the infection may enable natural hosts to prevent disease progression. Understanding these 
early events may be crucial to uncovering the mechanisms by which natural hosts avoid progression to 
AIDS, which in turn could lead to new treatment options for HIV+ individuals. Specifically, it may help 
unlock routes to reaching a ‘functional cure’ (i.e., prevention of progression to AIDS without viral 
clearance) for HIV+ individuals and eliminate their dependency on ART. Therefore, the goal of this 
dissertation study was to characterize the early events of intrarectal transmission of SIVsab in male AGMs. 
Given that it has been shown that chronic immune activation and inflammation are characteristic of 
pathogenic HIV/SIV infections, we therefore hypothesized that events occurring during the earliest stages 
of mucosal transmission contribute to the resolution of the immune activation characteristic of pathogenic 
lentiviral infection at the passage from acute-to-chronic infection and thus prevent disease progression in 
nonprogressive hosts. Among the characteristic features of mucosal transmission in natural hosts that are 
involved in the early events of infection and shape the long-term pathogenic outcome are: (i) lower 
availability of target cells at the mucosal site(s) of infection; (ii) lower levels of immune activation at the 
mucosal sites, which result in (iii) reduced recruitment of target cells to mucosal sites of infection and (iv) 
the establishment of an anti-inflammatory milieu that suppresses the virally induced proinflammatory  
response. To test this hypothesis, we proposed the following specific aims (SAs): 
SA1: Characterize the viral bottleneck and dissemination from the site of infection in AGMs 
intrarectally (IR) inoculated with SIVsab. 
SA2: Examine early changes in the immune cell populations following IR challenge of AGMs with 
SIVsab. 
SA3: Analyze the expression of inflammatory and anti-inflammatory genes following IR SIVsab 
challenge. 
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3.0 Acute SIVsab infection of African green monkeys is characterized by rapid viral dissemination 
and limited immune response at the site of inoculation 
3.1 Contributors 
Data contributed to the dissertation by several collaborators is included in the following chapter. 
Drs. Jacob Estes and Claire Deleage contributed the in situ hybridization data, the RNAscope data and the 
fluorescent in situ hybridization data. Dr. Brandon Keele contributed the single genome amplification data 
on the transmitted/founder viruses. Various members of the Apetrei/Pandrea labs contributed to the routine 
work, including tissue processing, immune cell isolation, flow cytometry, quantitative PCR, and single 
copy assay for plasma viral loads. The dissertation author managed the serial necropsies and tissue 
sampling, analyzed the majority of the flow cytometry data, performed the qPCR for the CSF viral loads 
and all DNA/RNA extractions and qPCR for the tissue viral load quantifications.  
3.2 Background 
As outlined in 1.0, prior research in African NHPs has indicated that the events that might 
contribute to the avoidance of disease progression in natural hosts, like the AGM, occur very early on during 
SIV infection, probably within the first few days following transmission (78, 91, 127, 154, 156, 164). These 
early events likely occur at the mucosal sites of viral entry or at the initial sites of viral replication. Most of 
what is known about these initial sites of replication has been derived  from studies of intravaginal 
transmission of SIVmac in RMs and provides a good approximation for transmission at other mucosal sites 
(see 1.3.1) (61, 72, 206–208). In these studies, it was observed that the virus must first cross the epithelial 
barrier, which is significant impediment to transmission; this is reflected by the fact that any preexisting 
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infections, inflammation or microabrasions that might compromise the integrity of the mucosal epithelium 
significantly increase transmission rates (72, 208–211). After crossing the epithelium, the virus enters the 
submucosa and infects a small number of target cells. This founder population of cells is comprised of CD4+ 
T cells, which are typically more numerous than other resident immune cells types (77). However, the initial 
population of target cells is not large enough to sustain viral replication; therefore, more cells must be 
recruited to the initial foci of replication by the virus-induced innate and inflammatory immune responses 
(210). Further viral expansion is facilitated when the virus reaches the draining lymph nodes (LNs), where 
there is an extremely high concentration of potential target cells. Lymphatic dissemination also allows the 
virus to move into the bloodstream through the thoracic duct and thereby enter systemic circulation (61, 
72). A similar pattern of viral dissemination has been observed in several studies of intrarectal transmission 
of SIVmac in RMs, supporting this model of early events of mucosal transmission of SIV (212, 213).  
 The macaque model of mucosal transmission also predicts that the combination of the epithelial 
barrier, the initially limited availability of resident target cells, and the antiviral immune response imposes 
a “mucosal bottleneck” (see 1.3.4) on the number of transmitted/founder viral variants that can successfully 
establish infection (214). The existence of this bottleneck is reflected by the fact that in 80% heterosexual 
transmission of HIV, only a single transmitted/founder genotype goes on to establish infection (80, 215). 
Similarly, limited transmitted/founder virus transmission has been observed in experimentally infected 
AGMs (216); our group demonstrated that in both adult AGMs intravaginally infected with SIVsab, only 
1-2 SIV T/F variants had been transmitted (78). This implies that the general features of mucosal 
transmission of natural hosts like AGMs and pathogenic hosts like RMs and humans are similar. 
 Nevertheless, there are a number of important characteristics of natural hosts that set them apart 
from pathogenic hosts that can impact transmission. Foremost amongst these is the fact that AGMs maintain 
significantly lower levels of CCR5+ CD4+ T cells in blood, LNs and, most importantly, the gut than are 
seen in humans and RMs. This reduced target cell availability is not sufficient to prevent SIVsab 
transmission, as discussed in 1.3.2 and 1.3.3. However, this reduction is sufficient to limit transmission, as 
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we found that infection rates for infant and juvenile AGMs were significantly lower than for adults when 
inoculated with SIVsab. In the same study we also found that PTMs had higher levels of CCR5+ CD4+ T 
cells at mucosal sites than AGMs and were infected with a dose of SIVsab 1 log lower than was needed to 
infect the adult AGMs (78).  
 Unfortunately, many of these previous studies of early SIVsab infection have been limited by 
several factors, including being based solely on peripheral blood or LNs, relying on intravenous (IV) 
inoculations or not encompassing the initial period of viral replication within the first few days of infection. 
Here, we performed a detailed characterization of the natural history of acute SIVsab infection following 
intrarectal inoculation in Caribbean AGMs, which we have established as a well-studied and readily 
available model of natural SIV infection (88, 217). The goal of the studies outlined in this section of the 
dissertation was to characterize both the virological and immunological parameters of infection 
immediately surrounding the earliest stages of mucosal transmission in AGMs, particularly at the site of 
inoculation. To this end, we used PCR analysis of both plasma and tissue sites to both establish the levels 
of virus and to try to track viral dissemination throughout the body. We also performed additional, more 
thorough dissection of the site of inoculation itself attempting to identify: (i) the initial sites of viral 
replication; (ii) the population of founder cells in the mucosa; (iii) any changes in immune activation, 
immune cell recruitment and cell death; (iv) the mucosal bottleneck of virus transmission by enumerating 




3.3.1  Ethics Statement 
All the animals included in these studies were housed at the RIDC animal facility of the University 
of Pittsburgh, an AAALAC International facility, as per the regulations outlined in the Guide for the Care 
and Use of Laboratory Animals (218) and the Animal Welfare Act (219). All animal experiments were 
approved by the University of Pittsburgh Institutional Animal Care and Use Committee (IACUC). Efforts 
were made to minimize NHP suffering, in agreement with the recommendations in "The Use of Nonhuman 
Primates in Research" (220). The NHP facility was air-conditioned, with an ambient temperature of 21-
25°C, a relative humidity of 40-60% and a 12-hour light/dark cycle. AGMs were socially housed in 
suspended stainless-steel wire-bottomed cages. A variety of environmental enrichment strategies were 
employed, including providing toys to manipulate and playing entertainment videos in the NHP rooms. The 
NHPs were observed twice daily and any signs of disease or discomfort were reported to the veterinary 
staff for evaluation. At the end of the study, the NHPs were euthanized following procedures approved in 
the IACUC protocol (#1008829).  
3.3.2  Animals and infections 
Thirty-three adult (4-9 years old) male AGMs (Chlorocebus sabaeus) of Caribbean origin were 
used in these studies. Caribbean AGMs are genetically identical to African AGMs and are much easier to 
obtain than their African counterparts, making them more practical for all intents and purposes of 
experimentation (43, 217, 221). The AGMs were intrarectally challenged with infectious plasma originally 
collected from an acutely infected AGM, diluted to contain 107 RNA copies of SIVsab.sab92018 (217). 
This dosage was established during a preliminary study as a relatively low dose that could reliably infect 
adult AGMs intrarectally (78). Infectious acute plasma was chosen as an inoculum to better reflect the 
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natural viral diversity in the wild; it is also more infectious than plasma taken from chronically infected 
NHPs (222). Male AGMs and the intrarectal route of infection were preferred to avoid the physiological 
variability of the vaginal mucosa associated with the estrus cycle (75) even though vaginal transmission is 
far more prevalent in wild NHPs (see 1.2.3). 
 Given the nature of the study, it was necessary to perform serial necropsies of the animals to obtain 
the tissues required for proper characterization of site of inoculation, the virus spread throughout the body 
and a wide-variety of different immune responses. Longitudinal biopsies would have provided neither the 
quantity nor the diversity of tissues necessary for such an extensive survey.  
 
 
Figure 1: Animal groups for study of the early events of intrarectal SIVsab infection. 
Thirty-three African green monkeys (AGMs) were included in this study and exposed intrarectially to 
SIVsab92018. The AGMs were euthanized throughout the acute and early chronic SIV infection and were 
divided into the following groups based on their predicted viremic status at the day postinfection (dpi) that 
the necropsy was performed: (i) preinfection (baseline); (ii) preramp-up (1-3 dpi); (iii) ramp-up (4-6 dpi); 
(iv) peak (9-12 dpi); (v) set-point (46-55 dpi). Each animal is assigned an individual symbol and color 
indicating at which stage of infection they were necropsied. 
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3.3.3  Tissue sampling and isolation of mononuclear cells 
Blood, intestinal biopsies and LN biopsies were collected from each animal prior to infection to 
establish the baseline levels for the tested markers. Then, immediately prior to necropsy, the maximum 
amount of blood allowed (based on weight) was collected. The bulk of the volume of the blood was 
collected with EDTA to prevent coagulation, but two separate smaller samples of blood mixed with heparin 
and sodium citrate were also taken. An extensive tissue sampling was performed during the necropsy. 
Sections of numerous tissue sites were collected for snap freezing in liquid nitrogen, or fixation in 4% 
paraformaldehyde. Additional tissue samples were collected for lymphocyte separation from specific 
tissues of interest, including a variety of regional LNs (colonic, iliac, obturator, mesenteric, axillary, 
inguinal and submandibular), jejunum, ileum, colon, and rectum. Lymphocytes were separated from whole 
blood and tissues and used fresh for flow cytometry. Any remaining cells were frozen for later use at -80ºC 
in freezing medium containing heat-inactivated fetal bovine serum with 10% dimethyl sulfoxide (DMSO). 
 Special attention was payed to collection of the tissue from the site of inoculation: the rectum and 
the distal colon. These tissues were removed prior to any other tissue compartment and then sectioned 6 
strips each, for a total of 12 strips. These strips were then divided into ~1cm2 pieces. The pieces were then 
collected for various purposes, including immunohistochemistry (IHC), RNA sequencing (RNAseq) and 
DNA/RNA extraction for PCR.  As the initial foci of viral replication within the site of inoculation can be 
widely distributed, the pieces were taken using a rotating collection strategy to maximize the probability of 
capturing one or more of these foci.  
 Plasma was separated from whole blood within 1 hour of collection by centrifugation at 2200 rpms 
for 20 mins, aliquoted and snap frozen at -80ºC. Peripheral blood mononuclear cells (PBMCs) were then 
isolated by density gradient centrifugation at 2200 rpms using lymphocyte separation media (LSM; MP 
Biomedicals, Santa Ana, CA), aliquoted and frozen as described (46, 223). 
 Cells were separated from LNs by first mincing the tissue and then pressing it through a 70 µm 
nylon filter (Fisher Scientific, Pittsburgh, PA). The cells were then passed through a nylon tissue specimen 
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bag (ThermoFisher, Waltham, MA) and washed with RPMI media (Lonza, Walkersville, MD) containing 
5% heat-inactivated newborn calf serum, 0.01% penicillin-streptomycin, 0.01% L-glutamine, and 0.01% 
HEPES buffer, as described (89, 193). LN biopsies were also dry frozen at -80ºC for DNA/RNA extraction 
or fixed in 4% paraformaldehyde for histological processing. 
 The intestinal biopsies were fixed and frozen in a similar fashion, though they were additionally 
preserved in RNALater (ThermoFisher) for use in RNAseq. No lymphocytes were separated from the 
intestinal biopsies due to their small size and the need to prioritize other assays. To isolate lymphocytes 
from the much larger gut sections taken during the necropsy, they were processed as previously described 
(78, 114). Briefly, the sections were first trimmed of fat, then opened longitudinally and gently scraped to 
remove waste. Next, the gut sections were diced into ~1-2mm2 pieces and then incubated in HBSS (Lonza) 
with 8 mM EDTA (Fisher Scientific) for 30 mins at 37ºC while shaking at 300 rpms on an orbital 
shaker/incubator. This was done twice, with fresh HBSS with EDTA added between, before the tissue was 
thoroughly minced. Then, the tissue was digested twice with RPMI with 0.75% collagenase (Sigma-
Aldrich, St. Louis, MO) under the same conditions. Finally, the lymphocytes were separated by density 
gradient centrifugation at 2200 rpms for 20 mins using 35% and 60% Percoll (Sigma-Aldrich). 
3.3.4  Plasma viral RNA extraction and cDNA synthesis 
Viral RNA was extracted from plasma using the QIAGEN viral RNA Mini kit (QIAGEN, 
Germantown, MD). RNA was then eluted and reverse transcription was preformed using the Taqman Gold 
reverse transcription PCR (RT-PCR) kit and random hexamers (PE, Foster City, CA), as described (217). 
The RT-PCRs were run in a Gene Amp PCR System 9700 thermocycler (Applied Biosystems, Grand 
Island, NY). 
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3.3.5  Plasma viral load quantifications 
Plasma viral loads were monitored by real time quantitative PCR (qPCR) based on a 180-bp 
segment located in the gag region (88, 91, 127). Primers and probes (46, 88) were synthesized by Integrated 
DNA Technologies (Coralville, IA). All qPCRs were run in duplicate and negative controls for the RT-
PCR and qPCR were included on each plate. The qPCRs were run on 7900HT Fast Real Time System 
(Applied Biosystems), as described (88). 
qPCR was performed by using TaqMan® Gene Expression Master Mix (PE Applied Biosystems). 
A set of primers and probe mapping the gag sequence was synthesized, as follows: SIV-gag-standard-F (5′-
ATA GCA GGG ACC ACT AGC ACA AT-3′), SIV-gag-standard-R (5′-TCT TTG AAT GGT TCC TTG 
GGT CC-3′), and fluorogenic SIV-gag-standard-Probe (5′-/56-FAM/ATA GCA GGG/ZEN/ACC ACT 
AGC ACA ATA C/3IABkF/-3′). 
Absolute viral RNA (vRNA) copy numbers were calculated relative to amplification of an SIVsab 
standard, which was subjected to RT-PCR in parallel with the samples being tested. The standard was 
generated as described (88). The detection limit of this conventional qPCR was 30 vRNA copies/mL of 
plasma (88). 
3.3.6  Single copy assay (SCA) 
SCA was originally designed to detect down to one copy of HIV RNA in 7.5 mL of plasma. The 
assay was previously adapted in our lab for quantification of SIVsab (224), and was performed as previously 
described (224, 225). Briefly, two sequential rounds of centrifugation (400 g x 10 mins and then 1,350 g x 
15 mins) were used to pellet cells and debris in the plasma. The plasma samples were then spiked with an 
internal control virus derived from avian Rous sarcoma virus (RSV) SR-A strain (RCAS) to assess virion 
recovery. Virions were then pelleted by ultracentrifugation at 170,000 g for 30 mins, digested with 
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proteinase K, and homogenized with guanidine thiocyanate (Sigma-Aldrich, St. Louis, MO) supplemented 
with glycogen (Sigma-Aldrich). The SIV RNA was then precipitated with isopropanol, washed with ethanol 
and resuspended in 10 mM Tris-HCl pH8.0 supplemented with dithiothreitol and an RNase inhibitor. 
RT-PCR was then used to convert vRNA to cDNA and the cDNA was then quantified by qPCR 
using external standard curves generated from serial dilutions of RNA transcripts synthesized in vitro. SIV 
RNA positive (5 copies/mL) and negative (0 copies/mL) control standards were included in each SCA run 
to evaluate run-to-run variation and exclude false-positive results. The RCAS internal standard was used to 
evaluate the efficiency of virion recovery. All samples were run in triplicate on 96-well plates. Any of the 
samples that returned negative results were retested, as the levels of circulating virus during very early acute 
infection (primarily during the preramp-up period, 1-3 dpi) were anticipated to be very low (224, 226). For 
the same reason, when large volumes of plasma were available from the AGMs euthanized at 1-3 dpi, SCA 
was performed multiple times. Only EDTA or sodium citrate blood was used for SCA, as heparin can 
interfere with the downstream PCR. 
3.3.7  Viral load quantification in the cerebrospinal fluid (CSF)  
CSF RNA extraction and PCR were performed with the same basic methodology described in 3.3.4 
and 3.3.5 but using slightly different reagents. vRNA was extracted from the CSF with the QIAGEN viral 
RNA Mini kit, followed by reverse transcription. Instead of the Taqman Gold reverse transcription kit, the 
M-MLV reverse transcriptase (Thermofisher) was used with random primers (Promega, Madison, WI) and 
RNasin ribonuclease inhibitor (Promega), as per the manufacturer’s specifications. 
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3.3.8  Single genome amplification for the enumeration of transmitted/founder viruses 
SGA was performed as described (52, 78, 80). Briefly, 1X High Fidelity Platinum PCR buffer 
(ThermoFisher), 2 mM MgSO4, 0.2 mM deoxynucleoside triphosphate, 0.2 μM primer, and 0.025 U/μL 
Platinum Taq High Fidelity polymerase were combined with cDNA. First-round PCR mixtures were 
denatured at 94°C for 1 min, followed by 35 cycles of 94°C for 20 sec, 55°C for 30 sec, and 68°C for 1 min 
per kilobase and terminated with a single 10 min 68°C extension. Next, 1 μL of these products were used 
for a second-round reaction, which was performed under the same PCR conditions for a total of 45 cycles. 
Positive secondary PCR products were isolated with gel electrophoresis. Both DNA strands were 
sequenced, and chromatograms were inspected at every position for double peaks, which would be 
indicative of a Taq polymerase error in an early cycle or PCR priming from more than one template. 
Sequences with mixed bases were excluded from further analysis (227, 228). 
3.3.9  Tissue DNA/RNA extraction from frozen tissue 
DNA/RNA was extracted from the tissue sections that had been snap frozen in liquid nitrogen (-
196ºC) in cryogenic vials, one for each tissue section. Prior to thawing, the mass of each tissue section was 
determined and then used to estimate a volume of TriReagent (Molecular Research Center, Cincinnati, OH) 
at ratio of 100 mg/1 mL. The snap frozen sections were carefully moved on dry ice from standard cryotubes 
to SPEX SamplePrep polycarbonate cryotubes. Then, stainless steel ball bearings and hex nuts (MSC, St. 
Louis, MO) were layered over each tissue before the estimated volume of TriReagent was added. The 
tissues were homogenized using a SPEX 2010 Geno/Grinder (SPEX SamplePrep, Metuchan, NJ), with a 
single cycle of agitation at 1,600 rpms for 2 mins. Some tissues that were difficult to break down, such as 
the heart, received two cycles of agitation.  Following homogenization, the tissues were allowed to sit for 
15-20 mins in TriReagent to solubilize small tissue particles. Next, 1 mL of tissue lysate was transferred 
from each sample to 1.5 mL snap cap tube. The RNA was extracted first by adding 100 µL 
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bromochloropropane (MRC, Cincinnati, OH) to each sample, vortexing for 30 seconds, and then spinning 
at 14,000 x g for 15 mins at 4ºC. After centrifugation, the upper aqueous phase was removed and transferred 
to a tube with 12 µL of 20 mg/mL glycogen (Sigma-Aldrich) before being mixed with 500 µL isopropanol. 
The solution was then spun at 21,000 g for 10 mins at room temperature (RT), the supernatant was removed, 
and the pellet was washed with 600-800 µL 70% ethanol. Each pellet was allowed to sit under ethanol for 
3 days at -20ºC before being dried and either immediately resuspended or stored at -80ºC for future use. 
The same protocol was repeated for DNA, except with 500 µL DNA Back Extraction solution (4 M GuSCN, 
1 M Tris base, 50 mM sodium citrate) instead of BCP. 
3.3.10  Total viral load quantification in tissues 
Tissue viral loads were quantified by qPCR based on a 180-bp segment located in the gag region 
(88, 91, 127) and the TaqMan® Gene Expression Master Mix (PE Applied Biosystems). Primers and probes 
(46, 88) were synthesized by Integrated DNA Technologies (Coralville, IA). All qPCRs were run in 
duplicate and negative controls for the RT-PCR and qPCR were included on each plate. The RT-PCRs were 
performed in a Gene Amp PCR System 9700 thermocycler (Applied Biosystems). The qPCRs were run on 
7900HT Fast Real Time System (Applied Biosystems), as described (88). 
qPCR was performed using TaqMan® Gene Expression Master Mix (PE Applied Biosystems). The 
set of primers and probe mapping the gag sequence was synthesized, as follows: SIV-gag-standard-F (5′-
ATA GCA GGG ACC ACT AGC ACA AT-3′), SIV-gag-standard-R (5′-TCT TTG AAT GGT TCC TTG 
GGT CC-3′), and fluorogenic SIV-gag-standard-Probe (5-ATA GCA GGG/ZEN/ACC ACT AGC ACA 
ATA C-3′). 
Absolute vRNA and viral DNA (vDNA) copy numbers were calculated relative to amplification of 
an SIVsab standard, which was subjected to RT-PCR in parallel with the samples being tested. The standard 
was generated as described (88). To quantify the number of vRNA/vDNA copies per million somatic cells, 
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3.3.11  RNAScope in situ hybridization for SIVsab 
To visualize early virus replication, RNAscope® in situ hybridization (Advanced Cell Diagnostics, 
Newark, CA) was performed to detect SIVsab mRNA transcripts in FFPE tissues using the 2.0 HD RED 
reagent kit (Advanced Cell Diagnostics) following the manufacturer’s instructions (229).  Mmu-PPIB 
(Advanced Cell Diagnostics and DapB (Advanced Cell Diagnostics) were used as positive and negative 
controls, respectively. Briefly, FFPE sections were baked and deparaffinized. Tissue-specific pretreatment 
was performed according to the manufacturer’s instructions for each tissue type, followed by multiple 
hybridization steps at 40ºC. The slides were finally counterstained using Gil’s Hematoxylin to visualize 
nuclei. The slides were then imaged at 200X magnification with an Olympus FV10i confocal microscope 
(Olympus, Central Valley, PA). 
3.3.12  Fluorescent in situ hybridization (FISH) 
To establish the identity of the SIVsab target cells, fluorescent in situ hybridization (FISH) was 
performed as previously described (230). In brief, 5-µm tissue sections were mounted on Superfrost Plus 
Microscope Slides (Fisher Scientific), heated at 60°C for 1 h, deparaffinized, and then rehydrated. Heat-
induced epitope retrieval was performed by placing slides in in 10 mM Citrate (pH 6.0) containing 0.05% 
Tween-20 or Pretreatment-2 buffer (Advanced Cell Diagnostics) at 100°C for 5 mins followed by 
immediate immersion into molecular biology-grade H2O at RT. The slides were then incubated for 5 mins  
at 37°C in a Tris-buffered solution containing 2 mM CaCI2 and proteinase K (1.25 µg/mL), then washed 
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in molecular biology-grade H2O, then acetylated (0.25% acetic anhydride) for 20 mins and placed in 0.1 
M triethanolamine (pH 8.0) until hybridization. The slides were then covered with hybridization solution 
(50% deionized formamide, 10% dextran sulfate, 0.6 M NaCI, 0.4 mg/mL yeast RNA (Ambion Inc, 
Austin, TX), and 1X Denhardt medium in 20 mM HEPES buffer (pH 7.2, with 1 mM EDTA) containing 
100-400 ng/mL pooled SIV riboprobes and hybridized for 18 hrs at 48°C. After hybridization, slides were 
rinsed with 5X SSC (1X SSC = 0.15 M NaCL+0.015 M Sodium Citrate) at 42°C for 20 mins , 2X SSC in 
50% formamide at 50°C for 20 mins , and 1X RNA wash buffer (0.1M TRIS-HCL PH 7.5, 0.4M NaCL, 
0.05M EDTA PH 8.6) at 37°C with ribonuclease A (25 µg/ml) and T1 (25 U/ml) for 30 mins . After 
rinsing with RNA wash buffer, 2X SSC, and 0.1X SSC at 37°C for 15 mins each, sections were 
transferred to 1X Tris-buffered saline (TBS), (Boston BioProducts, Ashland, MA) containing 0.05% 
Tween-20. Tissues were blocked in TBS with Tween-20 containing 2% donkey serum for 1 hour at RT, 
then incubated with antibodies specific to the markers of interest in TBS-Tween-20 containing 2% 
donkey serum overnight at 4°C. Slides were then rinsed in TBS-Tween-20, incubated with donkey anti-
goat Alexa594, donkey anti-mouse Alexa488, and donkey anti-rabbit Alexa647 (Invitrogen, Carlsbad, 
CA) for 1 hour at RT in the dark and then rinsed with TBS-Tween-20. Slides were incubated with 0.1% 
Sudan Black B in 70% ethanol (ENG Scientific, Clifton, NJ) and 1X TBS for 30 mins at RT to quench 
autofluorescence then incubated with 300 nM DAPI for 10 mins. Slides were rinsed, mounted with 
Prolong® Gold (Invitrogen) and imaged on an Olympus FV10i confocal microscope (Olympus) (230). 
All images were captured at 600X magnification using a 60X phase contrast oil-immersion objective and 
by imaging using sequential mode to separately capture the fluorescence from the different 
fluorochromes. 
3.3.13  Flow cytometry 
Cells were stained for flow cytometry as described (46, 193). Briefly, whole blood was lysed using 
fluorescence-activated cell sorter (FACS) lysing solution (BD Biosciences, San Jose, CA). Lysed blood 
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and isolated immune cells from LNs and intestine were incubated at 4C for 30 mins with monoclonal 
antibodies (mAbs). Cells were then washed with phosphate-buffered saline (1X PBS) and fixed with a BD 
stabilizing fixative (BD Bioscience). For intracellular stains, after the surface stain was completed, the 
lymphocytes were fixed with a 4% paraformaldehyde solution for 20 mins. Cells were then washed with 
1X PBS, followed by a wash with 0.1% saponin solution and another mAb incubation. Cells were next 
washed with 0.1% saponin solution and fixed with a BD stabilizing fixative. The absolute counts of 
peripheral blood lymphocytes were determined by using Trucount tubes (BD Bioscience) (225, 231). Blood 
CD45+ cells were quantified using 50 µL whole blood stained with antibodies in the TruCount tubes that 
contained a predefined number of fluorescent beads to provide internal calibration. The CD4+ and CD8+ T-
cell counts were then calculated using the ratio of CD4+ and CD8+ T cells to CD45+ cells in the whole blood 
at the same time point. 
Immunophenotyping of the immune cells isolated from blood, LNs, and intestine was performed 
using fluorescently conjugated mAbs (Appendix A), chosen to characterize a wide range of immune cell 
types and markers of activation, proliferation, apoptosis and cellular homing. Live/Dead stains were 
included only for the innate cell panels (natural killer cells, macrophages, and DCs). For the adaptive cell 
type panels, dead cells were omitted by gating first for singlets. An example of a gating strategy for primary 
T-cell populations (CD3+ CD4+, CD8+) and T-cell subsets (effector memory, central memory, naïve) is 
shown in Appendix B. Data were acquired on an LSR-II flow cytometer (Becton Dickinson, Franklin Lakes, 
NJ) and analyzed using the Flowjo software version 10.1r5 (Tree Star Inc, Ashland, OR).  
3.3.14  Statistical analysis of data 
To compare changes in the immune cell populations between preinfection and postinfection time 
points from the same AGMs, we used the nonparametric two-tailed Wilcoxon matched-pairs signed ranks 
test, with a p0.05. For comparisons between the flow cytometry results from the control and infected 
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AGMs, we used the unpaired nonparametric Kruskal-Wallis test, followed by a Dunn’s multiple means 
comparison test to correct for multiple comparisons. The family-wise significance and confidence levels 
were set at 0.05. All tests were performed using the Graphpad Prism 7 Software (Graphpad Software Inc, 
La Jolla, CA). 
3.4 Experimental results 
3.4.1  Intrarectal SIVsab transmission is characterized by rapid establishment of plasma viremia 
Viral load testing by RT-PCR and conventional qPCR showed that viremia was established towards 
the end of the ramp-up period, at 6 dpi. The ramp-up viral loads ranged between 103 and 104 (geometric 
mean [GM] 1.25 x 104) vRNA copies/mL plasma. Virus remained below the detectable limits of standard 
qPCR earlier during the ramp-up period, at 4-5 dpi. Following ramp-up, plasma viremia increased sharply 
by the peak of viral replication, with plasma viral loads rising to 105-107 (GM 2.01 x 106) vRNA copies/mL 
plasma. These elevated plasma viral loads were maintained for the entirety of the peak period, with similar 
levels of virus at both 9 dpi and 12 dpi. Entering the early chronic stage of infection, set-point viral loads 
were established at 104-105 (GM 3.62 x 104) vRNA copies/mL plasma. Note that the animals in the set-
point group had additional blood draws at the peak of viral replication. These additional samples were also 
tested and were found to be within the same range as the peak group animals, as shown in Figure 2. 
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Figure 2: Plasma viral loads in African green monkeys (AGMs) intrarectally-infected with SIVsab90218. 
The plasma viral loads are shown as log10 values. Each animal is represented by symbol with a unique color and shape 
combination, as shown in the key to the right. Blood from chronically infected animals were sampled once at acute 
infection and once during early chronic infection, as indicated by the appearance of the symbols for those animals 
twice.  Limits of detection for conventional and single copy assays are shown by dotted lines. The colors represent the 
different stages of infection as defined by viral replication status: preramp (green), ramp-up (blue), peak (red) and set-
point (yellow). The bars represent the geometric mean and geometric standard deviation of each group. Animals that 
were negative for viremia are plotted directly on the x-axis. 
 
 
The conventional qPCR employed for measuring plasma viremia has a detection limit of 30 vRNA 
copies/mL; therefore, the samples that had tested negative by qPCR (1-5 dpi) were tested with SIV-adapted 
SCA, which has a theoretical limit of 1 copy/mL (226). By SCA, the ramp-up animals were found to have 
viral loads within the range of 100-101 (GM 1.01 x 101) vRNA copies/mL plasma (Figure 2). Most of the 
preamp animals tested negative, even by when tested with SCA. However, two animals did exhibit 
detectable viremia: AGM122 (3 dpi) and AGM124 (2 dpi). For these animals, AGM122 had a viral load of 
5.75 x 10-1 viral RNA copies/mL plasma and AGM124 had a viral load of 1.12 x 10-1 viral RNA copies/mL 
plasma (Figure 2). While these values technically fall below the theoretical limit of detection for SCA, the 
 44 
plasma taken from those animals was retested by SCA two more times and returned positive results both 
times, so the data was considered potentially valid. 
3.4.2  CSF viral loads mirror the plasma viral loads 
We next monitored the viral loads in the CSF samples collected at the time of necropsy. CSF was 
processed in the same manner as plasma using the same methodology (see 3.3.4). By conventional qPCR, 
we detected virus in several of the ramp-up group animals: AGM125 (4 dpi) at 4.62 x 102 vRNA copies/mL 
and AGM136 (5 dpi) at 4.71E x 102 vRNA copies/mL, as shown in Figure 3. 
 
 
Figure 3: Cerebrospinal fluid (CSF) SIVsab90218 viral loads in African green monkeys (AGMs) during acute 
and early chornic infection. 
The CSF viral loads are shown as log10 values. Each animal is represented by a unique color/shape combination 
(shown on the right). The limit of detection for conventional qPCR (30 viral RNA copies/mL plasma) is indicated 
by a dotted line. The colors represent the different stages of infection as defined by viral replication status: 
preramp (green), ramp-up (blue), peak (red) and set-point (yellow). The bars represent the geometric mean and 
geometric standard deviation of each group. Animals that were negative for viremia are plotted directly on the x-
axis. 
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However, no virus was detected in any other animals during the ramp-up period of viral replication. 
Unlike in the plasma, peak CSF viral loads varied significantly from 9 dpi and 12 dpi. The animals sacrificed 
at 9 dpi exhibited viral loads from 104-105 (GM 6.41 x 104) vRNA copies/mL, while the 12 dpi viral loads 
ranging from 105-106 (GM 8.37 x 106) vRNA copies/mL (Figure 3). CSF viral loads dropped sharply by 
establishment of set-point replication, averaging just 103-104 (GM 8.37 x 103) vRNA copies/mL. It should 
be noted that the volume of CSF obtained was not great enough to facilitate SCA, so testing was limited to 
conventional qPCR. 
3.4.3  SIVsab rapidly disseminates systemically from the site of inoculation 
Following extraction and purification of total DNA/RNA from the tissues, vRNA and vDNA was 
quantified via qPCR utilizing primers specific for SIVsab gag and RM CCR5. The first round of tissue viral 
load testing focused on tissues from the site of inoculation, including: rectum, distal colon, and regional 
lymph nodes (LNs). By examining these tissues, several of the sections that were collected were identified 
as potential foci of early viral replication. All of these sections came from AGMs in the preramp-up group 
(1-3 dpi). Both vRNA and vDNA were measurable in tissues from this group, though the vRNA was 
somewhat more readily detectable (15 vRNA+ tissues from 1-3 dpi animals + versus 9 vDNA+ tissues from 




Figure 4: Total viral RNA in tissues of SIVsab-infected African green monkeys (AGMs). 
The total viral RNA (i.e, replicative and nonreplicative genomes, cell-associated and cell-free genomes) from 
each of the 38 tissues tested are shown, with dotted lines delineating each individual tissue. Viral RNA loads are 
shown on a logarithmic scale and represent the total number of virus RNA genome copies per 106 somatic cells. The 
names of the tissues are listed below the x-axis. The data are shown as box-whisker plots displaying the median, 1st 
and 3rd quartiles and the min/max outliers. The colors represent the different stages of infection as defined by viral 
replication status: preramp (green), ramp-up (blue), peak (red) and set-point (yellow). For the rectum and distal colon, 
S1-S6 indicates from which strip of tissue the section was taken. 
 
Figure 5: Total viral DNA in tissues of SIVsab-infected African green monkeys (AGMs).  
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The total viral DNA (i.e., replicative and nonreplicative genomes, cell-associated and cell-free genomes) 
from each of the 38 tissues tested are shown, with dotted lines delineating each individual tissue. Viral DNA loads are 
shown on a logarithmic scale and represent the total number of virus DNA genome copies per 106 somatic cells. The 
names of the tissues are listed below the x-axis. The data are shown as box-whisker plots displaying the median, 1st 
and 3rd quartiles and the min/max outliers. The colors represent the different stages of infection as defined by viral 
replication status: preramp (green), ramp-up (blue), peak (red) and set-point (yellow). For the rectum and distal colon, 
S1-S6 indicates from which strip of tissue the section was taken.   
 
 
Some of the preramp-up animals had multiple sections containing either vRNA or vDNA (AGM25, 
AGM13, AGM124, AGM122), while others only had one (AGM126). Very early vRNA was additionally 
detected in the draining (colonic) LN, the duodenum, and the PBMCs, while very early vDNA was found 
solely at the site of inoculation. Taken as a whole, the viral loads for the tissues from the preramp-up animals 
were low, ranging from 100-101 (GM: 2.31 x 101) vRNA copies/106 somatic cells and only 100 (GM: 4.49 
x 100) vDNA copies/106 somatic cells.  
After the preramp-up period, of the 38 tissue types tested, 37 had detectable levels of vRNA and 
36 had detectable levels of vDNA by the ramp-up period (4-6 dpi); even immunoprivileged sites like the 
testes and the brain tested positive for both vRNA and vDNA, though they had the lowest viral loads on 
average. The viral loads were highly variable between tissues, ranging from between 10-1-105 vRNA 
copies/106 somatic cells and 10-1-104 vDNA copies/106 somatic cells. The viral loads at the peak of virus 
replication, which varied widely amongst the tissues tested, reached from 100-107 vRNA copies/106 somatic 
cells and 100-104 vDNA copies/106 somatic cells. The early chronic stage of infection (i.e., set-point) also 
was higher than the ramp-up period, but still lower than the peak on average. At the set-point of SIVsab 
replication the viral loads alternated between 100-106 vRNA copies/106 somatic cells and 100-104 vDNA 
copies/106 somatic cells (Figures 4 & 5). 
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3.4.4  Viral RNA is observable in the mucosa and the lymphoid aggregates in the rectum and distal 
colon immediately following inoculation 
To support the presence of vRNA in the mucosa of rectum and distal colon and the draining LNs, 




Figure 6: RNAscope for SIVsab RNA at the site of inoculation and in the draining lymphatics. 
RNAscope was performed on multiple sections of the rectum and the distal colon, which represent the site of 
inoculation. Only images from the distal colon are shown for consistency. Viral RNA was stained red, with the 
surrounding tissue counterstained purple. Each column represents a different tissue type and each row represents a 
different time group. The following abbreviations were used: (i) LP, lamina propria; (ii) LA, lymphoid aggregate; (iii) 
TCZ, T-cell zone; (iv) BCF, B cell follicle. All images were captured at 200X magnification with a Olympus FV10i 
confocal microscope. The time groups are shown on the left side of the figure, reflecting the status of viral replication, 
with: preramp (1-3 dpi), ramp-up (4-6 dpi), peak (9-12 dpi) and set-point (42 dpi).  
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In several of the AGMs from the preramp-up group (1-3 dpi), virus was observed in lamina propria 
of the distal colon, along with the colonic lymphoid aggregates. Virus was also found in the colonic LN 
from these animals. However, vRNA overall was extremely rare at these time points. Virus was found less 
frequently in lamina propria and lymphoid aggregates of the colon and more commonly in both the colonic 
and iliac LN. Within these draining lymphatics, the virus was localized mostly to the T-cell zones, but also 
found occasionally within the B cell follicles (Figure 6).  
These rare occurrences of virus are in contrast to the amount of virus found throughout the site of 
inoculation and the draining lymphatics later during infection. At the peak of viral replication, SIVsab was 
frequently found in both the lamina propria and lymphoid aggregates of the colon. There was additionally 
extensive virus replication in the LNs in the T-cell zones, with extensive trapping of the virus by follicular 
DCs. Again, virus also present in B cell follicles, though much more frequently than during the early stages 
of infection. (Figure 6).  
Later, by the establishment of set-point viral replication, viral presence has declined to levels 
similar to early infection. Virus was detected occasionally in the lamina propria, but only rarely in the 
lymphoid aggregates. In the draining LNs, the majority of virus was trapped by follicular DCs, with little 
to no vRNA signal in the T-cell zones and B cell follicles (Figure 6). Overall, the presence of SIVsab 
detected by RNAscope follows the trend in both the plasma and the tissue of the SIV-infected AGMs.  
3.4.5  Multiple transmitted/founder viruses established infection in each animal, though a mucosal 
bottleneck still occurred 
Using SGA, we evaluated the total number of transmitted/founder viral variants that established 
infection in each of the animals that for which viremia was confirmed by conventional qPCR, starting at 6 
dpi and extending through the peak and set-point periods. Each animal in these time groups was infected 
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with multiple transmitted/founder variants, with the total number of transmitted/founder viruses per AGM 
ranging from 3-10, as shown in Figure 7.  
 
 
Figure 7: Single genome amplification of SIVsab transmitted/founder (T/F) viruses. 
The totality of T/F viruses from the animals listed on the left are shown as a circular phylogenetic tree. The color of 
the variant name corresponds to the color of the animal name, with the total number of T/F variants per animal listed 
to the right of the name. Viruses indicated by the red arrows represent the viral species found in the original inoculum 
used to infect the animals. The set-point animals (AGM129-AGM132) represent viral diversity from blood draws at 
12 dpi. All sequences were aligned using MUSCLE Alignment implemented in Geneious 
(https://www.geneious.com/) and then manually inspected and optimized. Phylogenetic trees were based on nucleotide 
sequences and constructed using the neighbor-joining method with Tamura-Nei distance model. 
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Phylogenetic analysis of transmitted/founder viruses from all the animals tested show that the 
variants lack any clear pattern of relationship to each other. There also appears to be no correlation between 
the diversity of the transmitted/founder viruses when compared to viruses in the original inoculum (Figure 
7, red arrows).  
3.4.6  SIVsab target cells at the site of inoculation are of the CD3+ lineage and not of the myeloid 
lineage 
It has been well-established that the primary target cell of both HIV and SIV are CCR5+ CD4+ T 
cells (7, 38, 109, 111, 113, 114). However, there has been some research to suggest that there might be 
alternative target cells for SIV, including macrophages, particularly in the case of SIVsab, where 
macrophages in the CNS of AGMs had previously been shown to support viral replication without disease 
progression (124). Furthermore, SIVsab is dual-tropic for both CCR5 and CXCR4, as well as the alternative 
coreceptor CXCR6 (see 1.4.2) (6, 11, 138). To establish the identity of the initial founder population of 
target cells at the site of inoculation, rectum and colon section were tested with FISH specific for SIVsab 
vRNA, CD3+ T cells and myeloid lineage cells (CD68neg CD163+ HAM56+) in all the AGMs, as shown in 




Figure 8: Fluorescent in situ hybridization (FIS) for SIVsab RNA, T cells and myeloid lineage cells. 
FISH was used to identify with which cells the SIVsab RNA genomes colocalize. Viral RNA copies are shown in red, 
CD3+ T cells are shown in blue and myeloid lineage cells (CD68+ CD163+) are shown in green. The tissue type and 
day post infection are shown in white in the lower righthand corner of each image. All images were captured at 600X 
magnification with an Olympus FV10i confocal microscope using a 60X phase contrast oil-immersion objective and 
by imaging using sequential mode to separately capture the fluorescence from the different fluorochromes. 
 
 
FISH showed that vRNA colocalized with CD3+ T cells, but not with any myeloid lineage cells, in 
all the tissues tested. Moreover, SIVsab vRNA was once again found in both the rectum and distal colon as 
early as 2 dpi, with virus in lamina propria and the lymphoid aggregates. Even later during the ramp-up and 
peak periods of viral replication, vRNA consistently colocalized only with T cells, strongly indicating the 
earliest target cells of SIVsab following intrarectal inoculation are T cells resident to lamina propria of the 
rectum and distal colon. It should be noted that that images were not quantified, and these results are 
representative of the general trends observed in the tissues.  
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3.4.7  CD4+ and CCR5+ CD4+ T-cell populations are not significantly altered at the site of 
inoculation 
Having established that the primary target cells at the site of inoculation are T cells, the populations 
of CD4+ T cells isolated at the time of necropsy from rectum were analyzed with flow cytometry to measure 
any changes in cell populations in response to infection, especially any depletion of CD4+ T cells. Here, the 
overall number of CD4+ T cells (Figure 9A) showed a decline from baseline levels over the course of 
infection, though this decline lacked significance. In contrast, the number of CCR5+ CD4+ T cells (Figure 




Figure 9: CD4+ T-cell populations and subsets at the site of inoculation in SIVsab-infected AGMs. 
Percent populations of total CD4+ T cells (A), CCR5+ CD4+ T cells (B), CD4+ central memory (CD28+ CD95+ CCR7+) 
(C), effector memory (CD28- CD95+ CCR7-) (D), and naïve cells (CD28+ CD95- CCR7+) (E) in the rectum and colonic 
LN. The data are shown as box-whisker plots displaying the median, 1st and 3rd quartiles and the min/max outliers, 
with individual points representing each animal. The five groups are based on the days postinfection, with: BL 
(baseline, preinfection), PRU (preramp, 1-3 dpi), RU (ramp-up, 4-6 dpi), PEAK (peak, 9-12dpi) and SP (set-point, 
46-55 dpi). The colors represent the different stages of infection as defined by viral replication status: baseline 
(orange), preramp (green), ramp-up (blue), peak (red) and set-point (yellow). Asterisks indicates statistical 
significance when compared to baseline values, with *=p<0.05. 
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In the colonic LN, which is the closest LN to the site of inoculation, the trend was the opposite. 
Here, the overall CD4+ populations remained relatively unchanged over the course of infection. By 
comparison, the relative number of CCR5+ CD4+ T cells appeared to decrease somewhat by the peak of 
infection, though this decrease was also not significant (Figure 9B). 
The populations of the various subsets of CD4+ T cells (effector memory, central memory, and 
naïve) also were not significantly changed at the site of inoculation or in the colonic LN (Figure 9C-E).  
3.4.8  CD8+ T-cell populations are not significantly altered at the site of inoculation 
In general, the relative number of CD8+ T cells were generally stable over the entire course of the 
infection in the colonic LN and rectum. The overall CD8+ T-cell population and the memory subsets in the 
rectum did exhibit a tendency to decrease during the ramp-up period (4-6 dpi) and increase by the 
establishment of set-point viral replication (46-55 dpi), but these trends were not significant (Figure 10A-
D). There were no trends or significant changes in the colonic LN in the general CD8+ T-cell population or 




Figure 10: CD8+ T-cell populations and subsets at the site of inoculation in SIVsab-infected AGMs. 
Percent populations of general CD8+ T cells (A), CD8+ central memory (CD28+ CD95+ CCR7+) (B), effector memory 
(CD28- CD95+ CCR7-) (C), and naïve cells (CD28+ CD95- CCR7+) (D) in the rectum and colonic LN. The data are 
shown as box-whisker plots displaying the median, 1st and 3rd quartiles and the min/max outliers, with individual 
points representing each animal. The five groups are based on the days postinfection, with: BL (baseline, preinfection), 
PRU (preramp, 1-3 dpi), RU (ramp-up, 4-6 dpi), PEAK (peak, 9-12dpi) and SP (set-point, 46-55 dpi). The colors 
represent the different stages of infection as defined by viral replication status: baseline (orange), preramp (green), 
ramp-up (blue), peak (red) and set-point (yellow). Asterisks indicates statistical significance when compared to 
baseline values, with *=p<0.05. 
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3.4.9  CD20+ cell populations decrease in the rectum, but the innate immune cell types are not 
significantly altered in response to infection 
At the site of inoculation, the levels of CD20+ B cells declined steadily over the course of infection, 
becoming significantly (p=0.0435) decreased from baseline levels by early chronic infection (Figure 11A). 
This is in contrast to the populations of CD20+ B cells in the colonic LN, which were not significantly 
altered, even by establishment of set-point viral replication, when a humoral response would have already 




Figure 11: CD20+ B cells and innate immune cell populations at the stie of inoculation in SIVsab-infected 
AGMs. 
Percent populations of general CD20+ B cells (A), myeloid dendritic cells (HLADR+ CD11c+ CD123- Lineageneg 
[CD3- CD20- CD14-]), (B), plasmacytoid dendritic cells (HLADR+ CD11c- CD123+ Lineageneg [CD3- CD20- CD14-
]), (C), and natural killer cells (D) in the rectum and colonic LN. The data are shown as box-whisker plots displaying 
the median, 1st and 3rd quartiles and the min/max outliers, with individual points representing each animal. The five 
groups are based on the days postinfection, with: BL (baseline, preinfection), PRU (preramp, 1-3 dpi), RU (ramp-up, 
4-6 dpi), PEAK (peak, 9-12dpi) and SP (set-point, 46-55 dpi). The colors represent the different stages of infection as 
defined by viral replication status: baseline (orange), preramp (green), ramp-up (blue), peak (red) and set-point 
(yellow). Asterisks indicates statistical significance when compared to baseline values, with *=p<0.05. 
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The populations of myeloid dendritic cells (mDCs) and plasmacytoid dendritic cells (pDCs), which 
are lineage negative (CD3-CD20-CD14-), HLADR+ cells, remained unchanged throughout the course of 
acute infection in both the colonic LN, and the rectum (Figure 11B & C). There were also no significant 
alterations in the levels of monocyte/macrophage and NK cells in the rectum or colonic LN (Figure 11C & 
D). Unfortunately, our analysis of these populations was limited by the availability of cells from some of 
the animals, which precluded staining for DCs, monocytes/macrophages and natural killer (NK) cells. It 
should be noted that this includes the entire set-point group (46-55 dpi), which are therefore absent from 
the analysis for the rectum. The reason for this discrepancy was that the staining for the T-cell and CD20+ 
cell populations were given priority, meaning that when there was only a small number of cells available, 
cells were aliquoted for those stains first. However, for the DC, monocytes/macrophage and NK populations 
in the colonic LN, only two of the four set-point animals were even stained at all. This was not the result of 
low cell counts, but due to a technical error with the staining; an attempt was made later to repeat the stains 
with cryogenically preserved cells from those set-point animals, but the cell viability was too low.  
3.4.10  CD4+ and CD8+ T cells are not significantly activated at the site of inoculation 
To estimate overall immune cell activation levels, three different activation markers were chosen: 
HLADR, CD38, and CD69. Examining the total CD4+ T-cell population in the rectum and colonic LN for 
expression of these markers, we found no significant alteration in the levels of CD4+ cells expressing 
HLADR and CD38 (Figure 12A) or CD69 (Figure 12B). While again there were no significant alterations, 
in the colonic LN there was a notable, though not significant, drop at the peak of infection in the level of 
CD69+ CD4+ T cells.  
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Figure 12: Immune activation of CD4+ and CD8+ T cells at the site of inoculation in SIVsab-infected African 
green monkeys (AGMs). 
The fraction of CD4+ T cells and CD8+ T cells populations of expressing HLADR+ and CD38+ (A & C), and CD69+ 
(B & D) in the rectum and colonic LN. The data are shown as box-whisker plots displaying the median, 1st and 3rd 
quartiles and the min/max outliers, with individual points representing each animal. The five groups are based on the 
days postinfection, with: BL (baseline, preinfection), PRU (preramp, 1-3 dpi), RU (ramp-up, 4-6 dpi), PEAK (peak, 
9-12dpi) and SP (set-point, 46-55 dpi). The colors represent the different stages of infection as defined by viral 
replication status: baseline (orange), preramp (green), ramp-up (blue), peak (red) and set-point (yellow). Asterisks 
indicates statistical significance when compared to baseline values, with *=p<0.05. 
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In addition to the CD4+ T cells, we also evaluated alterations in the activation and proliferation 
status of the total CD8+ T-cell population during acute SIV infection of AGMs. As with the CD4+ T-cell, 
there were no significant alteration in activation status in either the rectum or the colonic LN (Figure 12C 
& D). Once again, there was a notable, but not significant, drop in CD69 expression at the peak of infection 
in the colonic LNs. This is different than in RMs, where pathogenesis is characterized by an expansion of 
CD69+ CD8+ T cells and HALDR+ CD8+ T cells in the LNs (232). 
3.5 Discussion 
Similar to other natural hosts of SIVs, AGMs are characterized by high levels of viral replication 
which persists for the remainder of their natural lifespans (8–11), as well as frequent horizontal transmission 
between adult AGMs (58–61). While AGMs and other natural hosts have certainly evolved a number of 
adaptions to prevent disease progression (see 1.3), it is clear that they are unable to directly inhibit the 
lifecycle of SIV during transmission and infection. For this reason, we have previously studied AGMs as 
model for mucosal HIV transmission, as it approximates all the stages of transmission without progression 
to AIDS (46, 78, 88). By studying the earliest events of SIV infection in AGMs, we expected to obtain not 
only insight on how natural hosts like AGMs avert progression to AIDS, but also identify means to better 
understand the dynamics of early HIV replication during mucosal transmission. 
Characterization of the dynamics of SIVsab replication during the early stages of infection began 
with establishing the appearance of SIVsab in the plasma, after it had entered circulation. When using a 
conventional qPCR, plasma viremia first became detectable by 6 dpi, which was in agreement with previous 
studies of SIV-infected AGMs (Figure 2) (46, 78). However, by employing SCA adapted for use with 
SIVsab.sab92018 (with a limit of detection of 1 copy/mL plasma), we were able to demonstrate a very rapid 
viral spread, with detectable vRNA in the plasma from 3 out of 4 of the ramp-up animals, at 4-5 dpi (Figure 
2). To confirm these findings, the SCA was run in triplicate for each of animals. All the plasma samples 
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tested positive, documenting the virus presence in circulation. Interestingly, these results are in agreement 
with a previous study, which demonstrated replicative virus in the PBMCs of C. sabaeus as early as 4 dpi, 
though the animals in that study were inoculated intravenously (85). This study therefore shows that 
following intrarectal SIVsab transmission in AGMs, the virus is rapidly disseminated in the plasma, within 
4 dpi, the same timeframe as intravenous inoculation.  
 It should be noted that SIVsab RNA was also detected by SCA in the plasma of two of the animals 
sacrificed even earlier during infection, at 2 dpi (AGM124) and 3 dpi (AGM122) (Figure 2). However, the 
viral loads for both of these animals were at 10-1 vRNA copies/mL plasma, which falls below the technical 
limit of detection for the SCA. Also, for AGM124, the initial SCA returned only 2 out of 3 positive 
replicates. However, when the sample was retested, all 3 replicates returned positive. Even so, given the 
extremely low levels of virus, it can be assumed that this data may not be reliable and should be interpreted 
with caution. However, the possibility to detect the virus in circulation by 2 dpi would mean that viral 
replication and dissemination occur nearly simultaneously.  
 It was also found that during viral dissemination, SIVsab is able to gain access even to 
immunoprivileged sites, like the brain, as viral RNA was detectable in the CSF as early as 4-5 dpi even 
through conventional qPCR (Figure 3). While it is unusual that SIVsab was detectable in the CSF prior to 
virus in the plasma, studies of HIV have suggested that virus localized to the central nervous system may 
represent a separate, distinct population with different dynamics from the rest of the body (233). However, 
in terms of concentration, the peak and set-point levels of viral RNA present in the CSF were consistent 
with the levels found previously in both SIV infected RMs and AGMs, being about 1 log lower than plasma 
viral loads (124, 234, 235). 
 After documenting the rapid onset of plasma viremia, we next focused on assessing viral dynamics 
in tissues. In total, 38 different tissue sites were tested using qPCR of DNA and RNA extracted from snap 
frozen tissues. Invariably, both SIVsab DNA and RNA genomes were detected in all tissue sites by the 
peak of viral replication and into the early chronic stage of infection. Even during the ramp-up period of 
SIV replication at 4-6 dpi, 37 out of 38 tissues returned detectable levels of SIVsab DNA/RNA (Figures 4 
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& 5).  Considering the findings from the plasma viremia analysis, with the virus entering circulation by at 
least 4 dpi, if not earlier, this likely represents virus seeding throughout the body via the bloodstream. This 
means that following mucosal transmission, not only is viral dissemination rapid, it is also pervasive. 
However, it should be noted that one complicating factor in the survey of the tissue viral loads was 
the presence of blood within the tissue. The animals were not perfused with saline at the time of necropsy 
and no special measures were taken (i.e., washing or rinsing) to attempt to remove the blood from the tissue 
sections after collection and prior to snap freezing. This means that some unknown volume of blood, 
containing both cell-associated virus and free virus from plasma remained within the tissues and almost 
certainly contributed to the total number of viral copies measured with qPCR. 
Note that the actual volume of the contaminating blood in each sample was likely minimal, as the 
tissue samples were generally small, 1g or less. However, when examining the total viral RNA in the tissue 
(Figure 4), some highly vascularized tissues, such as the heart, spleen and stomach, exhibited among the 
highest viral loads of any tissue during the peak of viral replication. While it is possible that this was due 
to a larger volume of contaminating blood in these tissues, their viral loads during the ramp-up and set-
point of viral replication did not appear to diverge greatly from other tissues. Additionally, some other 
highly vascular tissues, like the kidney, liver and lung, had relatively low or average viral loads. It is 
therefore unclear how much contaminating virus was actually quantified. Furthermore, since every tissue 
surveyed contained at least some blood, the amount of additional virus should have been somewhat 
homogenously distributed across the samples. 
Apart from the systemic spread of the virus, we also sought to characterize the very earliest viral 
replication directly at the site of inoculation. Immediately after transmission, after crossing the mucosal 
epithelium, the virus infects resident target cells and forms small foci. These foci have been shown before 
in pathogenic models of HIV/SIV infection (61, 210), but have never been demonstrated in AGMs. To 
identify these foci, when collecting tissues for viral load testing, we excised the rectum and distal colon 
together, before any other tissues were taken. The two segments were then sectioned into strips and divided 
further into pieces. Each piece was used for a different assay, as assigned on a rotating basis, such that no 
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two contiguous pieces would be used for the same assay (see 3.3.3). The purpose of this sampling strategy 
was to capture any of these initial foci of viral replication, when the virus is limited to a small founding 
population of target cells. In this, we were successful, as we found multiple pieces of the rectum and distal 
colon that were positive for SIVsab RNA and DNA within 1-3 days following inoculation (Figure 4 & 5). 
Such early establishment of replication suggests that the population of “founder” cells is infected almost 
immediately after the virus crosses the mucosal barrier. This is in agreement with previous studies, which 
also found that viral replication is quickly established following inoculation, both during intrarectal 
transmission and at transmission at other mucosal sites (212, 236–238). 
In addition to the rectum and distal colon, SIVsab RNA was also detectable in the lymph node 
closest to the site of inoculation, the colonic LN, as early as 3 dpi (Figure 4). The presence of the virus here 
was shown even earlier, at 2 dpi, when surveying the colonic lymph node with RNAscope (Figure 6). The 
colonic LNs being the draining lymph nodes for this region, it is not surprising that this would be first tissue 
to which the virus spreads from the site of inoculation. However, such early presence of the virus in the 
colonic lymph node also provides a possible explanation for how SIVsab is able to travel so rapidly into 
circulation. Using the RNAscope, the virus was found only within the T-cell zone, with little to no trapping 
by follicular DCs occurring until after the ramp-up period (4-6 dpi), at which point the virus had already 
moved into circulation (Figure 6). This lack of virus trapping by follicular DCs in AGMs has been 
previously reported (239), and likely enable the virus to circulate unimpeded through the lymphatics, 
gaining rapid traction to the bloodstream via the thoracic duct.  
 Another possible explanation for the speed of viral replication and dissemination following 
intrarectal inoculation of SIVsab is that the rectum provides a somewhat easier route of transmission for 
the virus (61, 212). The rectal epithelium is relatively thin, being made up of single layer of columnar cells, 
and is easily crossed compared to other mucosal sites (see 1.3.4), particularly if there are preexisting 
microabrasions or breakages. Additionally, the mucosa of the rectum and distal colon are densely 
population with lymphoid aggregates containing many CD4+ T cells, which could serve to facilitate early 
viral replication, as well as provide more immediate access to the lymphatic system. 
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However, even if the rectal mucosa is more permissive to transmission than other mucosal sites, 
such as the vagina or the oral mucosa, it was still restrictive enough to impose a severe genetic bottleneck 
on the transmitted/founder viruses. In the current study, the original inoculum, which was derived from 
plasma taken from an acutely infected AGM, was shown to contain a diverse mixture of SIVsab variants, 
including multiple transmitted-founder strains. In contrast, SGA showed that only 3-10 transmitted-founder 
viruses in each of the animals surveyed (Figure 8). This indicates that during mucosal transmission, a 
combination of mucosal epithelium barrier, limited target cell availability and immune responses worked 
to restrict the number of virus that were able to successfully establish infection, creating a genetic 
bottleneck.  
It should be noted that during the preliminary study that served as groundwork for this dissertation 
study, the genetic bottleneck was also assessed using SGA following intrarectal and intravaginal 
transmission in AGMs and only 1-2 transmitted/founder viruses were found in each animal (78); a similar 
number of viral variants were also found to establish infection in wild AGMs (52) and absolutely similar 
to the number of transmitted founder viruses reported to occur in both humans and rhesus macaques (80, 
81). Given the greater number of transmitted/founder viruses found in the AGMs in this study, it is likely 
that the concentration of SIVsab in the inoculum was high and the animals were overexposed, resulting in 
an increased number of transmitted viral variants. However, given the terminal nature of the study, the 
dosage used for the inoculum (107 vRNA copies in 1 mL diluted plasma) was established in an attempt to 
maximize successful infection, rather than minimize overexposure. Underexposing the AGMs would have 
resulted in animals being euthanized without becoming infected and a major waste. As it was, even at this 
dosage, out of the original 29 animals inoculated, only 27 became infected; the remaining two “exposed, 
uninfected” animals had to be excluded from the study. 
To further complete the characterization of SIVsab intrarectal transmission, we sought to establish 
at least the partial identity of the target cells of the virus immediately following transmission. Using FISH, 
SIVsab RNA was shown to be associated with CD3+ T cells, but not with myeloid lineage cells (CD68+ 
CD163+). This was expected, as our stock was generated from diluted plasma taken from an acutely infected 
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AGM. Thus, it contained largely transmitted-founder viruses, which were reported to exclusively infect 
lymphocytes and not myeloid cells, unlike the lineages that emerge later during infection (240, 241). 
Overall, the characterization of the early events of SIVsab replication and dissemination following 
transmission showed that, at least upon intrarectal transmission, the virus becomes systemically spread very 
rapidly. It has a quick egress from the site of inoculation, possibly moving unabated through the draining 
lymphatics into the bloodstream, where it is disseminated throughout the body. The rapidity with which 
SIVsab moves after intrarectal transmission is of particular importance to HIV research in relation to 
interventions to attempt to prevent infection. It has been previously suggested that there exists a “window 
of opportunity”, a period during the eclipse phase of viral replication in HIV which represents the best point 
at which to target the virus with a vaccine, microbicide or some other intervention to prevent infection. This 
window was thought to occur only prior to establishment of systemic infection (61, 242). Here, we show 
that SIVsab replication and dissemination takes place nearly simultaneously, with viral RNA detectable at 
the site of inoculation and in the draining lymphatics by 1-3 dpi (Figures 4, 5, & 6) and plasma viremia by 
2-4 dpi. This means that at least in the case of intrarectal transmission, the window of opportunity to prevent 
systemic infection may by very short or even nonexistent. As such, these results suggest that future research 
might focus on measures to prevent transmission altogether, rather than trying to curtail the infection after 
it might already be too late. 
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4.0 African green monkeys avoid SIV disease progression by preventing intestinal dysfunction and 
maintaining mucosal barrier integrity 
4.1 Contributors 
Data contributed to the dissertation by several collaborators is included in the following section. 
Drs. Jacob Estes and Kathleen Busman-Sahay contributed the images and the quantitative image analysis 
data for the chronically SIVmac251-infected RMs. Dr. Frederick Barrenäs contributed the RNAseq analysis 
and IPA pathway analysis for the genes linked to epithelial damage in the gut, immune cell activation and 
inflammation. Various members of the Apetrei/Pandrea labs contributed to the routine work, including 
tissue processing, immune cell isolation, flow cytometry and immunohistochemistry. For the AGMs, the 
dissertation author managed the serial necropsies and tissue sampling, analyzed the majority of the flow 
cytometry data, performed the bulk of the immunohistochemistry staining, conducted the image capturing 
and quantitative analysis, and executed the ELISA assays.  
4.2 Background 
The vast majority of the studies performed over the last two decades collectively indicate that the 
main factor behind the lack of disease progression in the natural hosts of SIVs is their ability to actively 
control chronic immune activation and inflammation (2, 38, 90, 127, 157, 243, 244), which are the main 
drivers of disease progression and mortality in HIV-infected subjects (191, 245–247). Indeed, AGMs, SMs, 
and MNDs have the ability to resolve immune activation at the transition from acute-to-chronic SIV 
infection, and this is the best correlate of the lack of disease progression in these species so far (127, 154, 
156, 157, 248). 
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One of the defining features of African NHPs in preventing chronic immune activation and 
inflammation during SIV infection is the lack of mucosal dysfunction, which allows them to avert microbial 
translocation (6, 84, 89, 191), as described in 1.4.10. In pathogenic HIV/SIV infections, microbial 
translocation occurs as a result of acute viral replication and proinflammatory  responses causing extensive 
damage to the intestinal mucosa (249). These breaches of epithelial integrity allow microbes and microbial 
byproducts to move from the intestinal lumen into the surrounding tissues and general circulation (176, 
192), inducing: (i) recruitment of target cells to the site of viral replication; (ii) exhaustion of major immune 
cell populations; and (iii) establishment of a chronic inflammatory state which persists indefinitely (191, 
192, 249–251). Collectively, these effects perpetuate the destruction of the gut mucosa, triggering further 
inflammation and T-cell immune activation, which cause even more damage, creating a vicious cycle which 
is largely self-sustaining. This cycle does not depend on viral replication, as the chronic inflammation and 
contingent immune activation persist even in individuals on long-term ART (252, 253).  
The chronic inflammation induced by microbial translocation is now widely considered to be not 
only the driving force of the progression to AIDS, but also the cause of numerous AIDS-associated 
comorbidities, including cardiovascular disease, osteoporosis, neurological disease, liver disease, kidney 
disease and cancers (191, 194, 196, 245, 254–256). Therefore, understanding the mechanisms leading to 
the control of systemic inflammation in African NHP hosts of SIV could lead to new strategies to prevent 
not only HIV disease progression, but also the development of HIV-associated comorbidities. 
 African NHPs maintain mucosal integrity throughout the chronic infection, as demonstrated by 
both the lack of microbial translocation during either acute or chronic SIV infection (12, 52, 78, 84, 89, 
149) and by cross-sectional analyses of the gut epithelium of chronically SIV-infected SMs, which failed 
to identify any mucosal lesions (250). Yet, it is unknown whether mucosal integrity observed in 
chronically SIV-infected African NHP hosts results from their singular ability to repair the injury 
inflicted to the gut during acute SIV infection, or whether natural hosts can simply prevent loss of gut 
integrity throughout infection. 
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 Our group has previously demonstrated the importance of a healthy mucosal barrier integrity in 
natural hosts of SIVs. (see 1.4.10). Through administration of dextran sulfate sodium to chronically SIV-
infected AGMs, we experimentally induced colitis that led to increased viral replication and altered key 
parameters highly predictive of HIV disease progression (195). In contrast, attempts to directly control 
microbial translocation (196) and/or inflammation (257) in chronically SIV-infected PTMs without 
reducing the preexisting mucosal damage resulted in only transient positive effects. From this, it appeared 
that preventing gut dysfunction by maintaining mucosal barrier integrity during the early SIV infection may 
be the essential element that enables natural hosts to avoid microbial translocation and disease progression. 
 In order to affirm whether natural hosts can preserve the gut mucosa, an extensive in situ analysis 
of gut integrity was performed in our AGMs, which were serially sacrificed throughout the acute and 
postacute SIV infection. The gut mucosa was assessed for multiple markers for immune activation, 
inflammation, apoptosis, disruption of the epithelium and presence of bacterial proteins. When possible, 
the same parameters were measured in immune cell subsets by flow cytometry. Plasma cytokine levels 
were tested to monitor the systemic levels of mucosal immune activation and inflammation throughout the 
follow-up. Finally, RNA transcriptomics was used to evaluate any changes in gene expression in the gut 
that might be linked to mucosal damage or microbial translocation.  
4.3 Methodology 
4.3.1  Ethics Statements 
As described in 3.3.1. 
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4.3.2  Animals and infections 
As described in 3.3.2 for the AGMs.  For the purposes for comparison to a pathogenic SIV 
infection, we included results from chronically SIVmac-infected adult male RMs sacrificed during chronic 
infection (127-410 dpi). References for the care and infection strategies used for the RMs are listed below 
in Appendix A. All data from the chronically infected RMs was provided by Dr. Jacob D. Estes to 
supplement the original data. 
4.3.3  Tissue sampling and isolation of mononuclear cells 
As described in 3.3.2 for the AGMs. The tissues from the RMs were collected and processed in a 
similar manner to the AGMs, as previously described (153, 250). For the AGMs, testing was conducted 
largely on sections taken from the transverse colon and the jejunum, as opposed to the rectum or distal 
colon, as: (i) they provided much larger, more intact sections for IHC and other assays; (ii) more cells were 
isolated from these tissues for flow cytometry, avoiding the issues described in 3.4.10; (iii) only tissues 
collected from animals sacrificed at 6> dpi or greater were used for IHC, as it was thought that any lesions 
or damage to the epithelium might be too widely distributed to detect earlier during infection it was also 
thought that lesions might occur during or after the peak of viral replication. This also represents the point 
at which the virus is readily detectable in the plasma and has become widely disseminated, reaching sites 
distant from the site of inoculation (see 3.4.1 and 3.4.3). For this reason, it was decided that by 6 dpi, viral 
replication would be homogenous throughout the gut, allowing us to employ other compartments apart from 
the rectum. Additionally, the transverse colon was chosen for testing as it is more structurally similar to the 
distal colon and the rectum than the jejunum, making for a better approximation.   
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4.3.4  Tissue DNA/RNA extraction 
As described in 3.3.9. 
4.3.5  Tissue viral loads quantification 
As described in 3.3.10. 
4.3.6  Flow cytometry 
As described in 3.3.13. 
4.3.7  Testing the levels of plasma inflammatory cytokines and chemokines 
Systemic changes in chemokines and cytokines were measured using an Invitrogen Monkey 
Cytokine Magnetic 29-Plex Panel (Invitrogen), as per the manufacturer’s instructions using a Bio-Rad Bio-
Plex Pro II Wash Station (Bio-Rad, Hercules, CA) and the Bio-Rad Bio-Plex 200 System (Bio-Rad) (194, 
257). Briefly, in a 96-well flat bottom plate, 25 µL of magnetic beads coated with antibodies specific for 
29 different cytokines and chemokines were added to each well and washed. Washing was done in a Bio-
Rad Bio-Plex Pro II Wash Station (Bio-Rad, Hercules, CA) with a magnetic baseplate to retain beads during 
the wash cycles. Next, 100 µL of negative controls and the serially diluted standard were loaded into the 
appropriate wells, followed by 100 µL of diluted AGM plasma that had been snap frozen at the time of 
necropsy into each of the test wells. The plate was then incubated in the dark at RT on an orbital plate 
shaker for 2 hours, then washed twice. Next, 100 µL diluted Biotinylated Detector Antibody was added to 
each well and the plate was returned to the shaker to incubate for 1 hour. The plate was washed twice again, 
and then 100 µL Streptavidin-RPE solution was added before incubating for 30 mins. Finally, the plate was 
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washed 3 times before the beads were resuspended in 150 µL wash solution and the plate fluorescence was 
read using a Bio-Rad Bio-Plex 200 System (Bio-Rad, Hercules, CA). 
 Plasma samples taken from both pre- and postinfection were assayed and used to calculate the total 
fold change in the plasma chemokine and cytokine levels. These fold change values were then normalized 
using a log2 transformation. The transformed data was used to generate a heatmap with the publicly 
available Morpheus software from the Broad Institute (https://software.broadinstitute.org/morpheus/). 
4.3.8  Measuring plasma levels of markers of fibrosis and gut epithelial damage 
Systemic levels of intestinal fatty acid binding protein (I-FABP) and hyaluronic acid (HA) were 
measured by conventional ELISA. I-FABP, a known marker of intestinal damage (258), was assessed using 
a Monkey I-FABP ELISA kit (MyBioSource, San Diego, CA), as described (223). HA, a prognostic marker 
of fibrosis (259), was tested using a Monkey Hyaluronic Acid ELISA Kit (MyBioSource). 
4.3.9  Immunohistochemical assessment of mucosal tissues 
We examined the overall integrity of the gut mucosal barrier with a multifaceted set of markers to 
assess inflammation in the gut (MX1), epithelial cell proliferation (Ki-67), apoptosis (caspase-3), 
epithelium continuity (claudin-3) and microbial translocation (LPS-core and Escherichia coli). IHC and 
quantitative image analysis were performed as described (246, 250, 260). Briefly, paraffin fixed tissues 
mounted on glass slides were deparaffinized by a battery of 3 x 5 min washes in xylene, then rehydrated by 
3 x 5 min washes in 100%, 95% and 75% ethanol. Next, the tissues were boiled in diluted Antigen 
Unmasking buffer (Vector Laboratories, Burlingame, CA) for 25 mins, allowed to cool to RT, then rinsed 
5 mins in 1X PBS, and incubated with 3% H2O2 for 15 mins. After 2 x 5 min washes in 1X PBS, the tissues 
were blocked with Protein Block (Dako, Santa Clara, CA) for 30 mins  at RT, incubated with primary 
antibodies (listed in Appendix A) diluted to the appropriate concentration (Dako Antibody Diluent) for at 
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least 1 hour at RT, rinsed in 1X PBS for 2 x 5 min washes and incubated with diluted Vectastain secondary 
antibody (Vector Laboratories) for another 30 mins  at RT. After 2 x 5 min washes in 1X PBS, the tissues 
were incubated for 30 mins  at RT with Vectastain ABC solution (Vector Laboratories), followed by 2 x 7 
mins washes in 1X PBS, and addition of DAB diluted in DAB substrate (Dako) to generate a positive signal, 
at which point the reaction was quenched in deionized water for 5 mins before being counterstained with 
haematoxylin. The tissues were then dehydrated with a reverse battery of ethanol and xylene (75%, 95% 
and 100%) before being coverslipped.  The tissues taken from the RMs were processed for IHC and stained 
in a similar fashion to the AGMs, as previously described (246, 250). Note that this prior study of mucosal 
integrity served as an experimental framework for the IHC stains outlined in this dissertation.  
4.3.10  Assessment of the collagen deposition in the mucosal tissues 
We assessed collagen deposition in the tissues using the Chromaview Advanced Testing Masson 
Trichrome Stain (Thermofisher) as per the manufacturer’s instructions, with some modifications. Briefly, 
tissue slides were deparaffinized as done for IHC, and then incubated overnight in Bouin’s fluid. The slides 
were then washed repeatedly in deionized water until all yellow coloration was removed. The slides were 
next immersed in Working Weigert’s Iron Haematoxylin Stain for 10 mins and then washed again in water 
for 5-10 mins. The slides were transferred into Bierich’s Scarlet-Acid Fuchsin Solution for 5 mins before 
being rinsed in water for 30 seconds and then incubated for 5 mins with Phosphotungstic-Phosphomolybdic 
Acid solution. Finally, the slides were fully immersed in Aniline Blue Stain Solution for 30 mins, washed 
2 x 2 mins with 1% acetic acid, and then rinsed for 30 seconds in deionized water. The slides were then 
dehydrated with 2 x 1 min washes in 100% ethanol, followed by 3 x 1 min washes in xylene before 
coverslipping. The collagen staining for the RMs was done in a similar fashion to the AGMs, as previously 
described (261). 
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4.3.11  Quantitative image analysis 
Images of IHC stained tissues were captured using an AxioImager M1 brightfield microscope 
equipped with an AxioCam MRc5 (Zeiss, Oberkochen, Germany) and Axiovision software v.4.7 (Zeiss). 
To evaluate the levels of immune activation, inflammation and apoptosis markers, images were quantified 
by measuring the % area of positive signal in multiple images. The quantified regions were randomly 
selected to minimize bias. In the gut, any lymphoid structures were avoided, as they display distinct immune 
cell populations compared to the lamina propria. All images were taken at either 100X or 200X 
magnification, depending on the quantification technique. After image collection, 9-12 images from the 
same animal were processed by applying the Color Deconvolution function in the FIJI image processing 
package (version 2.0) (262), splitting the image into 3 separate color channels, one of which isolated the 
DAB coloration. An intensity threshold was then manually applied to each image to select the DAB signal. 
The total percent area occupied by the signal above the threshold (i.e., DAB-positive) was measured and 
averaged for all the images from the same animal. An example of the color deconvolution quantification 
strategy is shown in Appendix B. 
Quantification of tissue collagen was accomplished in a similar fashion, but by applying a threshold 
to isolate a particular range of color within the spectrum instead of preset color. This was accomplished by 
using the Color Threshold function in FIJI to manually set the maximum and minimum range based on the 
color hue. A range was selected that isolated as much of the blue coloration of the collagen while 
minimizing selection of background color. Note that the blue stain was also partially taken up by the goblet 
cells in the mucosal epithelium of the gut, so some background signal was unavoidable. However, we feel 
that this does not create a significant error, as goblet cells were present in all images of the lamina propria, 
therefore their contribution to the background should have been similar across all images. After the hue 
selection range was set, the image was converted to black and white, removing all non-selected regions 
from the image. A standard threshold was then applied to measure the total area of the positive collagen 
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signal (now black) in the image. An example of the color threshold-based quantification strategy is shown 
in Appendix B. 
To quantify enterocyte proliferation, we measured the proportion of the villi length with Ki-67+ 
epithelial cells, as previously published (246). As epithelial proliferation is localized to the base of the 
crypts, we measured both the total length of the crypt and the length of the crypt with Ki-67+ epithelial 
cells. Any increase in epithelial cell proliferation results in an increase in the total number of Ki-67+ cells 
along the crypt. In brief, this was done by manually drawing a black line through the middle of the villi 
from the base to the luminal end, then bifurcating the line based on the position of the Ki-67+ epithelial 
cells and measuring the two segments with the FIJI Wand tool. This allowed us to quantify the fraction of 
proliferating and activated mucosal epithelial cells. An example of this strategy is shown in Appendix B. 
To quantify the proliferation of cells specific to the lamina propria, we used FIJI to manually 
exclude the epithelium from the images, allowing us to quantify the total % area of the positive signal in 
the lamina propria alone. This was accomplished by overlaying white coloration on each of the individual 
sections of the crypts containing epithelial cells. Both transverse and longitudinal crypt sections were 
excluded, but images featuring primarily transverse sections were preferentially chosen due to the more 
consistent distribution of the epithelium. After excluding the epithelium, the images were quantified using 
the standard color deconvolution technique described above. An example of the exclusion technique is 
shown in Appendix B. 
To quantify the percent of the GI tract epithelial barrier that is damaged, we took multiple 
overlapping images of the gut epithelium stained for claudin-3 and used them to create large composite 
images of the GI tract with the Image Stitching plugin (263) in the FIJI software (262, 264). Once the 
composite image was generated, we first traced the length of the intact epithelium with a green line and 
then traced any regions lacking claudin-3 staining (i.e., damaged or discontinuous epithelium) with red line. 
The lines were drawn freehand at a constant width of 10 pixels. The total lengths of the two lines were then 
measured using the FIJI Wand tool to establish the length of intact versus broken epithelium, as previously 
described (250). For each animal, 3-4 composite images were quantified to establish an average. Similar 
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methodologies were used for quantification of the IHC stains for the RMs, as previously described (250). 
All AGM quantifications were done using the open-source FIJI software, v.1.0 (262, 264). 
4.3.12  RNAseq transcriptomics for differential gene expression 
RNAseq and the subsequent bioinformatic analysis was performed as described (265). Briefly, 
rectal tissues were immediately perfused in RNAlater and stored at -80°C until further processing. Whole 
transcriptome libraries were constructed using the TruSeqStranded Total RNA with Ribo-Zero Gold 
(Illumina, San Diego, CA) as per the manufacturer’s instructions. Libraries were quality controlled and 
quantitated using the BioAnalzyer 2100 system (Kapa Biosystems, Woburn, MA) and qPCR. The resulting 
libraries were then sequenced on a HiSeq 2000 using HiSeq v3 sequencing reagents, with read number 
finishing using a Genome Analyzer IIx using GA v5 sequencing reagents, both of which generated paired 
end reads of 100 nucleotides. The libraries were clonally amplified on a cluster generation station using 
Illumina HiSeq version 3 and GA version 4 cluster generation reagents to achieve a target density of 
approximately 700,000 (700K)/mm2 in a single channel of a flow cell. Image analysis, base calling, and 
error estimation were performed using Illumina Analysis Pipeline (version 2.8).  
4.3.13  Statistical analysis 
To compare changes in the immune cell populations between preinfection and postinfection time 
points from the same AGMs, we used the nonparametric two-tailed Wilcoxon matched-pairs signed ranks 
test, with a p0.05. For comparisons between control and infected AGMs, which included both the flow 
cytometry results and the IHC quantifications, we used the unpaired nonparametric Kruskal-Wallis test, 
followed by a Dunn’s multiple means comparison test to correct for multiple comparisons between the time 
groups. A Mann-Whitney U test was used to test differences between the set-point AGMs and the 
 78 
chronically infected RMs. The family-wise significance and confidence levels were set at 0.05. All tests 
were performed using the Graphpad Prism 7 Software (Graphpad Software Inc.) 
4.4 Experimental results 
4.4.1  SIVsab replicates to high levels in the jejunum, transverse gut and axillary LN during the 
early stages of infection 
As damage to the gut is triggered initially by inflammation driven by local viral replication (see 
1.4.10), we sought to assess the timing and magnitude of the viral replication in the gut and axillary LNs. 
We extracted DNA and RNA from the whole snap frozen tissue samples and quantified the total vDNA and 
vRNA SIVsab genomes in the transverse colon, jejunum and axillary LNs, as shown in Figure 4 and Figure 
5 of 3.4.3. 
In the transverse colon and jejunum, vRNA first became detectable between 4-6 dpi, at 101-102 
(GM: 1.250.08 log vRNA copies/106 cells) and 0-3 logs (GM: 1.290.83 log vRNA copies/106 cells), 
respectively. Similarly, vDNA became detectable between 4-6 dpi, at 0-1 log (GM: 1.491.54 log vDNA 
copies/106 cells) and 0-2 logs (GM: 0.950.46 log vDNA copies/106 cells), for jejunum and colon, 
respectively. The viral loads then rose sharply reaching peak between 9-12 dpi, at 4-5 log for both jejunum 
and colon (GM: 4.611.05 log vRNA copies/106 cells and 4.660.32 log vRNA copies/106 cells, 
respectively); at the same time points, vDNA levels ranged between 3-4 log (GM: 3.450.23 log vDNA 
copies/106 cells) in the jejunum and 2-4 log (GM: 3.610.76 log vDNA copies/106 cells) in the colon. At 
the transition to chronic infection (46-55 dpi), vRNA levels ranged between 3-4 log in both jejunum and 
colon (GMs: 3.440.31 log vRNA copies/106 cells and 3.590.28 log vRNA copies/106 cells, respectively), 
with vDNA showing only a slight decrease from peak levels, to 2-4 log (GM: 2.800.43 log vDNA 
copies/106 cells) in the jejunum, and 2-3 log (GM: 2.370.10 log vDNA/106 cells) in the colon. 
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In the axillary LNs, vDNA (but not vRNA) became detectable by 4-6 dpi, at 0-2 log (GM: 
1.440.75 log vRNA copies/106 cells) for vRNA and 1-2 log (GM: 1.540.31 log vDNA copies/106 cells) 
for vDNA.). This was similar to the jejunum and the colon, but not as early as the colonic LN, which drains 
the site of inoculation. The axillary LN viral loads peaked at 9-12 dpi, at 3-5 log (GM: 4.270.82 vRNA 
copies/106 cells) for vRNA, and 2-4 log (GM: 3.500.46 log vDNA copies/106 cells) for vDNA. The set-
point viral loads at the transition to chronic infection in the axillary LNs were 3-4 log (GM: 3.850.31 log 
vRNA copies/106 cells) for vRNA and 1-2 log (GM: 2.040.29 log vDNA copies/106 cells) for vDNA. 
4.4.2  Circulating CD4+ T cells transiently decrease, but CD4+ T cells remain relatively stable in 
other tissues 
CD4+ T cells are the primary target cells for SIVs, and are massively depleted during the acute 
infection, particularly in the lamina propria of the GI tract (61, 109, 114, 149, 193) (see 1.4.5). A significant 
depletion of the peripheral blood CD4+ T cells occurred early during SIV infection in AGMs and persisted 
throughout the acute stage of infection. Thus, circulating CD4+ T cells counts were significantly decreased 
during the preramp-up period (p=0.0039), the ramp-up period (p=0.0156), and the peak of viral replication 




Figure 13: Total CD4+ and CCR5-expressing CD4+ T-cell populations in the blood, jejunum and axillary 
lymph nodes of SIVsab-infected African green monkeys (AGMs). 
Total populations of (A) CD4+ T cells; (B) CCR5+ CD4+ T cells isolated from blood, axillary LN and jejunum. The 
values for blood represent absolute cell counts, while the values in the jejunum and axillary LN represent percent 
populations. The five groups are based on the days postinfection, with: BL (baseline, preinfection), PRU (preramp, 1-
3 dpi), RU (ramp-up, 4-6 dpi), PEAK (peak, 9-12dpi) and SP (set-point, 46-55 dpi). Each group is assigned a 
corresponding color: orange (baseline), green (preramp), blue (ramp-up), red (peak) and yellow (set-point). Asterisks 
indicates statistical significance when compared to baseline values, with *=p<0.05; **=p<0.01. 
 
 
By the onset of chronic infection, CD4+ T cells were partially restored in the blood, albeit below 
the preinfection levels. 
However, this trend was not reflected in other tissues. Thus, CD4+ T cells remained stable in the 
LNs, with little to no variation at any point during infection. In the jejunum, CD4+ T cells were not 
significantly decreased from baseline and remained mostly unchanged over the course of the acute stage of 
infection. The only exception was an appreciable drop in CD4+ T cells in the jejunum by the set-point of 
viral replication, though without reaching significance (Figure 12A). This trend was very similar to the 
what was observed for CD4+ T-cell populations in the rectum (Figure 9A). 
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We also examined the levels of CCR5-expressing CD4+ T cells in blood, jejunum and axillary LNs. 
Circulating CCR5-expressing CD4+ T cells displayed a similar pattern as the total CD4+ T-cell population, 
with significant decreases during the preramp-up (p=0.0156) and peak of viral replication (p=0.0312). 
However, the levels of CCR5+ CD4+ T cells did not undergo any significant alterations in the axillary LNs 
or the jejunum (Figure 13B) at any point during the course of infection; again, this mirrors the trends seen 
in the colonic LN (Figure 9B). 
4.4.3  CD8+ T cells and CD20+ B cells transiently decreased in circulation but are largely unaltered 
in other tissues. 
In the blood, the CD8+ T cells underwent a slight decrease during preramp-up and throughout the 
acute stage of infection. CD8+ T cells then returned to preinfection levels or greater by the time of the 
chronic infection. By comparison, the levels of CD8+ T cells in the axillary LNs were largely unchanged, 
with no significant alterations baseline levels at any point during the infection. In the jejunum, CD8+ T cells 
were also relatively stable, with only a slight decrease during ramp-up and a slight increase at the set-point, 
none of these reaching significance (Figure 14A), similar to what was seen for the CD8+ T-cell populations 




Figure 14: CD8+ T-cell and CD20+ cell populations in blood, jejunum and axillary lymph nodes of SIVsab-
infected African green monkeys (AGMs). 
Total populations of (A) CD8+ T cells; and (B) CD20+ B cells isolated from blood, axillary LN and jejunum. The 
values for blood represent absolute counts, while the values in the jejunum and LN represent percent populations. The 
five groups are based on the days postinfection, with: BL (baseline, preinfection), PRU (preramp, 1-3 dpi) RU (ramp-
up, 4-6 dpi), PEAK (peak, 9-12dpi) and SP (set-point, 46-55 dpi). Each group is assigned a corresponding color: 
orange (baseline), green (preramp), blue (ramp-up), red (peak) and yellow (set-point). Asterisks indicates statistical 
significance when compared to baseline values, with *=p<0.05; **=p<0.01. 
 
 
A significant decrease (p=0.0312) in the absolute counts of peripheral blood CD20+ B cells 
occurred by the peak of viral replication followed by rapid restoration to preinfection levels or higher by 
the time of early chronic infection. Conversely, CD20+ B cells expanded in the axillary LNs by the transition 
to chronic infection, though this expansion lacked significance, similar to the colonic LN (Figure 11A) 
While widely variable, the overall CD20+ B cell population remained relatively stable throughout infection 
in the jejunum (Figure 14B), unlike in the rectum, where CD20+ B cell populations were significantly 
decreased by early chronic infection (Figure 11A).  
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4.4.4  Dendritic cells, monocytes/macrophages and natural killer cells are not significantly altered 
in the blood, axillary LN and jejunum 
Since innate immune responses are mounted very early during infection and can drive inflammation 
in tissues, we thoroughly monitored the changes in different populations of innate immune effector cells. 
Both the mDCs or pDCs were slightly increased in the blood, axillary LN or jejunum during acute SIVsab 




Figure 15: Changes in innate immune cell populations in blood, jejunum and axillary lymph nodes in SIVsab-
infected African green monkeys (AGMs). 
The flow cytometry analysis encompassed multiple immune cell subtypes, including: (A) myeloid dendritic cells; (B) 
plasmacytoid dendritic cells; (C) monocytes/macrophages (CD14+ CD163+); and (D) natural killer cells (NKG2A+). 
These cells were isolated from a variety of different tissues, including blood, jejunum and axillary LN. The five 
different time groups are based on the days postinfection, with: BL (baseline, preinfection), PRU (preramp, 1-3 dpi) 
RU (ramp-up, 4-6 dpi), PEAK (peak, 9-12dpi) and SP (set-point, 46-55 dpi). Each time group is assigned a 
corresponding color: orange (baseline), green (preramp), blue (ramp-up), red (peak) and yellow (set-point). Asterisks 
indicates statistical significance when compared to baseline values, with *=p<0.05. 
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The monocyte/macrophage populations also showed no significant changes in the axillary LNs or 
the gut (Figure 15C) yet, a significant, transient decrease in the absolute counts of circulating monocytes 
occurred at the ramp-up, with return to baseline or greater levels by set-point. Also, the average populations 
of blood monocytes decreased between baseline and ramp-up regardless of the identifying monocyte 
markers used to survey the population (CD14+, CD163+, CD14+ CD163+). Finally, the absolute NK cell 
counts decreased slightly, but significantly (p=0.0273) in circulation during preramp-up. No significant 
changes of the NK cell populations in the LNs were observed throughout course of infection. The gut NK 
cells mirrored the changes observed for circulating NK cells, with a modest preramp-up decrease, followed 
by rebound during ramp-up and another decline at the peak (Figure 15D). The lack of significant changes 
in the jejunum and axillary LN somewhat parallels the lack of alterations in the rectum and colonic LN 
(Figure 11). It should be noted that only two of the four animals euthanized at set-point (46-55 dpi) were 
stained for DCs, monocytes/macrophages, and NK cells, as described in 3.4.9, despite attempts to restain 
the missing animals later. 
4.4.5  AGMs exhibit minimal and transient T-cell and B cell immune activation and proliferation in 
the blood, axillary LN and jejunum 
One of the key features of SIV infection in the natural hosts is the control of inflammation, immune 
activation and proliferation during the transition from acute-to-chronic SIV infection (2, 6, 127, 156, 168, 
248). Therefore, using Ki-67 as a cellular proliferation marker, we monitored changes in these parameters 
for CD4+ and CD8+ T cells from blood, LNs and intestine via flow cytometry. The Ki-67+ CD4+ T-cell 
fraction showed nonsignificant minimal alterations at all these three sites (Figure 16A).  
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Figure 16: General immune activation and proliferation in blood, jejunum and axillary lymph nodes in 
SIVsab-infected African green monkeys (AGMs). 
Ki-67 expression on (A) CD4+ T cells; (B) CD8+ T cells; and (C) CD20+ B cells isolated from a variety of different 
tissues, including blood, jejunum and axillary LN. The five groups are based on the days postinfection, with: BL 
(baseline, preinfection), PRU (preramp, 1-3 dpi) RU (ramp-up, 4-6 dpi), PEAK (peak, 9-12dpi) and SP (set-point, 46-
55 dpi). Each group is assigned a corresponding color: orange (baseline), green (preramp), blue (ramp-up), red (peak) 




There was a transient drop in the frequency of the Ki-67+ CD8+ T cells in the axillary LNs during 
the preramp-up (p=0.0078) and ramp-up periods (p=0.0312), with full restoration to baseline levels by the 
peak (Figure 16B). Ki-67+ CD8+ T cells then slightly increased at the set-point in the axillary LNs and, to 
a less extent, the jejunum, but did not reach significance. 
 As pathogenic SIV infections are associated with B cell dysfunction (266), we next assessed the 
fate of CD20+ B cell populations during the earliest stages of SIVsab infection of AGMs, and found that 
Ki-67+ CD20+ B cells remained relatively unchanged during acute infection in blood, LNs or jejunum, but 
increased in LNs by the early chronic stage of infection, though this increase lacked significance. In the 
jejunum, there were no significant alterations of the CD20+ B cell activation or proliferation status, though 
some animals exhibited elevated levels by early chronic infection (Figure 16C). 
4.4.6  Transient increases of systemic inflammation occur during the acute infection 
Plasma levels of a wide variety of cytokines and chemokines measured to assess systemic 
inflammation in acutely SIVsab-infected AGMs showed increases in two-waves, at 3-4 dpi and 9-12 dpi, 
with the second wave coinciding with the peak of viral replication. As the experimental design only 
encompassed the acute and postacute infection, four chronically infected historic controls were included 
for this analysis. These AGMs were also infected intrarectally, using the same SIVsab stock at the same 
infectious dose, but were euthanized much later in infection, at 180 dpi (78). In these controls, all plasma 
cytokines and chemokines were found to be at nearly baseline levels, as shown in Figure 17.  
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Figure 17: Heatmap of cytokine fold changes from baseline following SIVsab infection. 
Colors represent the fold change from preinfection to postinfection of the cytokines for each of the AGMs. Red 
indicates a positive fold change, while blue represents a negative fold change, with color intensity being proportional 
to the magnitude of the fold change, as shown below the heatmap. Animal numbers are shown above the heatmap 
along with dpi, with the colors below the numbers highlighting their time groups: orange (baseline), green (preramp), 
blue (ramp-up), red (peak), yellow (set-point), purple (AGM historical controls, late chronic). Cytokines and 
chemokines are listed on the right side of the heatmap. The results are clustered using a Spearman correlation, with 
the dendrogram showing relationship displayed on the left. The fold changes for the cytokines and chemokine levels 
were normalized with a log2 transformation. The heatmap was generated using the publicly available Morpheus 
software (Broad Institute). 
 
 
Several soluble markers of inflammation were increased during the acute SIVsab and early chronic 
infection in AGMs [i.e., eotaxin (CCL11), IL-1RA (IL1RN), IL-8 (CXCL8), IP-10 (CXCL10), I-TAC 
(CXCL11), MCP-1 (CCL2), MIF (GIF), RANTES (CCL5)] (Figure 17). Together, these results point to a 
robust, but relatively limited and transient increase of systemic inflammation during the acute infection of 
AGMs, in agreement with previous studies on SIV natural hosts (2, 6, 127, 156, 168, 248). This is in stark 
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contrast with pathogenic HIV/SIV infections, where rampant levels of inflammation persist throughout the 
chronic stage of SIV-infection and are strong predictors of progression to AIDS and death (6, 76, 153, 247, 
267, 268). 
In addition to the systemic inflammation, we also surveyed markers of T-cell immune activation 
by measuring expression levels of CD69, HLA-DR and CD38 (114, 269).  The levels of circulating and LN 
CD69+ CD4+ T cells increased significantly either at preramp-up (axillary LN p= 0.0391) or peak (blood 
p=0.0156), but transiently, with CD69+ T cells back to baseline level by viral set-point. Conversely, no 
significant increase in CD69+ CD4+ T cells was observed in the jejunum (Figure 18A), as was also the case 




Figure 18: Immune cell activation in blood, jejunum and lymph nodes in SIVsab-infected African green 
monkeys (AGMs). 
CD69 expression on (A) CD4+ T cells; (B) CD8+ T cells; and HLA-DR+ CD38+ expression on (C) CD4+ T cells and 
(D) CD8+ T cells isolated from a variety of different tissues, including blood, jejunum and axillary LN. The five groups 
are based on the days postinfection, with: BL (baseline, preinfection), PRU (preramp, 1-3 dpi) RU (ramp-up, 4-6 dpi), 
PEAK (peak, 9-12dpi) and SP (set-point, 46-55 dpi). Each group is assigned a corresponding color: orange (baseline), 
green (preramp), blue (ramp-up), red (peak) and yellow (set-point). Asterisks indicates statistical significance when 
compared to baseline values, with *=p<0.05. 
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Furthermore, the frequency of CD4+ T cells expressing HLA-DR+ and CD38+ did not change 
significantly in any tissue at any time during acute or early chronic infection (Figure 18C), however, the 
HLA-DR+ and CD38+ expression by CD4+ T cells were extremely variable across all groups. The levels of 
CD69+ CD8+ T cells showed no significant changes in the blood, axillary LN or jejunum at any point during 
the follow-up (Figure 18B). While we did observe a significant increase in the HLA-DR+ CD38+ CD8+ T-
cell levels at the peak of infection in the axillary LNs (p= 0.0156), CD8+ T-cell activation was back to 
baseline level by the set-point of viral replication (Figure 18D). 
4.4.7  Only a transient mucosal inflammation and interferon-stimulated response occurs in AGMs 
In progressive HIV/SIV infection, mucosal inflammation and extensive cell death during the acute 
infection trigger multiple alterations to the gut integrity and microbial translocation, as well as systemic 
inflammation and immune activation, setting the stage for later disease progression (191, 196, 270, 271). 
Since significant, but only transient systemic inflammation and immune activation occur during SIVsab 
infection of AGMs, we next investigated whether gut mucosal pathologies associated with pathogenic 
HIV/SIV infections are likewise resolved in the natural hosts or prevented altogether. Using IHC, we 
directly examined expression of three markers of mucosal immune activation/inflammation: (i) Ki-67; (ii) 
MPO, a major component of azurophilic granules, a defining attribute of neutrophils (272); and (iii) MX1, 
an antiviral protein, directly linked to stimulation by type I (IFN-, IFN-) and type II (IFN-) interferons 
(248, 273, 274). We stained for these immunological markers from several of the primary sites of viral 
replication and CD4+ T-cell depletion during the early stages of SIV infection: the transverse colon, jejunum 
and superficial LNs (61, 76, 84, 89, 114). There was no significant increase in the fraction of Ki-67 
expressing cells in the lamina propria or the epithelium of the transverse colon epithelium, as shown in 




Figure 19: Immunohistochemistry (IHC) for immune activation and proliferation in SIVsab-infected African 
green monkeys (AGMs). 
DAB-based IHC for Ki-67 in the (A) transverse colon, (B) axillary LN of AGMs and chronically SIV-infected RMs. 
In all the images, positive DAB signal is shown in brown, with the remaining tissue counterstained blue. The 
representative images of the gut display longitude cuts of the villi to better show the localization of proliferating 
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epithelial cells in the crypts. Representative images of the axillary LN are taken from the T-cell area, to avoid the 
dense clustering of proliferating cells in the B cell follicles. Below are shown image quantifications (C) of proliferation 
in the gut and gut mucosa. For the colon, the ratio of the length of Ki-67 epithelial cells along the colonic crypts vs 
the total crypt length was used to estimate epithelial cell proliferation, while exclusion of the epithelium from the 
images was used to measure Ki-67 in the lamina propria alone. The quantification for each animal represents the 
average of the values from 9-12 individual image quantifications. The four different time groups are based on the days 
postinfection, with: BL (baseline, preinfection), RU (ramp-up, 4-6 dpi), PEAK (peak, 9-12dpi) and SP (set-point, 46-
55 dpi). Each time group is assigned a corresponding color based on the stage of viral replication: orange (baseline), 
blue (ramp-up), red (peak) and yellow (set-point). The chronic RMs are shown in purple. All AGM quantifications 
were performed using FIJI version 1.0. Asterisks indicate statistical significance, with **=p<0.01. All AGM images 




Conversely, in the LNs, Ki-67 expression was slightly increased at the peak and remained elevated 
into early chronic infection (Figure 19B). By comparison, during pathogenic infection in RMs, the 
expression of Ki-67 remains highly elevated throughout the chronic infection in both the lamina propria 
and the mucosal epithelium (Figure 19A) of the gut, with large numbers of proliferating cells. This 
preponderance of Ki-67 is also reflected in the LNs, where there are far more Ki-67+ cells throughout the 
T-cell zone, as demonstrated by quantitative analysis (Figures 19B & C). We also did not observe any 
significant alteration in the total number of Ki-67+ cells in the jejunum (Appendix C) 
As immune activation and inflammation is normally associated with recruitment of neutrophils, 
tissue was stained for MPO, which is a component of the azurophilic granules found in neutrophils. There 
was a statistically significant (p=0.0153), but transient increase in the frequency of MPO-positive 
neutrophils in the transverse colon during the ramp-up period (Figures 20A & C), that returned to baseline 
level by peak, with no significant changes in the number of MPO-expressing neutrophils in any of the other 




Figure 20: Immunohistochemistry (IHC) for neutrophil infiltration and activation in SIVsab-infected African 
green monkeys (AGMs). 
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DAB-based IHC for MPO in the (A) transverse colon, and (B) axillary LN of AGMs and chronically SIV-
infected RMs. In all the images, positive DAB signal is shown in brown, with the remaining tissue counterstained 
blue. The representative images of the gut display lateral cuts of the crypts to demonstrate the presence of neutrophils 
in the surrounding lamina propria. Below are shown image quantifications (C) of the percent area of the total positive 
DAB signal. The quantification for each animal represents the average of the values from 9-12 individual image 
quantifications. The four different time groups are based on the days postinfection, with: BL (baseline, preinfection), 
RU (ramp-up, 4-6 dpi), PEAK (peak, 9-12 dpi) and SP (set-point, 46-55 dpi). Each time group is assigned a 
corresponding color based on the stage of viral replication: orange (baseline), blue (ramp-up), red (peak) and yellow 
(set-point). The chronic RMs are shown in purple. All AGM quantifications were performed using FIJI version 1.0. 
Asterisks indicate statistical significance, with *=p<0.05 and ***=p<0.001. All AGM images were captured at 200X 
magnification using an AxioImager M1 bright-field microscope equipped with an AxioCam MRc5. 
 
 
Interestingly, uninfected AGMs already had a significantly larger number of MPO-positive 
neutrophils present in the gut at the baseline, especially compared to normal SIV-infected RMs, which have 
only rare MPO-positive neutrophils present in the lamina propria (195). Indeed, the overall levels of MPO-
positive neutrophils present in the colon of AGMs preinfection are not dissimilar to those found in RMs 
during the chronic stage of infection, though in the LNs AGMs have significantly less neutrophils than RMs 
by the transition to chronic infection (Figures 20A & C). We also did not observe any significant change in 
the number of MPO+ cells in the jejunum (Appendix C) 
Conversely, any changes in MX1 were only transient, with expression increasing sharply at the 
peak and a full return to baseline level at the transition to chronic SIV infection, as seen in Figures 21A-C 




Figure 21: Immunohistochemistry (IHC) to inteferon-based responses to infection in SIVsab-infected African 
green monkeys (AGMs). 
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DAB-based IHC for MX1 in the (A) transverse colon, and (B) axillary LN of AGMs and chronically SIV-infected 
RMs. In all the images, positive DAB signal is shown in brown, with the remaining tissue counterstained blue. Below 
are shown quantifications (C) of the percent area of the total positive DAB signal. The quantification for each animal 
represents the average of the values from 9-12 individual image quantifications. The crypts were included in the 
quantification and the crypt enterocytes may have contributed to the overall % area of positive. The four time groups 
are based on the days postinfection, with: BL (baseline, preinfection), RU (ramp-up, 4-6 dpi), PEAK (peak, 9-12dpi) 
and SP (set-point, 46-55 dpi). Each time group is assigned a corresponding color based on the stage of viral replication: 
orange (baseline), blue (ramp-up), red (peak) and yellow (set-point). The chronic RMs are shown in purple.  All AGM 
quantifications were performed using FIJI version 1.0. Asterisks indicate statistical significance, with *=p<0.05 and 
**=p<0.01. All AGM images were captured at 200X magnification using an AxioImager M1 bright-field microscope 
equipped with an AxioCam MRc5.  
 
 
Notably, the MX1 expression during peak infection in AGMs is in the same range as during chronic 
pathogenic SIV infection in RMs in both the gut and LNs (Figures 21A-C). However, as MX1 expression 
is nearly absent by the set-point of infection, this likely reflects the fact that while there is an initial antiviral 
response, it is rapidly resolved in AGMs while being sustained in RMs; indeed, the chronically SIV-infected 
RMs have a significantly higher level of MX1 than AGMs by establishment of chronic infection (Figure 
21C). These responses parallel viral replication, suggesting that the interferon-based changes observed 
during the acute SIV infection are strictly determined by direct viral effects. 
4.4.8  AGMs show limited expression of genes associated with immune activation and epithelial 
damage in response to infection 
A transcriptomic profiling of gut tissues taken during necropsy (265) was performed (see 5.0) with 
the goal to assess changes in genes associated with epithelial damage and adaptive and innate immune 




Figure 22: Heatmap & network of changes in gene expression in the gut over course of SIV infection in 
African green monkeys (AGMs). 
RNAseq data from AGM gut tissue displayed as: (A) a heatmap showing gene expression changes in genes associated 
with biological processes related to SIVsab infection, immune responses and damage to the gut epithelium; (B) a 
network showing direct interactions between genes in SIV related processes at the peak of infection (9-12 dpi). For 
the heatmap, the level of alteration of gene expression is shown in blue (downregulation) and red (upregulation), with 
genes clustered using a Spearman correlation, with the dendrogram showing relationship displayed on the left. For the 
pathway, each gene is shown as a node and the arrows between nodes indicate direct gene interactions. Red nodes 
indicate upregulation of gene expression, green nodes indicate downregulation. In split nodes, the left and right node 
sections correspond to 9 dpi and 12 dpi, respectively. 
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 Most of the genes surveyed showed limited alterations. Notable exceptions include several CD4+ 
T cell-associated genes (including HPGDS and MYD88), which were transiently up-regulated during the 
ramp-up and peak stages of infection. While HPGDS can be linked to proinflammatory  Th2 CD4+ T cells, 
this primarily occurs in eosinophil-driven allergic responses in the gut (275). As an essential TLR signal 
transducer, MYD88 has been shown to be important for regulation of CD4+ T cells, including in promoting 
activation in the murine inflammatory bowel model (276). As such, MYD88 could potentially be directly 
associated with an antimicrobial response and microbial translocation. However, MYD88 has also been 
linked to promotion of normal wound healing response through TLR signaling (277, 278).  
Two genes linked to CD8+ T-cell regulation (including HSDL1 and FN1) were more widely up-
regulated during peak SIVsab infection. The HSDL1 enzyme itself is largely considered to be nonfunctional 
(279), but FN1 can activate degranulation of CD8+ T cells (280). However, as described in 5.4.5, we showed 
that FN1 is a key part of unique wound healing pathway in AGMs. Repair of any damage caused by early 
viral replication could play an important role in the resolution of inflammation, preventing establishment 
of chronic inflammation later on. 
Genes linked to CD20+ B cell regulation were also analyzed, with no clear expression patterns 
being apparent and any variation appeared most likely to be due to inter-animal variability (Figure 22A). 
We next established whether there were any interactions between these genes and their respective 
pathways. To this end, we linked established protein interactions between all included genes from the IPA 
database (see 5.3.4). The resulting network (Figure 22B) showed a central role for STAT3, a transcription 
factor associated with epithelial damage. However, most of the genes, including STAT3, did not show any 
significant alteration in expression from baseline. Furthermore, while STAT3 has been linked to both 
inflammatory  cytokines and chemokines, it has been shown to be critical to signaling necessary for repair 
of damage to the gut (281–283). 
Finally, the gene expression analysis also showed that in AGMs the strong antiviral response at the 
peak of infection is reflected by changes in gene expression levels. This is seen primarily through the highly 
increased expression of the interferon-induced genes CXCL10 and CXCL11, which promote immune cell 
activation and migration, and MX1, as shown in Figure 23.  
 100 
 
Figure 23: Comparative changes in gene expression in the gut over the course of SIV infection in African 
green monkeys (AGMs) and rhesus macaques (RMs). 
RNAseq data from AGM and RM gut tissue displayed as a heatmap showing gene expression changes in specific 
genes of interest associated with biological processes related to SIV-infection and the host immune response. The 
level of alteration of gene expression is shown in blue (downregulation) and red (upregulation), with genes clustered 
using a Spearman correlation, with the dendrogram showing relationship dispalyed on the left. Animal numbers are 
shown below the heatmap along with dpi, while the time groups are shown above the heatmap, with the colors 
indicating the groups: orange (BL, baseline), green (PRU, preramp), blue (RU, ramp-up), red (peak), yellow (SP, set-
point). The data for the time groups of the AGMs are listed in black text on the left, while the data from the equivalent 
RM time groups are listed in white text on the right. 
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The increase in MX1 at the peak of infection mirrors the increases we observed in situ in the AGMs 
and RMs (Figure 21). It also mirrors the increase in interferon regulated genes seen in SIV-infected RMs 
at the peak of viral replication (Figure 23)  
However, the AGMs alone showed strong, sustained upregulation of IL-17B expression starting 
immediately postinfection (Figure 23). Part of the IL-17 family, IL-17B has been demonstrated to have an 
anti-inflammatory effect during acute colon inflammation, suggesting that it may promote control of 
inflammation in the AGMs (284). 
4.4.9  Little to no apoptosis occurs in the gut lamina propria or epithelium during SIVsab infection 
Given the central role of microbial translocation in driving disease progression and that one of the 
main causes of microbial translocation is the “leaky gut”, we assessed the capacity of AGMs to maintain 
the integrity of their gut mucosal barrier (6, 61). Mucosal barrier integrity was examined by for three 
different conditions associated with gut damage: apoptosis, fibrosis and loss of tight junctions between 
epithelial cells (285–288). Apoptosis was measured in the gut and LNs by assessing the levels of active 
caspase-3, a central component of both the extrinsic and intrinsic apoptosis pathways (289). Relatively few 
cells expressed active caspase-3 in all tissues surveyed, especially the axillary LNs (Figures 24A & B & 




Figure 24: Immunohistochemistry (IHC) for apoptosis in SIVsab-infected African green monkeys (AGMs). 
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DAB-based IHC for active caspase-3 in the (A) transverse colon, and (B) axillary LN of AGMs and chronically SIV-
infected rhesus macaques (RMs). In all the images, positive DAB signal is shown in brown, with the remaining tissue 
counterstained blue. The representative images display lateral cuts of the crypts to show apoptosis in both the 
epithelium and lamina propria. Below are shown image quantifications (C) of the percent area of the total positive 
DAB signal. The quantification for each animal represents the average of the values from 9-12 individual image 
quantifications. The four time groups are based on the days postinfection, with: BL (baseline, preinfection), RU (ramp-
up, 4-6 dpi), PEAK (peak, 9-12dpi) and SP (set-point, 46-55 dpi). Each time group is assigned a corresponding color 
based on the stage of viral replication: orange (baseline), blue (ramp-up), red (peak) and yellow (set-point). All AGM 
quantifications were performed using FIJI version 1.0. Asterisks indicate statistical significance, with *=p<0.05. All 
AGM images were captured at 200X magnification using an AxioImager M1 bright-field microscope equipped with 
an AxioCam MRc5. 
 
 
Using quantitative image analysis, we found a slight increase of the levels of active capase-3 in the 
transverse colon during the ramp-up, which did not reach significance and rapidly returned to baseline 
(Figure 24B), similar to the transient increase in neutrophils in the colon (Figure 20). In the jejunum and 
axillary LN, active caspase-3 levels remained largely unaltered, with slight tendencies to increase by the 
early chronic infection in jejunum and to decrease during the early stages of infection in the LNs (Figures 
24B & Appendix C). Finally, active caspase-3 was expressed almost exclusively in the lamina propria of 
the gut with few, if any, of the enterocytes of the gut epithelium staining positive for active caspase-3 
(Figures 24A & Appendix C). In contrast, a large number of enterocytes expressed high levels of active 
caspase-3 in chronically SIV-infected RMs (Figure 24A), reflecting the apoptosis of these cells due to 
chronic inflammation. The LNs of the RMs also had higher levels of active capase-3 expression than in the 
AGMs in both the T-cell zones and B cell follicles (Figure 24B). 
4.4.10  Gut epithelial integrity is maintained throughout the course of SIV infection in AGMs 
The lack of epithelial cell death was confirmed by staining for claudin-3, a principal component 
protein of cellular tight junctions in the gut. Tight junctions are vital not only for cell-to-cell adhesion, but 
also for regulating paracellular permeability and allowing small molecules and ions to move across the 
epithelial barrier (290). Any loss of claudin-3 due to cell death or internalization via endocytosis in response 
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to infection would be indicative of a loss of mucosal integrity (192). Importantly, no such loss was observed 




Figure 25: Immunohistochemistry (IHC) for mucosal integrity and continuity in SIVsab-infected African 
green monkeys (AGMs). 
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DAB-based IHC for claudin-3 in the transverse colon of AGMs and chronically SIV-infected rhesus macaques (RMs). 
In all images, positive DAB signal is shown in brown, with the remaining tissue counterstained blue. The 
representative images of the gut display longitude cuts of the villi to show continuity of the epithelial barrier (A). (B) 
Composite image of continuous transverse colon epithelium from an AGM during peak acute viral replication. (C) 
Image of continuous transverse colon epithelium from an RM during late chronic viral replication. (D) The percent 
area of the total positive DAB signal and the ratio of damaged/total epithelium. (E) Plasma concentrations in ng/L 
of I-FABP, a marker of epithelial damage in the gut. The images were stitched together to form a composite image 
using the Stitching plugin for FIJI version 1.0. Overall continuity of the mucosal epithelium was estimated by tracing 
the length intact vs damaged epithelium and quantifying their relative areas. The total DAB quantifications for the 
AGMs represent the average of the values from 9-12 individual image quantifications, while the epithelial damage 
quantifications represent 3-4 composite images. The four different time groups are based on the days post infection, 
with: BL (baseline, preinfection), RU (ramp-up, 4-6 dpi), PEAK (peak, 9-12dpi) and SP (set-point, 46-55 dpi). Each 
time group is assigned a corresponding color based on the stage of viral replication: orange (baseline), blue (ramp-
up), red (peak) and yellow (set-point). The chronic RMs are shown in purple. All AGM quantifications were performed 
using FIJI version 1.0. Asterisks indicate statistical significance, with **=p<0.01. All AGM individual images were 
captured at 200X magnification using an AxioImager M1 bright-field microscope equipped with an AxioCam MRc5. 
For the composite images, each individual image was captured at 100X magnification. 
 
 
Measurement of the ratio of intact/damaged epithelium in the colon showed that the percent of 
damaged epithelium did not significantly change during SIV infection of AGMs. This is a very different 
scenario than in the chronically SIV-infected RMs, where the percent of damaged epithelial barrier was 
quite extensive and is easily observable (Figures 25C-D), consistent with previous reports (250).  
To further confirm that the gut epithelium did not sustain any significant injury during early SIVsab 
infection, we monitored the plasma levels of I-FABP. This protein was recently established as a marker of 
gut damage, as it is highly expressed by mucosal epithelial cells in the small intestinal and is rapidly released 
upon injury (291). While the I-FABP levels (measured by ELISA) increased slightly in some animals during 
the preramp-up and ramp-up periods, this did not reach statistical significance and it quickly returned to 
baseline by the peak and remained at these levels during the early chronic infection (Figure 25E). 
The jejunum was also stained for claudin-3 and, while integrity of the continuous epithelial was 
not quantified as was done with the transverse colon, we did not observe any noticeable loss of mucosal 
integrity (Appendix C). 
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4.4.11  Acute SIVsab infection does not induce fibrosis of the gut or LNs of AGMs 
A hallmark of pathogenic HIV/SIV infections is the loss of structure and fibrotic damage of 
lymphoid tissues (292); therefore, we assessed whether SIV infection of AGMs is also associated with early 
gut and lymph node fibrosis, similar to pathogenic HIV/SIV infections (285). Collagen levels in the 
transverse colon, jejunum and axillary LNs did not significantly change during SIV infection of AGMs 
(Figures 26 & Appendix C), in contrast to the significant amount of collagen deposition in the LNs of 




Figure 26: Immunohistochemistry (IHC) for collagen deposition and fibrosis in SIVsab-infected African 
green monkeys (AGMs). 
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Masson’s trichrome stain for collagen in the (A) transverse colon, and (B) axillary LN of AGMs and chronically SIV-
infected rhesus macaques (RMs). For the trichrome stain, red/pink are myosin fibers and cytoplasm, black is nuclei, 
and blue is collagen. The representative images of the gut display longitude cuts of the villi to better show the presence 
of collagen in the lamina propria. Below are shown image quantifications (C) of the percent area of the total blue 
signal indicating collagen. (D) Plasma concentrations in ng/L of hyaluronic acid, a marker of fibrosis. The 
quantification for each animal represents the average of the values from 9-12 individual image quantifications.  The 
four different time groups are based on the days post infection, with: BL (baseline, preinfection), RU (ramp-up, 4-6 
dpi), PEAK (peak, 9-12dpi) and SP (set-point, 46-55 dpi). Each time group is assigned a corresponding color based 
on the stage of viral replication: orange (baseline), blue (ramp-up), red (peak) and yellow (set-point). The chronic 
RMs are shown in purple.  All AGM quantifications were performed using FIJI version 1.0. Asterisks indicate 
statistical significance, with **=p<0.01. All AGM images were captured at 200X magnification using an AxioImager 
M1 bright-field microscope equipped with an AxioCam MRc5. 
 
 
As limiting fibrosis and maintaining the LN architecture has been shown to be critical in preserving 
CD4+ T-cell populations (261) during pathogenic SIV infection, avoiding early fibrosis in the LNs could 
contribute to prevention of disease progression in AGMs.  
To further confirm the lack of fibrosis in SIVsab-infected AGMs, we monitored the plasma levels 
of hyaluronic acid, a biomarker of liver fibrosis (259). Our results showed no perceptible changes in 
hyaluronic acid levels at any point of acute SIV infection, even at the peak of viral replication, with the 
exception of a few outliers (Figure 26D). Together, our results demonstrate that acute SIV infection of 
AGMs, a natural, nonprogressive host of SIVs, is associated with no increase in intestinal epithelial 
apoptosis, fibrosis, or breakage of the mucosal epithelium, supporting that the overall integrity of the 
intestinal epithelium is maintained throughout the course of SIV infection. 
4.4.12  No increased microbial translocation during early SIV infection in AGMs 
To confirm the maintenance of mucosal integrity and prevention of microbial translocation in 
acutely SIV-infected AGMs, we performed quantitative IHC using: (i) a monoclonal antibody to the core 
region of lipopolysaccharide (LPS), a highly immunogenic endotoxin found in the outer membrane of 
Gram-negative bacteria (293); and (ii) a polyclonal anti-Escherichia coli antibody that cross-reacts with 
numerous enterobacteria species and that have previously been used as a markers of microbial translocation 
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in pathogenic SIV infections (250). Interestingly, prior to SIV infection, AGMs had LPS-core already 
present in the transverse colon, largely localized to the lamina propria. The LPS-core levels did not increase 
in the colon postinfection though, indicating that the observed levels of LPS are independent of SIV 




Figure 27: Immunohistochemistry (IHC) for the translocation of LPS in SIVsab-infected African green 
monkeys (AGMs). 
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DAB-based IHC for LPS-core protein in the (A) transverse colon, and (B) axillary LN of AGMs and chronically SIV-
infected rhesus macaques (RMs). In all the images, positive DAB signal is shown in brown, with the remaining tissue 
counterstained blue. Below are shown image quantifications (C) of the percent area of the total positive DAB signal. 
The quantification for each animal represents the average of the values from 9-12 individual image quantifications. 
The four time groups are based on the days postinfection, with: BL (baseline, preinfection), RU (ramp-up, 4-6 dpi), 
PEAK (peak, 9-12dpi) and SP (set-point, 46-55 dpi). Each time group is assigned a corresponding color based on the 
stage of viral replication: orange (baseline), blue (ramp-up), red (peak) and yellow (set-point). The chronic RMs are 
shown in purple.  All AGM quantifications were performed using FIJI version 1.0. Asterisks indicate statistical 
significance, with **=p<0.01. All AGM images were captured at 200X magnification using an AxioImager M1 bright-
field microscope equipped with an AxioCam MRc5. 
 
 
Quantitative image analyses of the LPS-core levels in the lamina propria at different stages of 
SIVsab infection in the colon revealed no significant change from baseline level (Figure 27C). Likewise, 
LPS-core levels were very low in the jejunum and axillary LNs and did not significantly change during SIV 
infection of AGMs (Figures 27B & Appendix C). In contrast, chronically SIV-infected RMs had abundant 
levels LPS-core present both beneath the epithelium in the gut (Figures 27A & C) and throughout the 
parenchyma of peripheral LNs (Figures 27B & C). It is worth noting that the presence of LPS-core in the 
RM peripheral LNs is extensive and contrasts sharply with the almost complete absence of LPS-core in 
AGM axillary LNs. This indicates that the LPS found in the lamina propria of the colon in AGMs is retained 
within the GI tract and not systemically disseminated, in contrast to SIV-infected RMs.  
Using the additional stain to measure microbial translocation, we found that E. coli was present 
only very sparsely within the gut lamina propria (Figures 28A & Appendix C), and at very low levels in the 




Figure 28: Immunohistochemistry (IHC) for translocation of E. coli in SIVsab-infected African green 
monkeys (AGMs). 
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DAB-based IHC for E. coli in the (A) transverse colon, and (B) axillary LN of AGMs and chronically SIV-infected 
rhesus macaques (RMs). In all the images, positive DAB signal is shown in brown, with the remaining tissue 
counterstained blue. Below are shown image quantifications (C) of the percent area of the total positive DAB signal. 
The quantification for each animal represents the average of the values from 9-12 individual image quantifications.  
The four different time groups are based on the days post infection, with: BL (baseline, preinfection), RU (ramp-up, 
4-6 dpi), PEAK (peak, 9-12dpi) and SP (set-point, 46-55 dpi). Each time group is assigned a corresponding color 
based on the stage of viral replication: orange (baseline), blue (ramp-up), red (peak) and yellow (set-point). The 
chronic RMs are shown in purple. All AGM quantifications were performed using FIJI version 1.0. Asterisks indicate 
statistical significance, with **=p<0.01. All AGM images were captured at 200X magnification using an AxioImager 
M1 bright-field microscope equipped with an AxioCam MRc5. 
 
 
Quantitative image analysis demonstrated that none of the tissues displayed any significant changes 
in the E. coli levels during the course of SIV infection in AGMs. In contrast and, as with LPS, abundant 
levels of E. coli were present in both the gut lamina propria and peripheral LNs of the chronically SIV-
infected RMs, with significantly higher levels of E. coli in the LNs than early chronic AGMs (Figures 28A-
C). In summary, AGMs are able to maintain gut mucosal integrity throughout all stages of SIV infection, 
thereby preventing the translocation of microbes or microbial products from the lumen to surrounding 
tissues and, as such, preventing chronic inflammation and disease progression. 
4.5 Discussion 
African NHPs that are natural hosts of SIVs avert disease progression despite sustaining high levels 
of SIV replication by mechanisms only partially understood. It is widely acknowledged that understanding 
these mechanisms has the potential to generate new strategies for preventing HIV disease progression in 
humans (46, 78, 88, 96, 97, 124–127, 135, 156, 243, 248, 294), and could help alleviate the social and 
financial burden of HIV infection and long-term ART (294, 295). 
Here, we thoroughly assessed the impact of acute SIVsab infection in AGMs at the mucosal sites 
to understand if their ability to avoid disease progression stems from maintenance of a healthy gut 
throughout infection, or an exquisite capacity to rapidly resolve the effects of viral replication and T-cell 
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depletion at mucosal sites. In progressive lentiviral infections (i.e., SIV infection of macaques and HIV 
infection of humans), the majority of gut CD4+ T cells are initially killed by direct viral cytopathic effects 
due to ongoing viral replication, which drives apoptosis of epithelial enterocytes, immune activation in the 
gut, recruitment of innate immune cells and inflammation, leading to further damage the gut epithelium 
fueling destruction of the gut mucosal barrier and MT that trigger chronic systemic immune activation and 
inflammation (253, 254, 296). 
 Given the importance of the initial virus-host interactions and viral cytopathic effects in 
establishing this vicious cycle, we assessed the dynamics of viral replication in the GI tract after intrarectal 
challenge and found high levels of viral replication starting as early as 4-6 dpi in the gut and even earlier in 
the draining LNs. We anticipated that these high levels of viral replication would be paralleled by depletion 
of CD4+ T cells, the major cellular targets of SIVsab. However, in spite of the high levels of virus replication 
in both the gut and LNs (Figures 4 & 5), the overall levels of CD4+ T cells were relatively stable during the 
early stages of infection (Figures 13), in contrast to previous reports of significant mucosal CD4+ T-cell 
depletion in AGMs during acute and early chronic infection (46, 78, 88). 
 One possible explanation for this discrepancy is that while the previous studies have largely relied 
on longitudinal blood and tissue sampling from the same animal, our cross-sectional study mostly compared 
data between different animals; thus, individual variations between animals (which can be very large in 
AGMs) may have partially obfuscated the CD4+ depletion. Indeed, for the blood and LNs, where 
preinfection samples were available for all the animals, allowing for direct pre- versus postinfection 
comparison, we were able to document CD4+ T-cell depletion (Figure 13).  
 As the early viral replication induces high levels of immune activation in pathogenic infections 
(61), we assessed the levels of immune activation in early SIVsab infection of AGMs. As a marker of 
activation via proliferation, Ki-67 expression by CD4+and CD8+ T cells or CD20+ B cells did not 
significantly increase in either the gut or the LNs at any time, by either flow cytometry (Figure 14) or IHC 
(Figures 18). While low levels of immune activation by establishment of chronic infection is in agreement 
with previous studies of natural hosts (78, 88, 89, 126, 159), sooty mangabeys previously showed increased 
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markers of T-cell activation in the LNs during acute infection (153). This suggests that reduced early 
immune activation may be a unique feature of AGMs as a natural host of SIV. 
In contrast, Ki-67 expression increased in the gut and LNs of pathogenically infected RMs (Figures 
18 & Appendix C) Our observation of low levels of immune activation was also supported by our finding 
that there were few alterations in gene expression that would indicate a major uptick in CD4+ or CD8+ T-
cell activation during acute infection and essentially no major alteration to CD20+ linked genes (Figure 22 
& Figures 23). The most notable alterations were linked to interferon-stimulated genes (ISGs), with highly 
elevated gene expression around the peak of infection. This is similar to what was previously observed, 
though our study only examined gene expression in gut tissue and didn’t follow the animals into late chronic 
infection (156). 
 As T-cell immune activation is usually accompanied by an innate immune response, we assessed 
neutrophil recruitment to the gut and found little to no neutrophil accumulation in the gut mucosa and 
superficial LNs (Figure 20 and Appendix C). These results are in stark contrast with the large scale 
recruitment of MPO-positive neutrophils to the gut epithelium in chronically SIV-infected RMs, both in 
our study (Figure 23) and previous studies (249), as well as in HIV-infected subjects (245), or in other 
pathological conditions associated with gut inflammation and MT, such as IBD (297). We also saw no 
major change in MPO gene expression levels in the AGMs at any time during infection (Figure 23) 
supporting the lack of sustained alteration to neutrophil populations in response to SIV infection in AGMs, 
though the expression levels of MPO do not necessarily correlate with the number of neutrophils in the gut.  
Interestingly, the AGMs actually had similar levels of neutrophils in the gut to some of the 
chronically infected RMs (Figure 23C) and to RMs during early acute infection (249). Historically, it has 
been shown that both uninfected RMs (195) and HIVneg individuals (245, 298) tend to have very small 
numbers of neutrophils resident in the gut, so their presence in AGMs suggests some role in responding to 
SIV infection. One possible explanation is that the resident gut neutrophils respond immediately to any 
possible leakage, no matter how minimal, from the gut lumen during the acute infection, through 
mechanisms like phagocytosis and the release of NETs. Indeed, we do see a significant increase in the 
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number of MPO-positive cells in the colon only during the ramp-up period (Figure 23C), possibly indicating 
a transient increase of neutrophils during the earliest period following infection. However, any activity by 
neutrophils would have to be carefully controlled to minimize collateral damage to the epithelium, as occurs 
in many inflammatory mucosal disorders (299). Another possible explanation for their presence is that the 
resident gut neutrophils in AGMs play a nontraditional role and contributing directly to maintaining the 
epithelial barrier, though the vast majority of evidence supports neutrophils having net negative impact on 
tissue homeostasis (300). 
 Populations of other immune cell types typically involved with the initial innate response and the 
subsequent inflammation, including DCs, macrophages and NK cells (Figure 15) were also virtually 
unchanged from baseline in acutely SIVsab-infected AGMs. Together with the lack of sustained MPO-
positive neutrophil infiltration, this suggests a limited recruitment of innate response effectors to the major 
site of early viral replication, which may help dampen the early proinflammatory responses in AGMs. 
Previous research has shown that in both pathogenic and nonpathogenic hosts, activated immune 
cells and epithelial cells exhibit increased production of proinflammatory cytokines in response to HIV/SIV 
infection (6, 202–204, 249). However, in pathogenic hosts, this increase is sustained chronically, while 
nonpathogenic hosts resolve their inflammation by establishment of an anti-inflammatory milieu early 
during infection (127). Supporting this trend, we found that there were only transient increases in a limited 
set of immune-linked cytokines/chemokines (Figure 22) that were mostly resolved by chronic infection. 
Additionally, we observed that almost immediately following infection the AGMs exhibited increased 
expression of the gene encoding IL-17B (Figure 23), which is a T cell-derived cytokine with potential anti-
inflammatory effects in the gut (283). 
 However, control of inflammation does not mean lack of response by the host, as demonstrated in 
previous studies by the ability of the natural hosts to mount robust innate immune responses during acute 
infection (154, 156, 157, 163), particularly the type 1 ISGs genes (ISGs), including MX1, MX2 and IP-10. 
These responses are then rapidly resolved at the transition to chronic infection, as we observed here with 
MX1 in our AGMs (Figures 21 & 23). In contrast, SIV-infected RMs exhibit strong innate immune 
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activation and ISG upregulation throughout the entire course of SIV infection (154, 156, 157, 163), as 
reflected by the high levels of MX1 in our chronically infected RMs (Figures 21 & S23). Persistence of 
IFN-based responses in pathogenic SIV infections eventually induces IFN desensitization and decreased 
ISG expression, resulting in increased SIV reservoir size and CD4+ T-cell loss (272). 
 Interestingly, while some acute SIV infection studies observed upregulation of MX1 and other 
ISGs as early as 1 and 6 dpi (156), here the tissue protein levels of MX1 did not increase prior to the peak, 
at 9-12 dpi (Figure 21). This discrepancy may be due to the route of inoculation (mucosal versus IV), that 
could shift the acute infection towards later time points (78). Additionally, some of the individual AGMs 
did exhibit increased expression levels of ISGs, including MX1, earlier during infection (Figure 23). This 
suggests that the early virus replication might be sufficient in some cases to induce a response that is both 
transient and of a far lesser magnitude than seen at the peak of virus replication. 
 Going hand-in-hand with the greater levels of immune activation, pathogenic SIV infections are 
also differentiated from nonpathogenic infections by the massive increase in apoptosis of both the CD4+ T 
cells in the lamina propria and the mucosal epithelial cells in the gut (76, 285), as we observed in our 
chronically SIV-infected RMs (Figure 24). This drives the mucosal epithelium into a compensatory state 
of regeneration, with high levels of proliferation and turnover, as reflected by a significant, simultaneous 
increase in both Ki-67+ and active caspase-3-positive epithelial cells (285). We found no increase of either 
of these markers in SIV-infected AGMs (Figures 18 & 24), despite the sustained high levels of viral 
replication in the gut (Figure 4 & 5), in agreement with previous studies (198).  
 Epithelial cell death and loss of mucosal barrier integrity is also reflected by degradation of the 
tight cell junctions, resulting in breaks in the gut epithelial layer (249, 301). In SIV-infected RMs, claudin-
3 staining has been used to measure the breakdown in mucosal epithelium continuity, while expression of 
claudin-encoding genes (i.e., CLDN3) has been shown to be downregulated as early as 3 dpi (302), similar 
to what was also observed in rats during experimentally-induced IBD (287). Importantly, at no timepoint 
post SIVsab infection in AGMs did we find that the mucosal epithelium integrity was significantly 
damaged, nor were the levels of claudin-3 gene (CLDN3) expression in the gut altered, in stark contrast 
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with reduced mucosal epithelium integrity in chronically infected RMs (Figures 25A,B,&D & Appendix 
C). These histologic data were supported by the finding of relatively stable levels of plasma I-FABP in the 
SIVsab infected AGMs (Figure 25E). We also observed upregulation of several genes linked to wound 
healing and repair of epithelial damage (Figures 22 & 23), suggesting that the lack of damage might be 
connected to maintenance of the gut epithelium itself, as shown in 5.0 (264). The importance of 
maintenance of the gut barrier in natural hosts was shown when experimental colitis induced in AGMs 
recapitulated many of the features of pathogenic SIV infections, including higher levels of plasma SIV 
RNA, sCD14, LPS, C-reactive protein and an increased rate of mucosal CD4+ T-cell loss (195). 
 Apart from loss of gut mucosal integrity, increased collagen deposition is also a hallmark of 
pathogenic HIV/SIV infections and impaired immune recovery in the gut (284, 303). It has also long been 
known that destruction of LN architecture and the subsequent fibrosis is characteristic of chronic HIV-
infection in humans and SIV-infection in RMs (Figures 26B & C) (304, 305). In keeping with the lack of 
chronic inflammation, we found no evidence of increased fibrosis (i.e., collagen deposition) in either the 
gut or LNs of SIVsab-infected AGMs (Figures 26 & Appendix C), and we confirmed this result by showing 
stable levels of hyaluronic acid in the plasma throughout the follow-up (Figure 26D).  
 Finally, we directly assessed the levels of MT in SIVsab-infected AGMs by measuring LPS-core 
and E. coli in the lamina propria and LNs by quantitative IHC. None of these markers showed significant 
increases during either acute or postacute SIVsab infection (Figures 27 & 28 & Appendix C), in contrast 
with chronically SIV-infected RMs (Figures 27 & 28). This is also unlike the results seen in SIV-infected 
AGMs that were treated to induce experimental colitis (191, 195, 248, 249, 269).  
 Interestingly, the uninfected AGMs did have higher levels of LPS, but not of E. coli, in the lamina 
propria of the transverse colon compared to uninfected RMs, though these levels were stable even after 
infection and lower than those seen in the chronic RMs (Figures 27 & 28). It is possible that gut resident 
phagocytic cells in AGMs, such as neutrophils, macrophages or DCs, take up LPS from the colonic lumen, 
but actively attenuate inflammatory responses. It has been shown that human colonic macrophages are 
highly anergic to LPS as a proinflammatory stimuli, possibly through interaction with the commensal 
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colonic flora (306, 307), making it plausible that an analogous form of anergy to LPS may exist in AGMs. 
This may even contribute to dampening the early inflammatory response induced by MT following SIV 
infection. Indeed, a study in SMs, another natural SIV host, showed an alteration to the TLR4 gene 
associated with a blunted response to TLR4 ligands (308). As LPS is one of the most important TLR4 
ligands, a similar LPS anergy in AGMs could promote an attenuated SIV pathogenesis.  
 As such, our results showed that in the absence of mucosal damage, the transient increases in 
inflammatory responses observed in natural SIV infection do not have any major pathogenic consequences. 
It follows that any interventions to prevent or modulate intestinal mucosal damage during HIV/SIV 
pathogenic infection may result in a lack of disease progression, even in the presence of active viral 
replication. A similar situation has been observed with viremic nonprogressor HIV-infected subjects, where 
limited immune activation and inflammation are associated with lack of disease progression (309, 310). 
Our study therefore suggests that early interventions aimed at repairing or preventing gut epithelial damage 
may represent a viable alternative to the current interventions intended to curb the deleterious consequences 
of HIV infection. 
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5.0 Macrophage associated wound healing contributes to control of SIV pathogenesis in African 
green monkeys 
5.1 Contributors 
Data contributed to the dissertation by several collaborators is included in the following section. 
Notably, all work related to the RNAseq, including design and implantation of the bioinformatic analyses, 
was done by Dr. Frederick Barrenäs. Because of this, Dr. Barrenäs is cofirst author on the associated 
publication, along with the dissertation author. Dr. Qingsheng Li contributed the immunohistochemistry 
staining, imaging and image analysis for the fibronectin. Drs. Guido Silvestri and Steve Bosinger 
contributed to the macrophage sorting. The dissertation author managed the serial necropsies and tissue 
sampling, performed all the immunofluorescence stains and the confocal microscopy, and conducted 
immunohistochemistry staining, imaging and image analysis for the tissue macrophages.  
5.2 Background 
As described in 1.4.6, one of the defining trait of the natural hosts of SIV is lack of persistent 
immune activation (97, 126, 127, 154). In non-natural hosts like humans and macaques, sustained 
expression of markers of immune activation are strong indicators of mortality (311). Some of the 
immunological mechanisms linked to the control of immune activation in natural hosts include: (i) 
alterations in sequence or expression of CD4 or CCR5 (38, 135, 312) on target cells, restricting infection; 
(2) resolution of viral induced interferon signaling and activation of innate immune cells (see 4.4.7) (154, 
156, 177); (3) preservation of the maintenance of mucosal integrity (see 4.410) (89, 135, 177, 191, 249). 
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Transcriptomic analyses of RMs acutely infected with SIVmac have found that genes associated 
with activation of NK cells, monocytes and T cells in rectal tissues are strongly up-regulated (313). The 
intestinal tract also has a dramatic decrease in the expression of tight junction protein during the acute stage 
of pathogenic SIV infection in RMs (302). This allows microbial components to penetrate the epithelial 
barrier, leading to microbial translocation and setting up the chronic inflammatory responses crucial to 
driving the development of AIDS (249). 
In contrast, CD4+ T cells of SIV-infected AGMs actually mount interferon responses earlier than 
in RMs, but resolve them after the acute stage of infection; resolution of this early innate immune response 
could potentially have a major effect on preventing a pathogenic outcome of infection (156, 163, 177). 
Likewise, both the colon and lymph nodes show strong but transient immune activation, along with 
polarization of naïve T cells into Th1 cells and progenitor cell regeneration during acute infection in AGMs 
(163). Myeloid DCs also show diminished immune activation and apoptosis during acute SIV infection in 
AGMs, compared to pathogenic hosts (180). Taken together, these factors demonstrate the importance in 
natural hosts of regulating immune responses in such a way to minimize the deleterious impact of viral 
replication and help maintain homeostasis, both of immune function, as well as mucosal integrity. 
To define the gene expression signatures of acute SIV/HIV infection that link the immune response 
at the site of inoculation with systemic immune regulation, we simultaneously examined alterations in gene 
expression and the associated tissue responses after intrarectal SIV inoculation of both AGMs and RMs 
with their respective SIVs. Using total RNAseq, bioinformatics, viral load testing and IHC, we found highly 
dissimilar gene expression dynamics between AGMs and RMs postinfection.  
To fully investigate these differences, a novel systems biology approach was developed, referred 
to as conserved gene signature analysis (CGSA). This approach operates by correlating gene expression 
signatures from acutely SIV-infected animals with multiple informative transcriptomic datasets from the 
public domain. These datasets encompassed relevant tissue, such as immune cell subsets, mucosal tissue, 
and epithelial cells, along with related conditions, like tissue damage, immune activation and cytokine 
stimulation. The data sets were also derived from a variety of different species. This enabled CGSA to 
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perform a data-driven, unbiased investigation of novel pathogenic or protective mechanisms of SIV disease 
progression in both natural and non-natural hosts. 
5.3 Methodology 
5.3.1  Animals and infections 
For the AGMs, as described in 3.3.1 and 3.3.2. The RMs were housed at the Washington National 
Primate Research Center according to guidelines approved by the University of Washington Environmental 
Health and Safety Committee, the Occupational Health Administration, and the Primate Center Research 
Review Committee. Experiments were approved by the Institutional Animal Care and Use Committees 
(IACUCs) of the University of Washington (#214207), and Emory University (#2002173). Each RM was 
intrarectally inoculated with 1 ml of inoculum containing 6000 TCID50s (50% tissue culture infectious 
doses) of SIVmac251. 
The RMs were serially euthanized over the course of acute and early chronic SIV infection and 
were divided into the following groups based on their predicted viremic status at the time of sacrifice: (i) 
preinfection (baseline); (ii) preramp-up (1-3 days postinfection (dpi); (iii) ramp-up (6 dpi); (iv) peak (12 
dpi); (v) set-point (84 dpi), as outlined in Figure 29. This design paralleled the one used for the AGMs 
(Figure 1). It should be noted that the uninfected RMs in the baseline group were only used for histological 
surveys, as gene expression baselines were established from samples collected prior to infection, as 
described below.  
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Figure 29: Rhesus macaque (RM) groups for study of intrarectal SIVmac251 infecton. 
The RMs were euthanized throughout the acute and early chronic SIV infection and were divided into the following 
groups based on their predicted viremic status at the day post infection (dpi) that the necropsy was performed: (i) 




5.3.2  Tissue processing and isolation of mononuclear cells 
Tissues were collected and processed for the RMs similarly to the AGMs, as described in 3.3.3. To 
create baseline transcriptomic profiles, pinch biopsies were taken from the rectum 50 days prior to 
inoculation for the AGMs and 14 days prior to inoculation for the RMs. At the time of necropsy, all rectal 
tissue samples were taken using the method outlined in 3.3.3 and at a depth of 25 mm from the anus, 
corresponding to the depth at which the inocula were deposited. During necropsy, blood draws and other 
tissues were taken from the RMs for viral load measurement, cell separation and histology, as was done 
with the AGMs. Sections of the rectum and distal colon were immediately perfused in RNAlater, and then 
stored at -80°C until extraction of genomic material later. 
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5.3.3  Rectal tissue transcriptomic profiling 
As described in 4.3.12. The full rectal sequencing data, including gene counts, can be found in 
Gene Expression Omnibus (GSE111077). 
5.3.4  Bioinformatic analysis 
Differentially expressed (DE) genes were identified using the edgeR library and defined as having 
an adjusted p-value (false discovery rate) less than 0.05 and absolute fold change greater than1.5. 
For CGSA co-expression network construction, the log counts per million (CPM) from 
RM/SIVmac251 and AGM/SIVsab92081 were combined into one matrix, creating a single row for the RM 
and AGM homologues of each human gene, respectively. To focus the analysis on the response to SIV 
inoculation (and not on differences between the species) the average baseline expression value for the RM 
and AGM data was subtracted from their respective time series, resulting in log CPM fold change values 
(i.e. positive values where genes show above-baseline expression and negative values where genes show 
below-baseline expression). 
The Acute SIV Co-expression Network was created from the pool of DE genes using rank-based 
network construction (302), with midweight bicorrelation (bicor) (314) as distance metric. The only 
parameter for this method is the number (d) of interactions to assign each gene, which was selected using 
gene ontology (GO) biological process similarity (315). We found that d values of 1 and 2 added 
interactions with high biological relevance, compared to when d was increased to 3 and above. We therefore 
selected to use a d value of 2. 
Transcriptomic datasets from Gene Expression Omnibus were included based on four criteria: (1) 
relevance for the biological process in which the DE genes were enriched, as shown below in Figure 30C; 
(2) that data was obtained from relevant tissue, such as epithelial cells or colon biopsies, based on enriched 
GO terms; (3) a high number of samples, for statistical power; (4) the data described a time series similar 
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to the time course of acute SIV infection, or was from a large clinical study. Each interaction between two 
genes (termed a and b) was given a weight, defined as a weighted mean between the bicor values in acute 
SIV infection and the 23 reference datasets: 
 
𝑊𝑎,𝑏 =




Where Aa,b is the bicor value between gene a and b in the acute infection data; Ra,b is the bicor 
provided by the reference datasets. In reference datasets from mouse, rat and axolotl, probe IDs were 
mapped to ensemble gene IDs, and to their human orthologue when one-to-one orthologues were available. 
Otherwise, they were excluded from the rest of the analysis. The weight (5.75) was selected to optimize 









Where Dg1,g2,i is the bicor value between g1 and g2 in reference dataset i. Given that the datasets 
can be of varying size and quality, the datasets were given individual weights (u), defined as the Spearman 
correlation coefficient between the vector of bicor values for the dataset (D) and the similarity values of the 
corresponding GO term. Biological modules were identified in the network using a modularity optimization 
algorithm (316). 
The complete R code and more details about the methods and the analytical pipeline used are 
available from Dr. Barrenäs (fredrik.barrenas@icm.uu.se) upon request. 
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5.3.5  Immunohistochemistry 
Samples of rectal tissue were collected from animals euthanized at baseline, at 1 dpi and at 3 dpi. 
The samples were fixed in SafeFix II (RMs) (cat# 23-042-600, Fisher Scientific) or paraformaldehyde 
(AGMs, see 3.3.3) and later embedded in paraffin. Antibodies against fibronectin (FN) (1:5,000 dilution; 
cat# 3776-1, Epitomics Inc.) and HAM56 (1:100 dilution, cat# 14-6548-93, eBioscience) were used for 
IHC as previously described (193). The IHC for FN was performed by Li et al. (School of Biological 
Sciences, University of Nebraska-Lincoln). and the HAM56 IHC was performed in our lab.  
Whole FN stained slides were scanned and digitized using an Aperio ScanScope slide scanner 
(Leica, Buffalo Grove, IL). For quantitative image analysis, the slide scans were imported into Aperio 
ImageScope software (Leica). Regions of the rectal lamina propria and epithelium were selected using the 
ImageScope drawing tools. FN expression was quantified using a positive pixel count algorithm in the 
Spectrum Plus analysis program (version 9.1). The parameters of the algorithm were manually tuned to 
accurately match the FN+ markup image over the background DAB stain. Once the parameters were set, 
the algorithm was applied automatically to all images to measure FN+ signals by area.  
Quantitative image analysis was also performed for HAM56 using the methodology described in 
4.3.11. Additionally, given that variable structure and cell distribution within the rectal lamina propria, the 
initial quantification was verified by performing additional imaging for the entire lamina propria from the 
epithelium to the underlying muscularis mucosa, when possible. To isolate the lamina propria alone for 
quantification, for each image the luminal space and all the surrounding tissue were manually excluded. 
Then, the standard color deconvolution technique was applied, with manual thresholding to isolate the DAB 
signal. Examples of this technique are shown in Appendix C. 
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5.3.6  Immunofluorescence 
We histologically examined fibronectin expression by macrophages in the gut by performing a 
double immunofluorescence (IF) stain for FN and HAM56, as described previously (317). Briefly, the 
paraffin tissue sections were deparaffinized by a battery of three 5 min washes in xylene and then rehydrated 
by 3-5 min sequential washes in 100%, 95% and 75% ethanol. Next, the slides were boiled in diluted 
Antigen Unmasking buffer (Vector Laboratories, Burlingame, CA) for 20-23 mins before being allowed to 
cool to RT. The slides were then washed three times in 1X PBS for 5 mins. The slides were then blocked 
with Protein Block (Dako, Santa Clara, CA) for 30 mins. The blocking solution was dumped off and the 
slides were incubated with the FN antibody (mouse IgG, ThermoFisher, clone FBN11, ref# MA5-11981) 
diluted to 1:100 with Antibody Diluent (Dako, Santa Clara, CA) for 1 hour at RT. After incubation with 
the first primary antibody, the slides were again washed three times in 1X PBS before incubating with the 
corresponding secondary antibody (donkey anti-mouse IgG, Abcam, Alexa Fluor® 488, ref# A-21121) 
diluted to 1:100 with Antibody Diluent for 30 mins. The slides were then washed three times in 1X PBS 
and incubated with the HAM56 antibody (mouse IgM, ThermoFisher, clone HAM56, ref# 14-6548-93) 
diluted to 1:100 with Antibody Diluent for another 60 mins. Following three more washes in 1X PBS, the 
slides were incubated with the corresponding secondary antibody (goat anti-mouse IgM, ThermoFisher, 
polyclonal, Alexa Fluor® 633, ref# A-21046) diluted to 1:100 with Antibody Diluent for 30 mins. The 
slides were then washed three more times in 1X PBS and incubated for 5 mins with DAPI (MilliporeSigma, 
Burlington, MA) at 1:5000 dilution in 1X PBS and then washed again. To reduce lipofuscin 
autofluorescence, the slides were incubated for 30-60 seconds with TrueBlack autofluorescence quencher 
(Biotium, Fremont, CA) and then washed in 1X PBS. Finally, the slides were washed for 5 mins in dH2O 
and then coverslipped using Fluorescence Mounting Medium (Dako). After staining, the slides were stored 
in the dark at 4°C until they were visualized with an Olympus Fluoview 1000 Confocal microscope 
(Olympus) housed at the Center for Biologic Imaging (University of Pittsburgh, Pittsburgh PA). All images 
were taken at 200X magnification. Maximum intensity projections (IPs) were generated from image z-
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stacks of 11-28 images using NIS Elements 5.20.00 (https://www.lim.cz/). Each image in the z-stack was 
taken 1.87 μm apart, with a resolution of 0.321 μm/pixel. The maximum IPs were processed and edited 
using FIJI version 2.069 (https://fiji.sc/).  Editing includes adjustment of color channel brightness for clarity 
and application of the built-in FIJI Despeckle median filter to reduce noise.  
5.3.7  Monocyte sorting and RNA sequencing 
To obtain monocytes for sorting, AGM and RM PBMCs were isolated from whole blood with 
EDTA diluted in sterile phosphate-buffered saline (PBS) and centrifuged for 30 mins at 1850 RPMs at 25°C 
layered over Ficoll-Paque gradient separation media (Lonza) at a 3:2 ratio. The isolated buffy coat was 
washed with 1X PBS and any contaminating red blood cells lysed using an ammonium-chloride-potassium 
lysing buffer (Lonza) for 10 mins before washing and pelleting the cells in 1X PBS (10 mins, 1800 RPM, 
25°C). Cells were counted using a LIVE/DEAD® Aqua Dead Cell Stain Kit (Life Technologies), stained 
with antibodies against CD14 and CD16 (Beckman Coulter) and incubated for 30 mins at RT before 
washing with FACS buffer (PBS + 2% FBS). Samples were sorted using a FACS ARIA II (BD 
Immunocytometry) and analyzed using FlowJo software. Collected monocytes (~50,000 cells/sample) were 
stored in RLT. RNA was isolated using RNeasy MicroKit (Qiagen) including DNase Digestion (Qiagen, 
cat# 74004 and 79254). The RNA quality and quantity were determined using a Bioanalyzer RNA Pico 
chip (Agilent, #5067-1513). The SMARTer Ultra Low Input RNA Kit for Sequencing-v3 
(Clontech/TAKARA, #634851) was used for first-strand cDNA synthesis and cDNA amplification (14 
cycles) starting with ~2 ng of total RNA. The amplified cDNA was cleaned using DNA Clean & 
Concentrato-5 kit (Zymo, D4014) and quantified using Qubit dsDNA High Sensitivity kit (Thermo, 
Q32854). Using the resulting purified cDNA (500 pg/library), the library construction was completed using 
three steps from the Illumina Nextera XT Library Prep (Illumina, FC-131-1096) workflow (Tagment DNA, 
Amplify Tagmented DNA, and Clean Up Amplified DNA). The resulting libraries were quantified (Qubit 
dsDNA High Sensitivity Kit) and sizes confirmed using a Bioanalyzer High Sensitivity DNA Chip Kit 
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(Agilent, 5067-4626). The gene libraries were sequenced to a depth of ~ 25 million raw reads/sample using 
a NextSeq 500, and 150 cycle, NextSeq 500/550 High Output v2 kits (Illumina, FC-404-2002). The rectal 
sequencing data, including gene counts, can be found in Gene Expression Omnibus (GSE111233). 
5.4 Experimental results 
5.4.1  Principal component analysis reveals differentially expressed genes between AGMs and RMs 
To identify the host responses that determine pathogenic outcomes in natural and  non-natural hosts, 
28 AGMs and 24 RMs were intrarectal inoculated with two genetically diverse swarm stocks (SIVsab92081 
and SIVmac251) previously shown to have comparable infection kinetics (127, 267).  
As such, in both the AGMs and the RMs, peak viral load occurred at 9-12 dpi, with 1.39 x 107 
vRNA copies/mL plasma in AGMs, and 2.48 x 107 vRNA copies/mL in RMs, as shown in Figure 30A. 
Here, the data are given as log10 values, with the AGMs shown in teal and the RMs shown in pink. There 
was a statically significant difference (p<0.05) between the plasma viral loads of the AGMs and the RMs 
at D50, as indicated by the asterisk. In Figure 30B, the principal component analysis of the 7420 
differentially expressed genes is shown, with the number on the axis to indicate the percentage of the total 
genetic variation explained. In Figure 30C, a heatmap displays representative genes sets derived by the 
principal component analysis. Genes with the strongest contribution to the genetic variation in proportional 
numbers are shown, taken from the top six principal components. The top enriched biological functions for 
each set of genes is listed on the right side of the heatmap. 
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Figure 30: Plasma viral loads, principle component analysis and differentially expressed genes of African 
green monkeys (AGMs) versus rhesus macaques (RMs). 
(A) Plasma viral loads in AGMs (teal) and RMs (pink), given as log10 values. Asterisks indicate statistical significance, 
with *=p<0.05. (B) Principle component (PC) analysis of the 7420 differentially expressed genes between the AGMs 
and RMs that showed the greatest divergence over time. The numbers on the axis indicate the percentage of total 
variation between the two species explained by the PC. (C) A heatmap showing the representative gene sets generated 
by the PC analysis. The genes with the strongest contribution to variation within the top six PCs are shown. A 
functional enrichment test was applied to these genes sets, with the top biological functions listed on the right side of 
the heatmap. 
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 At the set-point, the AGMs had plasma viral loads approximately one log lower than RMs (6.95 x 
104 vRNA copies/mL and 5.69 x 105 vRNA copies/mL, respectively, p<0.05). However, in the rectum 
samples, the viral loads were comparable between the AGMs and RMs (data not shown). 
The transcriptomic profiling showed highly divergent responses to acute SIV infection between 
AGMs and RMs. The rectal tissues collected during pre- and during the necropsy underwent total RNAseq 
profiling. The resulting sequence reads were mapped to the AGM and RM genomes for differential 
expression (DE) and other bioinformatic analyses. Direct comparisons between the two species utilized 
genes for which there were human ENSEMBL one-to-one orthologues for both the RMs and the AGMs. 
DE analysis was conducted in two ways: (i) for each time point, preinfection pinch biopsies taken from the 
rectum were used as baseline to compare with the rectal necropsy samples, resulting in hundreds of DE 
genes at each time point, with fewer than 10% being shared between the species at most time points (Table 
3); (ii) to avoid any potential bias due to utilizing different tissue sample type for baseline versus 
postinfection, pairwise comparisons were done between all the time points tested (all-to-all comparisons) 
for each animal model, which resulted in a union of 7420 DE genes between the two species (Table 3).  
 
Table 3: Results of DE Analysis of AGMs and RMs 
Time point 
AGM/SIVsab92081 RM/SIVmac251 Intersection 
n= Up-regulated Down-regulated n= Up-regulated Down-regulated Up-regulated Downregulated 
1 dpi 3 1703 687 4 903 2058 117 270 
2 dpi 3 690 71 4 231 893 41 17 
3 dpi 3 535 40 4 651 241 197 1 
4 dpi 3 1035 422 4 NA NA NA NA 
5-6 dpi 4 
2241 525 
4 28 195 25 9 
9 dpi 3 2265 1063 4 NA NA NA NA 
12 dpi 4 1707 526 4 729 575 299 77 
46-55/ 84 dpi 4 905 82 4 180 267 93 7 
All-in-all 
genes  6033  4294 4294 
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The principle component (PC) analysis (Figure 30B & C) demonstrated that many genes in AGMs 
were persistently up-regulated early during SIV infection (first PC). Conversely, the response from 1-4 dpi 
in the RMs was transient, subsequently returning to baseline gene expression levels (second PC). Gene 
Ontology (GO) enrichment revealed that the first PC (AGMs) showed up-regulation of genes linked to 
extracellular matrix organization, wound healing, fibroblast migration and focal adhesion assembly. The 
second PC (RMs) showed transient down-regulation of genes linked to epidermal growth factor signaling, 
endocytosis, viral transcription and embryonic development. The PCs enriched for typical immune 
responses (the fourth, fifth and sixth PCs) comprised only 16% of the total variability in the dataset. These 
gene sets were associated with antiviral immunity, T and B cell activation and chronic inflammation. The 
fourth PC (antiviral immunity, T-cell activation) was strongly induced at 12 dpi in RMs, which corresponds 
to the peak of viral replication. (Figure 30C).  
5.4.2  Systems biology approach defines distinctly different gene signatures across biological 
processes between pathogenic and nonpathogenic models 
As the initial analysis identified thousands of genes with divergent time kinetics between the AGMs 
and the RMs, we reasoned that the infection outcome is affected by specific cellular responses, occurring 
at different times following SIV infection. To understand the impact of these responses, the CGSA was 
devised as a systems biology approach for correlating acute SIV infection data with informative time series 
datasets from the public domain. 
This data-driven approach adds time dimensions to documented, static gene functions, avoids false 
positive gene-gene interactions and increases statistical robustness. To develop CGSA, we collected 
transcriptomic datasets (reference datasets) pertaining to GO Biological Processes enriched amongst the 
genes identified during the PC analysis, resulting in a catalogue describing four biological processes: wound 
healing (from skin or mucosal tissues samples collected post-wounding), experimental colitis (from colon 
tissues sampled post-oral dextran sulfate sodium or dinitrobenzene sulfonic acid administration), in vitro 
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cytokine stimulation of epithelial cells, and microbial colonization (from colon tissues collected from germ-
free mice after introduction of normal intestinal microbiota). Datasets from large-scale clinical studies of 
colon cancer and inflammatory bowel diseases were also included. These six biological processes 
encompassed 23 reference datasets, representing a total of 2438 microarray samples (Appendix A). We also 
constructed a co-expression network (the Acute SIV Co-expression Network) using our acute SIV infection 
RNAseq data, thereby identifying gene pairs that were co-expressed in both species.  
To determine if transcriptomic signatures from the reference datasets could produce the differences 
in gene expression between the AGMs and the RMs, we examined CGSA on a whole genome scale. 
Specifically, we calculated the Pearson correlation coefficient between the gene expression log fold change 




Figure 31: Whole geneome correlations between acute SIV infection of African green monkeys (AGMs) 
versus rhesus macaques (RMs) and gene reference datasets. 
Colors in the heatmaps represent the Pearson correlation coefficient between the log fold change values of gene 
expression during acute SIV-infection in the AGMs and RMs and the reference datasets for each of the timepoints 
listed on the left. The associated biological functions are listed above, and the specific species are listed below. For 
the wound healing response, datasets for wound healing at two time points post wounding, 24 hours and 7 days, are 
shown. For cytokine stimulation, changes in genes linked to interferon response at 12 hours post-stimulation and TNF-
 at 6 hours post-stimulation, are shown. Similarly, the colitis model dataset represents 7 days following chemical 
induction of colitis and the microbial colonization dataset represents 16 days post colonization of germ-free mice by 
normal intestinal flora.  
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This revealed that at the peak of viral replication, the transcriptional profile in RMs was correlated 
with microbial colonization, cytokine stimulation and, perhaps most importantly, tissue damage. These 
genes were associated with a variety of biological conditions included: the inflammatory stage of wound 
healing (Figure 31, Wound healing 24h), a period of strong neutrophil and M1 macrophage activation (318), 
and chemically induced colitis (Figure 31, colitis models). In contrast, the gene expression profile in the 
AGMs only moderately correlated to colitis models and cytokine stimulation (including type I (IFN-, IFN-
) and type II (IFN-), but not TNF-α) starting from the previremic (i.e., preramp-up) stage and then 
throughout the course of infection. However, any correlations to inflammatory wound healing and microbial 
colonization were negligible or negative. This suggests that AGMs upregulate certain immune pathways 
during the previremic (preramp-up) stage, but even during peak viremia, immune activation and tissue 
damage are limited. AGMs also showed stronger correlation to late stage wound healing (day 7) in the 
reference datasets. By day 7, the inflammatory stage of wound healing is normally resolved, and tissues are 
undergoing re-epithelization, angiogenesis and remodeling (319). 
5.4.3  Absence of microbial translocation signatures in AGM innate immune response 
The genome-wide comparison between acute SIV and reference datasets showed a stronger 
association between for RMs than AGMs with inflammatory tissue damage at peak viremia. To identify the 
genes responsible for this discrepancy, we systematically removed each of the 23 gene modules from the 
Acute SIV Co-Expression Network and re-calculated the correlation to the reference datasets in the AGMs 
and RMs separately. The module removal analysis suggested that in AGMs, the genes in the interferon 
module were specifically activated by innate immune signaling (“Cytokine stimulation”), while in RMs the 
module was also affected by bacterial PAMPs and tissue damage (“Wound healing 24h” and “Microbial 
colonization”). To confirm this independently, we used Ingenuity Pathway Analysis (IPA), which is based 
on manual curation of scientific publications, to identify upstream regulators of DE genes from both the 
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AGMs and the RMs. We performed Fisher’s exact tests between targets of each IPA upstream regulator, 
and DE genes in AGMs and RMs, using the interferon module as background (Figure 32A). 
 
 
Figure 32: Enrichment tests for biological functions of differentially expressed genes linked to inteferons 
during acute SIV infection. 
Enrichment of differentially expressed genes from African green monkeys (AGMs) (teal) and rhesus 
macaques (RMs) (pink) linked to upstream regulator targets (A & C) and biological functions (B & D) compared to 
all genes in the interferon gene module. The enrichment tests were performed for gene expression at 3 dpi and 12 dpi 
and the -log10 of the p-value are shown on the axis, with dashed lines indicating that p=0.05. The p-values were 




This interferon-based analysis supported a regulator role for bacterial LPS in RMs, but not AGMs, 
supporting the possible anergy to LPS observed in 4.4.12. However, both interferon-γ (IFN-γ) and 
interferon-α (IFN-α) type interferons had similar p-values for the two model systems. The AGM  immune 
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response showed stronger enrichment for interferon-λ (IFN-λ), a potent antiviral cytokine (320), and growth 
factor prolactin (PRL) which shows elevated levels in individuals with HIV (321). We repeated the 
enrichment analysis on biological functions, confirming stronger activation of antiviral and antimicrobial 
immune responses in RMs, while only the AGMs showed activation of leukocyte and myeloid cell 
recruitment genes (Figure 32B). This outcome agrees with the upstream regulator analysis, as several 
myeloid cell types, including macrophages and DCs, produce high levels of IFN-λ in response to viral 
infection (322). IFN-λ is known to inhibit HIV infection of macrophages, potentially contributing to the 
low rates of SIV infection of macrophages in natural hosts (323). 
Before the viremic (ramp-up) stage, there was little genome-wide correlation between 
inflammatory processes in the reference datasets (such as acute wounding, cytokine stimulation, colitis, 
microbial colonization) and SIV infection. However, several events that contribute to pathogenesis are 
previremic, including reduction of tight junction protein expression at 3 dpi (302). We therefore performed 
an upstream regulator analysis on the interferon module to determine if there was a gene expression 
indicating the presence of LPS at day 3 in RMs (Figure 32C). While the LPS signature was present 
(p=0.0038), there was no enrichment of any of the IFN-α, IFN-γ or IFN-λ targets. AGMs, by contrast, 
showed a stronger enrichment for targets of IFN-α, IFN-γ, IFN-λ and PRL without the presence of LPS, 
thus supporting an early antiviral response in the absence of microbial translocation. The functional 
categories at day 3 (Figure 32D) showed that AGMs were already expressing genes associated with myeloid 
cell migration. In addition, even though the genes encompassed by the interferon module are specifically 
regulated by interferons, the AGM DE genes within this module were also associated with tissue 
development (adipose, epithelial and muscle tissue). 
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5.4.4  Dominant signatures of noninflammatory wound healing occur early in host response to 
infection in AGMs but not RMs 
The genome-wide analysis showed an inflammatory tissue damage signature in RMs, while AGMs 
activated a signature similar to those seen during the later stages of wound healing. These observations 
suggested that unlike RMs, AGMs can limit tissue disruption of the gut epithelium during acute infection 
by rapidly repairing SIV-induced damage before it results in a colitis-like state and microbial translocation. 
The end result of this would be the prevention of the chronic inflammation associated with microbial 
translocation and maintenance of mucosal T-cell homeostasis (195). To investigate the gene signatures 
linked to these outcomes, we explored wound healing mechanisms in the Acute SIV Co-Expression 
Network and reference datasets. 
The six wound healing datasets included genes expression signatures from biopsies of healing skin 
or mucosal tissue in human, mouse or rat, as well as axolotl (Ambystoma mexicanum). Different from 
wound healing response in the majority of animal species, aquatic axolotl wound healing is non-
inflammatory and results in fully functional, scar-free tissue (324). The genome of the terrestrial axolotl 
species was used as comparison, as they exhibit a more mammal-like wound healing process (325). Using 
this data, we created a unique resource of wound healing signatures from different species, and different 
time points and tissues during acute SIV infection. The resulting network, referred to as the Wound Healing 
Network, contained 191 interactions between 166 genes.  
Using CGSA further revealed that the genes in the Wound Healing Network also showed consistent 
gene expression dynamics for wound healing across all reference datasets, except for the aquatic axolotl. 
For this species, the dynamics entailed down-regulation during the first 24-72 hours post-wounding, 
corresponding approximately to the inflammatory stage of normal mammalian wound healing, followed by 
up-regulation of genes during the later tissue remodeling and re-epithelization stage (326), as shown in  
Figure 33A.  
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Figure 33: Fold change, total number of genes and functional enrichment of differentially expressed genes 
within the Wound Healing Network. 
(A) The average log fold change values of the Wound Healing Network genes from each wound healing reference 
dataset, with day post wounding shown on the x-axis and log fold change shown on the y-axis. Filled circles indicate 
a significant change from baseline values, while empty circles indicate a lack of significance. (B) The number of up-
regulated and down-regulated genes in the Wound Healing Network at each time point during acute and early chronic 
SIV-infection in African green monkeys (AGMs) (teal) and rhesus macaques (RMs) (pink). (C) Functional enrichment 




 In the aquatic axolotl, the Wound Healing Network genes stayed near baseline expression level 
during the mammalian inflammatory stage but showed strong up-regulation during remodeling at day 7. In 
RMs, the Wound Healing Network genes were down-regulated during the first days post infection, and then 
returned to baseline expression levels. This pattern suggests that the RM host response to acute SIV 
infection involves the inflammatory stage of wound healing, but not the tissue remodeling (Figure 33B). In 
 140 
stark contrast, AGMs showed up-regulation of the Wound Healing Network genes at all time points, 
suggesting that they immediately activate late stage wound healing processes and, like the aquatic axolotl, 
bypassing the inflammatory stage of wound healing. Functional enrichment of the genes emphasized wound 
healing mechanisms critical for axolotl wound repair, including blood vessel development (327) 
(angiogenesis, proliferation/attachment of endothelial cells), tissue density (325) (permeability of blood 
vessel, integrity of basement membrane) and cell migration (328) (endothelial cells, fibroblasts and 
monocytes) in the Wound Healing Network (Figure 33C). 
5.4.5  Role of fibronectin in maintenance of AGM epithelial integrity 
In the Wound Healing Network, the contrast between the early response to SIV infection between 
the AGMs and RMs was similar to the contrast between early axolotl and mammalian wound repair gene 
signatures. To identify which specific axolotl-like repair mechanisms were present in the AGM SIV model, 
we examined what biological functions were up-regulated at day 1 of axolotl wound healing by calculating 
the Pearson correlation coefficient between membership in each IPA biological category (0 for non-
members, 1 for members), and the log fold change values of the genes. Six functional categories were found 
to be positively correlated with day 1 of axolotl wound repair, including known wound healing mechanisms 
(fibroblast development, infiltration of cells), but also tissue formation (adiposity, fibrous tissue 




Figure 34: Axolotl wound healing genes and immunohistochemistry for fibronectin in the rectal mucosa. 
(A) A heatmap of Wound Healing Network genes in axolotl wound repair and acute SIV infection. The genes are 
ordered based on the gene expression during day 1 of aquatic axolotl wound repair, with the most up-regulated genes 
at the top and the most down-regulated genes at the bottom. Six of the biological functions with a positive Pearson 
correlation coefficient with day 1 wound repair in the aquatic axolotl are shown to the right of the heatmap, along with 
their associated genes. (B) A IPA network showing the interactions of various proteins encoded by genes in the Wound 
Healing Network. At each of the nodes, red indicates up-regulation and blue indicates down-regulation at day 1 post 
wounding, with the aquatic axolotl on the left side of the node and the terrestrial axolotl on the right. (C) 
Immunohistochemistry staining for fibronectin in the rectum lamina propria at 1 dpi and 3 dpi in the African green 
monkeys (AGMs) and the rhesus macaques (RMs). At the top are shown the results of image-based quantification of 
fibronectin by pixel density. Asterisks indicating statistical significance, with *=p<0.05. Representative images of the 
immunohistochemistry staining for fibronectin are shown below, with the AGMs shown on top and the RMs shown 
on the bottom. 
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As genes frequently encode proteins that have a wide variety of functions and protein-protein 
interactions, we constructed a new network between the Wound Healing Network genes using protein 
interactions from IPA (329) (Figure 34B). The resulting network consisted mainly of ECM and cellular 
membrane proteins. The up-regulated genes at day 1 of axolotl wound repair (FN1, SDC2, FGFR1, LOXL2 
and SPARC) were all associated with cell migration, and most were critical for network connectivity. Many 
of the contacts between ECM components and cell surface proteins were mediated by FN1, through SDC2 
and FGFR1, while SPARC mediated connections between fibrous collagen proteins. These observations 
imply the wound healing mechanism in AGMs uses an axolotl-like repair process entailing FN1 mediated 
recruitment of endothelial cells, fibroblasts and monocytes. To confirm the role of the FN1 protein, 
fibronectin (FN), in maintenance of AGM tissue integrity, we performed IHC staining in rectal tissue at 
baseline, 1 dpi, and 3 dpi post SIV inoculation, for both the AGMs and the RMs. Quantification of FN 
expression showed down-regulation (p < 0.05, t-test) by day 3 in RMs, consistent with observations from 
the RNAseq, albeit delayed (Figure 34C). During SIV infection in both species, FN was primarily expressed 
in the lamina propria. However, in RMs FN showed more fibrillar structure than in AGMs, where the FN 
was more localized to the ECM (Figure 34C). 
5.4.6  AGM monocytes show overexpressed wound repair genes and transforming growth factor β 
Normal wound healing requires that every growth factor, cytokine and cell type is activated within 
a precise timeframe (318). Monocytes participate in both early and later stages of the process, as they can 
differentiate into inflammatory M1 macrophages or regulatory M2 macrophages. The M2 macrophages 
orchestrate later stages of mammalian wound repair and have been shown to be essential for axolotl wound 
healing (330, 331). 
Thus, we examined if macrophages support the wound healing mechanisms found in AGMs by 
conducting double IF staining for the macrophage marker HAM56 and the wound healing protein FN, as 
shown in Figure 35 & Appendix C.  
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Figure 35: Immunofluorescent staining for HAM56/FN in rectum lamina propria of African green monkeys 
(AGMs) versus rhesus macaques (RMs). 
Rectum from AGMs (top) and RMs (bottom) was doubled stained for HAM56 (red) and FN (green), with a DAPI 
stain (blue) to visualize nuclei. Colocalization, if any, appears as yellow. From left to right, representative images are 
shown from 0-6 days post infection. All images are at 200X magnification and were captured with an Olympus 
Fluoview 1000 Confocal Microscope housed at the Center for Biologic Imaging, Pittsburgh, PA. Each image 
represents a maximum intensity projection form a z-stack of 11-28 images at 1.78 m per step. The resolution of every 
image is 0.321 m/pixel. Maximum intensity projections were created with NIS Elements 5.20.00 
(https://www.lim.cz/). All image editing was performed using FIJI version 2.0 (https://fiji.sc/). Editing includes 




This showed while many HAM56+ cells were also FN+ in AGMs, most HAM56+ cells were FN- in 
RMs. Single HAM56 IHC staining did show any difference in the numbers of macrophages in the AGMs 
compared to the RMs (Figure 36 & Appendix C). 
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Figure 36: Quantification of immunohistochemistry for HAM56+ macrophages in African green monkeys 
(AGM) rectum lamina propria. 
Image based quantitative analysis was performed to measure the total positive DAB signal as percent area in the rectal 
lamina propria of AGMs (teal) and rhesus macaques (RMs) (pink).  (A) For each animal, a total of 9-12 individual 
images of the lamina propria were quantified and averaged. Selection of image regions was randomized to minimize 
bias. (B) However, given the variable structure and cell distribution within the lamina propria, the initial quantification 
was verified by performing additional imaging of the entire lamina propria from the underlying muscularis mucosa to 




These results strongly suggested that while the numbers of macrophages were similar in the two 
species, they exhibit a stronger wound healing phenotype in AGMs than in RMs.  
To test this hypothesis, we performed deep mRNAseq on M1 (CD14+) and M2 (CD14-/CD16+) 
monocytes isolated from blood samples taken at 7, 14, and 28 dpi from a different group of animals than 
used for the rest of the transcriptomics; this study group included two AGMs and four RMs. Due to the 
small number of animals, we avoided DE analysis, and leveraged the genome-wide dataset by a PC analysis 
analyzing the 1000 genes with the highest variance. The first PC allowed for separation of the AGM and 
RM monocytes, while the second PC delineated the M1 from M2 subtypes, including in samples taken 
before SIV inoculation, as shown in Figure 37A.  
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Figure 37: Genetic profiling of monocytes from African green monkeys (AGMs) and rhesus macauqes (RMs). 
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Monocytes were isolated from tissue collected from a set of AGMs and RMs not included in the original study and 
were used for RNAseq. (A) Principal component (PC) analysis of the 1000 most variable genes between the AGMs 
(teal) and RMs (pink). The shapes of the symbols representing each animal indicate the day postinfection: baseline 
(circle), 7 dpi (diamond), 14 dpi (triangle), 28 dpi (square). Dark colored symbols indicate M1 macrophages, while 
light colored symbols indicate M2 macrophages. (B) Functional enrichment of the monocytes transcriptomic 
signatures from the AGMs and the RMs. The biological functions represent the 300 genes with the strongest positive 
and negative correlation with PC1 shown in (A). (C) The number of up-regulated and down-regulated genes from the 
rectum of the AGMs and RMs that overlapped with the genes in the AGM or RM monocyte signatures. (D) Expression 
levels for predicted upstream regulators of the Wound Healing Network genes in the AGM and RMs peripheral blood 
monocytes. Number (“N”) indicates the number of genes in the Wound Healing Network linked to that regulator and 
p-values are for the corresponding enrichment test. The symbol shapes and colors used are the same as in (A). (E) A 
heatmap of the expression of Wound Healing Network genes in the AGM and RM monocytes. As the greatest 
contribution to variation here was introduced by the species and monocyte subset, not the time postinfection, 
expression Z-scores are shown instead of log fold change values. The column to the right of the heatmap shows genes 
that are significantly up-regulated in the axolotl wound healing response. Genes that are up-regulated at 1 day post-




These results clearly demonstrate that for both AGM and RM monocytes, the M1 and M2 
monocytes had distinct transcriptomic profiles, both before and after SIV infection. Functional enrichment 
tests revealed that the 300 genes most over-expressed in AGMs (i.e., the AGM monocyte signature) was 
associated with embryonic tissue development (abnormal morphology of embryonic tissue, morphology of 
ectoderm) and epithelial-mesenchymal transition (EMT) of epithelial cells (Figure 37B). These gene 
signatures suggested that AGM monocytes have stem cell-like properties and greater differentiation 
potential than normal monocytes, in keeping with axolotl-like tissues. In contrast, the corresponding RM 
monocyte signature was primarily enriched for macrophage mediated antiviral immunity (Figure 37B).  
As the monocytes and rectal tissues analyzed here were obtained from different sets of animals, we 
evaluated the overlap between the genes in the AGM or RM monocyte signatures to the DE genes from the 
rectal tissue data (where most monocytes are differentiated into tissue macrophages). In AGM rectal tissues, 
genes from both the determined AGM and RM monocyte signatures were differentially expressed 
throughout the course of infection (Fig 38C). On the other hand, in the RMs both the AGM and RM 
monocyte signatures are predominantly down-regulated during the previremic stage of infection (1-4 dpi). 
Only at 12 dpi was the immune-associated RM signature up-regulated.  
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Thus, AGM tissue macrophages showed a wider range of monocyte responses, encompassing both 
tissue development and immune activation. RM tissue macrophages, by contrast, lack the wound healing 
profile of AGM macrophages, and produce a primarily inflammatory monocyte response to SIV infection.  
To investigate how the monocytes contribute to wound healing in AGM rectal tissue, we examined 
the expression of predicted upstream regulators of the Wound Healing Network from IPA, in both the AGM 
and the RM peripheral blood monocytes. Out of the all the wound healing regulators that were expressed 
in the monocytes, three (TGFB1, ERBB2, and SMAD7) showed higher average expression levels in AGM 
monocytes (both M1 and M2) compared to RM monocytes. One, AHR, had comparable levels of expression 
in the two models, as shown in Figure 37D. Here, the number of regulator target genes in the Wound 
Healing Network and the p-values pertain to the corresponding enrichment test are shown, with the colors 
and symbols matching Figure 37A. 
It is known that during axolotl limb regeneration, macrophages secrete TGF-β to supply the 
growing tissue with new cells through influx and proliferation (332). The remaining regulators encoded an 
epidermal growth factor receptor (ERBB2), nuclear receptor (AHR) and transcription factor (SMAD7), that 
presumably regulate gene expression in the monocytes themselves. We therefore examined the Wound 
Healing Network genes that were over-expressed in AGM peripheral blood monocytes. Among the 1000 
most variable genes in the monocyte dataset, 19 were Wound Healing Network genes (Figure 37E). Since 
most of the variation within the genes was introduced by species and monocyte subset and not time point, 
we show expression Z-score instead of log FC values. Three of the 19 genes were up-regulated at day 1 of 
axolotl wound repair, as shown by the dark blue marks on the column to the right of the heatmap (the light 
blue marks indicate genes up-regulated at 7 dpi): FN1, TGF-β release factor LTBP3 and cellular receptor 
SDC2, a mediator of TGF-β signaling (333). The PCA analysis also included WLS, a mediator of wnt 
secretion, which was elevated in AGMs. Wnt is another major meditator in tissue regeneration pathways in 
several different species, including the aquatic axolotl (334).  
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5.5 Discussion 
Natural hosts of SIV, such as the AGM, avoid disease progression and maintain immune cell 
homeostasis following SIV infection and in the face of persistent viral replication. Additionally, natural 
hosts are characterized by a lack of the chronic inflammation that is typical of pathogenic SIV/HIV 
infections. By studying how natural hosts control pathogenesis, new avenues for the development of 
therapies to prevent both AIDS and chronic inflammatory diseases. To help determine the mechanisms by 
which AGMs are able to avert progression to AIDS, a transcriptomic analysis was performed to study 
differential gene expression over the course of infection in a nonpathogenic (AGM) and pathogenic (RM) 
SIV host. By using tissue samples, including the site of inoculation, collected during acute SIV infection 
into early chronic infection, this study complements previous transcriptomic studies, which have focused 
only on  later time points during infection or immune cells from peripheral blood (156, 163). 
 However, one of the major issues during transcriptomic profiling of whole tissues is that it lacks 
biological resolution, being unable to differentiation factors like individual cell types. To help circumvent 
this, CGSA was developed, which is a unique bioinformatic pipeline that integrates curated transcriptomic 
reference data from a diverse set of species to interpret gene expression signatures. By drawing from a large 
and varied body of reference data, CGSA avoids some of the limitations in preexisting knowledge. The 
large amount of CGSA reference data also adds statistical robustness to the analysis and reduces the false 
gene-gene associations that are common in co-expression analysis, as biologically relevant interactions tend 
to be conserved (335). 
 Following SIV challenge, the transcriptomic analysis revealed thousands of differentially 
expressed genes in rectal tissue samples taken from the AGMs and the RMs (Figure 30). A major feature 
of the AGM response to infection was a unique regenerative wound healing signature facilitated by blood 
monocytes and tissue macrophages. This tissue repair process was associated with preservation of mucosal 
integrity and absence of the inflammatory phenotype of tissue damage in progressive HIV/SIV infections. 
Thus, the wound healing signature in AGMs could be critical for the maintenance of mucosal integrity and 
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preservation of mucosal immunity, which, in turn, may contribute to the prevention of disease progression 
in SIV/HIV infections. While this response seems to be spearheaded by monocytes and macrophages, it is 
likely that other immune cells types are involved and should be investigated in future studies.  
 The AGM wound healing signature was identified by CGSA using reference data from a Mexican 
salamander species, the aquatic axolotl. Unlike their terrestrial cousins, aquatic axolotls never fully mature 
from their tadpole-like form, and possess semi-undifferentiated, almost fetal-like tissues. This enables the 
axolotl to accomplish healing in a fashion similar to embryonic development, totally bypassing the 
inflammatory stage of healing. After wounding, axolotl epithelial cells and keratinocytes migrate rapidly 
across the wound to restore the external barrier, then initiate basement membrane regeneration and tissue 
remodeling (328). This produces scar-free, fully functional new tissue (325). Outside of restoring 
functioning tissue, limiting tissue damage without killing the pathogen is known strategy for achieving 
immune tolerance and avoiding inflammatory responses to microbial infections (336). As such, the AGM 
wound healing phenotype links with protection against disease progression in SIV infection. 
 In addition, several recently reported genetic factors can support the wound healing profile AGMs. 
These include accelerated evolution of genes that viral interactions with host cells and growth factor 
signaling (337), as well as variant of TLR4 that can limit LPS responses in natural hosts, possibly limiting 
the amount of tissue damage caused by events such as MT (308).  
 In AGMs, the wound healing response includes several constituents of the basement membrane, 
which is a collagen-rich sheet separating the intestinal epithelium from the lamina propria; it is also one of 
the first tissue structures to regenerate after limb amputation in salamanders (338). Normal basement 
membrane proteins involved in wound healing include: (i) collagens, which are major structural proteins; 
(ii) laminins, which anchor cells to basement membrane (339); (iii) nidogens, which tether collagen to 
laminin (339); and (iv) fibrillin, which improves ECM elasticity (340). Collagen deposition in axolotl 
wound healing is minimal, similar to the lack of collagen formation that we observed in the AGMs 
postinfection (see 4.4.11) However, various other ECM proteins are transiently expressed at the margin of 
the wound, including fibronectin. Fibronectin is a large ECM protein, crucial for both early and late wound 
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healing stages (341) and expressed in the basement membrane of regenerating axolotl limbs (342). 
Formation of the fibronectin matrix starts at cellular surfaces, where α5β1 integrin binds soluble fibronectin 
to create complexes, that are then stretched into fibrils through cellular contractions. Here, IHC and IF 
(Figures 34 & 35) showed that in AGMs, the fibronectin was concentrated to the ECM, were it would be 
primed to initiate the wound healing response (341) and thus accelerate the tissue repair process.   
The axolotl regeneration ability is based on their embryonic maturation state and entails a distinct 
immune cell profile, characterized by low neutrophil infiltration, as we observed in the IHC of the gut (see 
4.4.7). It is also involves the specific recruitment of TGF-β secreting M2 macrophages (332). Although 
mammalian wound healing is also associated with M2 macrophages, both M1 and M2 AGM monocytes 
showed a distinct embryonic tissue development profile, including the TGF-β gene. Thus, CGSA has 
expanded the wound healing/M2 macrophage paradigm to protection and will be used in future studies to 
explore for other immune cells that might regulate the wound healing response.   
The transcriptomic analysis showed that the embryonic development signature (Figure 37) and 
fibronectin tissue localization (Figures 34 & 35) were present in the monocytes/macrophages of the AGMs 
prior to infection. This implies that the intestinal mucosa of AGMs, a natural host of SIV, is constitutively 
poised to mount a protective wound healing response to infection. In a similar fashion, axolotl keratinocytes 
are constantly poised to migrate into any fresh wounds or injuries, due to their constitutive integrin 
expression (343). It is possible that the noninflammatory wound healing response in AGMs (and possibly 
other natural hosts) is an evolutionary adaption developed over many generations (see 1.1) to prevent loss 
of gut integrity and the subsequent establishment of the highly deleterious chronic inflammation that 
follows.  This supports the conclusion that the tissue repair phenotype in AGMs is dynamic and directed 
by monocytes in general as a feature of protection against SIV pathogenesis (177). 
Given the critical role of the wound healing response in preventing pathogenesis in SIV infected 
AGMs, development of therapeutic strategies that could replicate this response to at least some degree in 
humans might serve to help suppress and control HIV disease progression. In an era of widespread antiviral 
therapy, even without achieving viral clearance, relieving the financial and social burden of long-term 
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treatment to prevent progression to AIDS would be a great boon to millions of HIV+ individuals around the 
world. Already, some therapies, such as the administration of IL33 to cutaneous wounds, have shown 
beneficial effects in accelerating wound healing, enhancing re-epithelization, activating M2 macrophages 




6.1 Site of inoculation 
6.1.1  SIVsab replication is established immediately at the site of entry following rectal inoculation 
We identified sections of the rectum and distal colon that might represent the original foci of viral 
replication, with detectable levels of virus DNA/RNA in the tissue by 1-3 dpi (Figure 4 & 5). Using 
RNAscope, we were able to confirm these findings by visualizing SIVsab RNA in the lamina propria of the 
distal colon during the same preramp-up period (Figure 6), with rare instances of viral RNA as early as 1 
dpi.  
6.1.2  The virus enters into circulation very rapidly following infection 
Using standard qPCR, SIVsab RNA was first detectable in the plasma by 6 dpi, (Figure 2). This 
standard qPCR method has a limited sensitivity though, being only able to detect down to 30 RNA 
copies/mL plasma. Viral concentrations lower than this limit of detection are not quantifiable. We bypassed 
this limitation by employing an adapted version of the SCA, which has a limit of detection of 1 RNA 
copy/mL plasma. By SCA, we found that most of the animals that had been previous detectable earlier 
during the ramp-up period, at 4-5 dpi, had viral loads between 100-101 RNA copy/mL plasma (Figure 2). 
SIVsab RNA was also detected by SCA in the plasma AGMs at 2 dpi and 3 dpi (Figure 2), though the level 
of virus in these animals technically fell below the limit of detection. 
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6.1.3  SIVsab is disseminated through the lymphatics early during infection 
Apart from the rectum and distal colon, one of the other tissue compartments that SIVsab first 
became detectable in was the colonic LN (Figure 4). Viral RNA was found in the colonic LNs, which drain 
the site of inoculation, as early as 1-3 dpi. Detection of SIVsab very early in the draining LNs, followed by 
establishment of plasma viremia by 4-6 dpi, indicates that the virus disseminates rapidly from the site of 
inoculation to the lymphatics and then through the lymphatics into the bloodstream. 
6.1.4  Viral spread during acute SIVsab infection is highly pervasive 
Not only is the dissemination of SIVsab from the site of inoculation extremely rapid, it is also 
highly pervasive. Out of 38 tissue compartments that were surveyed, 37 of them were positive for vRNA 
by 4-6 dpi and all became positive for vRNA by the peak of viral replication. The virus even rapidly crossed 
the blood brain barrier, as was reflected not only by the tissue viral loads, but also the levels of virus in the 
CSF. In fact, in some cases, the virus became detectable by qPCR in the CSF early during the infection, 
when the virus was undetectable in the plasma without the use of SCA (Figure 3).  
6.1.5   A partial bottleneck of transmitted/founder viruses occurs during SIVsab intrarectal 
transmission 
In the preliminary study, it was demonstrated with SGA that infection was established by a single 
transmitted/founder virus in in both intravaginally and intrarectally infected AGMs (78). However, the 
observed number of transmitted/founder viruses per AGM in this study ranged from 3-10 variants (Figure 
7). However, the original inoculum was highly diverse, meaning that the number of viruses that went on to 
successfully establish infection was severely reduced by the genetic bottleneck imposed by the mucosal 
epithelium. 
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6.1.6  CD3+ T cells are the primary target cell of SIVsab 
Using FISH, SIVsab was shown to infect CD3+ T cells in both the rectum and the distal colon, 
reinforcing these cells as the primary target cells supporting viral replication following transmission. This 
was true in both the lamina propria, as well as in the lymphoid aggregates. The virus did not appear to infect 
myeloid lineage cells at the site of entry, with no viral RNA association with the myeloid cell types. This 
is expected of transmitted/founder viruses, as discussed in 1.4.4 and in agreement with previous studies 
(88, 107, 139) (Figure 8).  
6.1.7  There were minimal alterations to primary and innate immune cell populations at the site of 
entry, with little to no immune activation 
While transmission and viral dissemination from the site of inoculation were rapid in AGMs, 
SIVsab infection appears to have had very little impact on both primary and secondary immune cell 
populations in the rectum or the draining LN (Figures 9-12). In general, the levels of various immune cells 
at the site of inoculation, including CD4+ and CD8+  T cells, CD20+ B cells, DCs, monocytes/macrophages, 
and natural killer cells, did not change during acute or early chronic SIVsab infection. These same 
populations also showed little to no alteration in activation status, as measured by activation markers such 
as HLADR, CD38 and CD69. Any changes that did occur either lacked significance or were transient, with 
return to baseline levels by the set-point of viral replication.  This was similar to the low levels of immune 
activation observed elsewhere in the tissues more distal to the site of inoculation, including other sections 
of the gut and peripheral LNs (see 6.2.1).  
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6.2 Mucosal integrity 
6.2.1  CD4+ T-cell populations are relatively stable in the gut despite high levels of viral replication 
Following intrarectal challenge with SIVsab, we found high levels of viral replication starting as 
early as 4-6 dpi in sites distal from the site of inoculation, including the jejunum, transverse colon and 
axillary LN. We identified both viral DNA and viral RNA in these tissues (Figures 4 & 5). Appearance of 
virus in these distal tissues matched establishment of plasma viremia levels detectable by qPCR, indicating 
that this likely represents seeding of the tissues by plasma virus (Figure 2).  Virus replication in the jejunum, 
transverse colon and axillary LNs (Figures 4 & 5) was not associated with significant loss of target cells, 
with CD4+ T cells populations being unaltered during the early stages of infection (Figure 13), as was also 
the case in the rectum and colonic LN (Figure 9). However, there was a significant depletion of CD4+ T 
cells in the blood during the acute stage of SIVsab infection. This depletion was only transient, with loss of 
significance by early chronic infection, though this may have been due to smaller number of animals in that 
time group.  
6.2.2  AGMs also exhibit low levels of immune activation in tissue distal to the site of inoculation 
Used as a maker of immune cell activation and proliferation, Ki-67 expression levels by CD4+and 
CD8+ T cells or CD20+ B cells did not significantly increase in either the gut or the LNs at any point during 
acute SIVsab infection, by either flow cytometry (Figure 16) or IHC (Figure 19 & Appendix C). In contrast, 
Ki-67 expression increased in both the gut and LNs of chronically SIVmac-infected RMs (Figures 19A-C). 
There was also little to no alteration of expression of activation markers such as HLADR, CD38 and CD69 
by either the CD4+or CD8+ T cells (Figure 18), as was also observed at the site of inoculation (Figure 12).  
Additionally, RNAseq revealed little to no change in gene expression related to immune activation that 
would indicate CD4+and CD8+ T cells or CD20+ B cell activation during acute infection (Figures 22 & 23). 
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6.2.3  Alterations in plasma cytokine and chemokine levels in response to infection are limited and 
transient, with two distinct waves of expression 
We observed that several soluble markers of inflammation were increased during the acute SIVsab 
and early chronic infection in AGMs: (i) eotaxin (CCL11), a chemokine for eosinophils and possibly resting 
T cells and neutrophils (345), was strongly increased at both 3-4 dpi and 9-12 dpi; (ii) IL-1RA (IL1RN), an 
antagonist of the inflammatory IL-1 receptor (346), was also increased in plasma during acute infection and 
remained elevated at the set-point, but fell to baseline levels during the chronic infection; (iii) IL-8 
(CXCL8), a neutrophil chemotactic factor also shown to be a chemoattractant for T-cell and basophils (347, 
348), was increased throughout the acute and postacute infection, but returned to the baseline levels during 
late chronic infection; (iv) IP-10 (CXCL10), a chemoattractant for monocytes and T cells associated with 
HIV disease progression (266, 349, 350), exhibited very large increases (>100x) in some AGMs, 
particularly around the viral load peak, but was already normalized by the set-point of infection; a similar 
increase was observed in the levels of I-TAC (CXCL11), a T-cell chemokine strongly induced by IFN-γ 
along with IP-10 (351). Apart from these, MCP-1 (CCL2), a chemoattractant for monocytes, memory T 
cells and DCs (352), MIF (GIF), a proinflammatory  cytokine associated with HIV infection (353, 354) and 
RANTES (CCL5), a T-cell chemotactic chemokine and possible CD8+-mediated HIV suppressor (355, 356) 
were all increased in the majority of 3-4 dpi AGMs, and in all 9-12 dpi and 46-55 dpi animals, but returned 
to preinfection levels in the chronically SIV-infected historic controls (Figure 17).  
6.2.4  AGMs have little to no recruitment of neutrophils to the gut despite having relatively large 
populations of resident neutrophils 
As T-cell immune activation is usually accompanied by an innate immune response and recruitment 
of neutrophils, we assessed neutrophil populations and found little to no neutrophil accumulation in the gut 
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mucosa or the superficial LNs (Figure 20 & Appendix C). In comparison, the chronically SIV-infected RMs 
had large numbers of neutrophils recruited to the gut. (Figures 20A & C). We also saw no major change in 
MPO gene expression levels in the AGMs at any time during infection (Figure 23), suggesting that 
neutrophil activation and MPO expression is not altered during acute SIVsab infection.  
6.2.5  There are few alterations to macrophage, dendritic cell, and natural killer cell populations in 
the gut 
The overall levels of innate immune cells types, including DCs, monocytes/macrophages and NK 
cells (Figure 15) remained relatively stable in the distal tissues during acute SIVsab infection. This is in-
line with the same populations at the site of inoculation (Figure 11), and in agreement with the lack of 
neutrophil recruitment during acute and early chronic SIV infection. It should be noted that there were 
significant decreases in the levels of monocytes/macrophages and natural killer cells in the blood during 
the preramp and ramp-up periods of acute infection, but these changes were only transient, with a loss of 
significance at the peak of viral replication (Figure 15).  
6.2.6  AGMs exhibit a strong interferon-linked response to infection 
The SIVsab-infected AGMs exhibited a significant anti-viral response in both the gut and the LNs, 
observed here as a large increase in production of MX1 at the peak of viral replication (Figure 21 & 
Appendix C). However, this response was only transient, with a total return to baseline levels by the early 
chronic stage of infection. Inversely, the RMs had high levels of MX1 expression into chronic stage of SIV 
infection (Figures 21). The magnitude of the MX1 present in the tissues was similar at the peak of SIVsab 
infection in the AGMs and during chronic SIVmac infection in the RMs, which was reflected in the RNAseq 
analysis of gene expression in both species (Figure 23), where MX1 and the interferon-linked CXCL10 and 
CXCL11 showed strong up-regulation. 
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6.2.7  There is little to no increase in the fraction of apoptotic immune cells in response to SIV 
infection 
Despite the high levels of viral replication,  we found no significant increase in the levels of active 
caspase-3 in the tissues (Figures 24) at any time-point during acute or early chronic infection in SIVsab-
infected AGMs, as was seen in previous studies (198). This is in contrast our findings in the SIV-infected 
RMs, where we observed high levels of active caspase-3 during the chronic stage of infection (Figure 24). 
The lack of apoptosis in the AGMs mirrors the lack of immune activation, proliferation and inflammation 
in response to infection (Figures 13-23) 
6.2.8  AGMs maintain the homeostasis and integrity of the gut epithelium during acute and chronic 
SIVsab infection  
In line with the lack of apoptosis in the gut, staining for the tight junction protein claudin-3 showed 
that AGMs sustain no major cell death or damage to the gut epithelial during SIVsab-infection, even during 
the peak of viral replication (Figures 25A, B & D & Appendix C). By comparison, there were numerous 
lesions and breakages in the gut in the chronically infected RMs (Figure 25C & D). The constancy of the 
gut mucosa in AGMs in the face of SIVsab-infection was also reflected by the lack of significant alterations 
in the plasma levels of I-FABP, a marker of enteropathy (Figure 25E).  
 Preservation of the gut architecture in the AGMs was also observed by total lack of fibrosis, both 
in the gut and the LNs (Figures 26 & Appendix C), with none of the build-up of collagen associated with 
fibrosis in pathogenic infections (284, 303–305). This is unlike the chronically infected RMs, where large 
amounts of collagen were present, particularly in the LNs, indicating extensive fibrosis. To support these 
results, we tested for plasma levels of a hyaluronic acid, a marker of fibrosis, and found that hyaluronic 
acid in the plasma was not significantly altered throughout the follow-up (Figure 26D).  
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6.2.9  No microbial translocation occurs during acute SIVsab infection in AGMs 
Maintenance of the mucosal integrity in the AGMs would result in lack of MT and, indeed, we 
found no increase in the amount of LPS-core or the number of E. coli in the lamina propria and LNs of our 
SIVsab-infected AGMs. None of these markers showed significant increases during either acute or 
postacute SIVsab infection (Figures 27 & 28 & Appendix C), in contrast with the chronically SIV-infected 
RMs, which had high levels of LPS and E. coli (Figures 27 & 28). Furthermore, quantitative image analysis 
revealed that these two markers of MT were significantly higher in the LNs of the RMs during chronic 
SIVmac infection than in the AGMs during early chronic SIVsab infection.   
6.3 Epithelial wound healing response 
6.3.1  AGMs exhibit a unique wound healing response mediated by macrophages and monocytes 
Following intrarectal inoculation with SIVmac251 in RMs and SIVsab92018 in AGMs, 
respectively, we found highly divergent patterns of gene expression. This schism included thousands of 
genes which were differentially expressed in response to infection (Figure 30).  From this set of DE genes, 
a unique regenerative wound healing signature was identified in AGMs, which was wholly absent in the 
RMs. This wound healing response was activated by monocytes in the peripheral blood and then further 
propagated by tissue macrophages resident to the site of inoculation (Figure 37). The AGM-specific wound 
healing was linked with preservation of mucosal integrity and the absence of the inflammatory phenotype 
typically associated with the normal wound healing response following injury (Figure 31) and matches the 
observations made of the AGM gut during SIV infection, as described in 4.0.  
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6.3.2  The AGM wound healing response is scar-free and is not associated with inflammation 
AGM wound healing signature was discovered by CGSA to be similar to gene expression in a 
primitive species of Mexican salamander, the axolotl. Axolotls are able to accomplish wound healing via a 
noninflammatory pathway that bypasses the early inflammatory stage of wound healing (Figures 33 & 34). 
This enables the axolotl to avoid the immune activation and tissue damage that accompany the inflammation 
that occurs post wounding. Given that acute SIV-infection is already associated with limited immune 
activation and inflammation (see 3.0 and 4.0), the AGM wound healing phenotype could contribute to 
protection against both inflammation and disease progression during SIVsab infection. 
6.3.3  Fibronectin plays a critical role in the wound healing response in the AGM gut epithelium 
Here, IHC and IF imaging for fibronectin (Figures 34 & 35) showed that in AGM mucosal tissue, 
fibronectin, a scaffolding protein that is critical for organization of proteins necessary for the wound healing 
(Figure 34B), was concentrated to at the ECM, where fibronectin polymerization is initiated during wound 
repair (341). In RMs, fibronectin was predominantly present at low levels or as diffuse extracellular fibrils. 
This cellular localization of fibronectin in AGMs could potentially accelerate wound healing compared to 
RMs.  
6.3.4  Fibronectin is strongly associated with macrophages in AGM.  
Using IF staining and imaging, we found that fibronectin frequently colocalized with macrophages, 
which were delineated using HAM56, a marker specific to mature macrophages (Figure 35 & Appendix 
C). This colocalization occurred both prior to inoculation and during the early stages of acute SIVsab-
infection. In the RMs, colocalization of fibronectin with the macrophages was rare to nonexistent. This 
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suggests that in AGMs the macrophages play an integral role production and assembly of fibronectin and 
therefore facilitate formation of the entire complex of wound healing proteins.  
6.3.5  AGM macrophages exhibit a distinct wound healing phenotype 
Normally, wound healing is predominantly associated with M2 macrophages and not with 
inflammatory M1 macrophages. However, the wound healing gene expression signatures observed in both 
classically activated M1 and alternatively activated M2 monocytes in AGMs (Figures 37 & 38). Both the 
M1 and M2 macrophages in the AGMs also were found to express several upstream regulators of the wound 
healing response, including TGF-, SMAD7, and ERBB2. Similarly, the AGM macrophages, but not the 
RM macrophages, expressed key genes upregulated during the early axolotl wound healing response, 
including FN1, MRC2, ADAMTS2 and SCD2 (Figure 37).  
6.3.6  The AGM gut epithelium is already primed for wound healing prior to SIVsab infection 
When examining gene expression linked to wound healing in AGMs, both the embryonic 
development signature and fibronectin tissue localization were present in AGM monocytes pre-inoculation, 
as shown by both the transcriptomics and IF imaging (Figures 34B, 35 & Appendix C). The upstream 
regulators of wound healing and the axolotl wound healing genes were also already upregulated in the 
baseline AGMs, prior to SIV infection (Figure 37). This shows that in AGMs, the wound healing response 
is already primed for activation before the infection even begins.   
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6.4 Future Directions 
6.4.1  Assessing the ability of AGM macrophages to repair damage in an epithelial wounding model 
 As shown in 5.4, one of the defining characteristics of AGMs is their unique wound healing 
process, which is similar to that of the aquatic axolotl. This type of wound healing is nonfibrotic, forming 
new, fully functional, scar-free tissue. It is also noninflammatory, having a similar gene expression profile 
immediately post wounding that other species would have much later, at 7 days post wounding (Figures 31 
& 33). The transcriptomic analysis identified that at least one of the major mediators of the AGM wound 
healing response are monocytes/macrophages, with AGM peripheral blood monocytes exhibit similar 
wound healing signature to the axolotl (Figure 37). Macrophages were also shown to be strongly associated 
with the wound healing related-linked protein fibronectin in AGMs, but not RMs, using IF (Figure 35 & 
Appendix C) 
 However, this singular capacity of AGM monocytes/macrophages to facilitate tissue repair was not 
demonstrated functionally. To show this, one possible experiment would be to use an in vitro model of 
epithelial wounding. Recently, a new model for studying epithelial wound healing has been described. 
Compared to previous models which relied on undifferentiated monolayers of epithelial cells, this model 
uses stratified human corneal epithelial cells, which exhibit proper cellular differentiation and polarization. 
Even more importantly, these cells demonstrated normal wound healing response, with epithelial cell 
migration and restoration of the transcellular barrier and apical intercellular junctions (357).  
 Using this model, it would be possible to test the wound healing capacity of AGM macrophages 
by introducing them in culture and inducing wounding of the epithelial cells. The macrophages would need 
to be isolated from a tissue, likely from the blood, as was done in this study (see 5.3.7), before being added 
to the epithelial cell culture. Several factors would need to be addressed, including: (i) assessing the viability 
of the AGM macrophage in culture with human epithelial cells; (ii) testing macrophages from AGMs versus 
RMs: (iii) ascertaining if the macrophages require additional activation to stimulate repair.  
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6.4.2  Functional characterization of M1 and M2 macrophages from AGMs and RMs  
 The transcriptomic analysis of the monocytes/macrophages from the AGMs and RMs was extended 
to differentiate M1 and M2 macrophages. Generally, M1 macrophages are “kill” macrophages are involved 
in the immune responses against infection and stimulate inflammation and immune activation. M2 
macrophages are the “heal” macrophages, producing growth factors, reducing inflammation and helping to 
clear cellular debris (358). Here, we found that the M1 and M2 monocytes/macrophages from AGMs had 
distinct genetic signatures and phenotypes compared to the RMs; here, both M1 and M2 macrophages 
expressed genes linked to wound healing. Some of these same genes were also associated with the wound 
healing response in the axolotl. 
 Not only is this phenotype crucial to the AGM wound healing response, it is also highly unusual in 
a more general sense. However, it has traditionally be difficult to separate due to lack of specific cell 
markers and, consequently, M1 and M2 macrophages are frequently generated by differentiation in culture 
(359). Recently, two new markers have been described to delineate M1 (CD38) and M2 (Egr2) 
macrophages. Using these markers, it may be possible to separate the M1 and M2 monocytes/macrophages 
from peripheral blood taken from AGMs and RMs. Functional studies could then be performed to 
characterize the macrophages and determine if the M1 and M2 cells from AGMs exhibit similar functions 
related to wound healing, such as production of TGF-. It would also be informative to attempt to introduce 
the M1 and M2 cells from the AGMs and RMs separately into the epithelial wound healing model described 
in 6.4.1. 
6.4.3  Depletion of macrophages in AGMs prior to SIVsab infection 
 A studies from our group showed that depletion of CD8+ T cells (174) and CD20+ B cells (187) 
had no lasting impact on SIVsab-infection in chronically infected AGMs. That being said, the essential role 
that monocytes/macrophages in facilitating the wound healing response in AGMs that was demonstrated 
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by this study suggests that removing them from the equation might impact disease progression. The problem 
is that there is little to no work done on depleting monocytes/macrophages in nonhuman primates. In mice, 
monocyte/macrophage depletion is often accomplished through injection of liposome-encapsulated 
clodronate (360, 361). However, this treatment has not been adapted to NHPs due to a narrow therapeutic 
window, poor tolerability and liver toxicity (362).  
A relatively recent study demonstrated a novel method for monocyte/macrophage depletion; after 
failing to deplete using a CD14-depelting antibody, rhesus macaques were treated with liposomal 
bisphosphonate alendronate, resulting in consistent depletion of the monocytes in the blood and 
macrophages in the tissues and an increased frequency of monocytes in the bone marrow. The treatment 
had no adverse clinical effects or significant alterations in serum chemistry, making it viable method for 
monocyte/macrophage depletion in NHPs (362). 
6.4.4  Surveying other immune cell types involved in immune response with CGSA 
 While monocytes/macrophages were the most prominent cell type to be associated with the wound healing 
pathway using CGSA, they aren’t the only cell type associated with wound healing. Other cells, including 
neutrophils, fibroblasts, and myofibroblasts, play roles in the wound healing response, and could be 
potential targets of interest for future CGSA. Of particular interest are the neutrophils, as we found that the 
AGMs in this study had relatively high levels of neutrophils present in the gut prior to infection, which 
remained unchanged following infection (Figure 20). Neutrophils are traditionally associated with 
inflammation and tissue damage, but their presence prior to SIV infection makes them a potential cell type 
of interest. Additionally, the current CGSA analysis revealed a unique genetic signature in the gut of the 
AGMs for eosinophils and subsequent IHC for major basic protein, a core protein of eosinophilic granules, 
showed a large number of eosinophils in the lamina propria (data not shown). The role of eosinophils in 
wound healing is unclear (363), although there is some evidence to suggest that they might facilitate wound 
healing during ulcerative colitis (364), so further investigation may be warranted.  
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6.4.5  Promoting macrophage-mediated wound healing response in chronically SIV-infected RMs 
 The importance of gut damage in driving disease progression was clearly shown in a previous 
study, where colitis was induced in uninfected RMs through treatment with dextran sodium sulfate (DSS). 
Experimental administration of DSS to the RMs resulted in inflammation and immune activation similar to 
pathogenic SIV-infection. Additionally, DSS treated AGMs exhibited increased viral loads and markers of 
disease progression, though these changes were only transient (195). The return to homeostasis by the 
AGMs is particularly notable in the context of this study in regard to the macrophage-mediated wound 
healing response.  
This is because the majority of HIV-infected persons represent chronic stages of infection, with the 
associated levels of chronic inflammation. The DSS treatment of the AGMs demonstrated their wound 
healing response was sufficient to restore normal gut function following the insult imposed by the treatment. 
This implies that if a treatment or strategy induced a similar response in individuals chronically infected 
with HIV, the wound healing may be able to reduce or suppress the chronic inflammation and restore gut 
integrity.  
Recently, several studies have linked improved wound healing and macrophage survival with IL-
33 (344) and IL-35 (365) in mice. In a future study, it would be highly informative to attempt treatment of 
chronically SIVmac-infected RMs with IL-33 or IL-35 or another agent designed to stimulate the 
macrophage-mediated wound healing response and evaluate any changes in inflammation status, immune 
activation, epithelial integrity and disease progression.  
6.4.6  Treating chronically SIV-infected RMs to minimize loss of mucosal integrity in the gut 
 As the findings of this study reinforce the importance of maintenance of gut integrity in preventing 
disease progression, a future study might focus on the impact of reducing the amount of damage to the gut 
epithelium in pathogenic SIV infection. This could be done readily in RMs infected with SIV and would 
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need to address: (i) whether minimizing gut damage during acute pathogenic infection effects later disease 
progression: (ii) whether reducing gut damage during chronic infection impacts further disease progression 
or chronic inflammation. There are numerous potential candidates for testing; in just the past year, baicalein 
(366), PAP-1(367), syringic acid (368), and several strains of the probiotic bacterium Akkermansia 




At the start of this dissertation project, the following core hypothesis was proposed: that events 
occurring during the earliest stages of mucosal transmission may contribute to the resolution of the immune 
activation characteristic of pathogenic lentiviral infection at the passage from acute-to-chronic infection 
and thus prevent disease progression in nonprogressive hosts (see 2.0). To test this hypothesis, the three 
following specific aims were proposed: 
7.1 SA1: Characterize the viral bottleneck and dissemination from the site of infection in AGMs 
intrarectally (IR) inoculated with SIVsab 
To address this specific aim, we intrarectally inoculated 29 adult male AGMs with SIVsab92018 
and then performed serially necropsies on them. Each AGM was euthanized at a specific point in time, 
corresponding to the predicted state of the plasma viremia (Figure 1). The viremic state was later confirmed 
by either qPCR or SCA (Figure 2). From each animal, samples were collected from a wide variety of tissues, 
snap frozen and, later, total DNA/RNA was extracted from each specimen. By testing the total number of 
vRNA and vDNA copies in over 38 tissues (Figures 4 & 5), it was established that all tissues were seeded 
with SIVsab92018 by the peak of viral replication, at 9-12 dpi. With only a few exceptions, such as in the 
oral mucosa, virus was already present by 4-6 dpi. This corresponded with the establishment of reliably 
detectable plasma viremia, as measured with qPCR and SCA, indicating that by this time, the virus had 
already reached the blood stream through the lymphatics and been distributed systemically. Virus was only 
detectable early, at 1-3 dpi, in tissues taken from the site of inoculation (rectum, distal colon) and the 
draining colonic LN. Therefore, enough SIVsab92018 to establish systemic infection was transmitted from 
the rectal site of inoculation through the lymphatics to the thoracic duct and into the blood stream within 3 
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dpi. This timeframe for viral spread was supported by RNAscope (Figure 6) and FISH (Figure 8), which 
revealed the presence of virus within the lamina propria of the rectum and distal colon as early as 1-3 dpi. 
Despite the more permissive nature of the rectal mucosa to infection, viral transmission itself was 
not unrestricted, as SGA revealed there was a genetic bottleneck of the transmitted/founder during 
intrarectal inoculation, with 3-10 transmitted/founder viruses generating infection in each animal tested 
(Figure 7). While this number was higher than expected, possibly due to overdosing during inoculation, it 
still reflected restriction of virus in the original inoculum.  
7.2 SA2: Examine early changes in the immune cell populations following IR challenge of AGMs 
with SIVsab 
At the time of necropsy, apart from the tissues used for viral load quantification, multiple tissues 
were collected to use for cell separation (see 3.3.3). These included the site of inoculation (rectum, distal 
colon), other sections of the lower and upper intestinal tract (transverse colon, jejunum, and ileum), draining 
LNs (colonic, iliac, obturator) and LNs progressively more distant from the site of inoculation (mesenteric, 
axillary, inguinal and submandibular).  Cells were isolated from many of these tissues and stained for flow 
cytometry to analyze any changes in immune cell populations or activation status (Figures 9-12 & 13-15). 
However, in the majority of these tissues, including those collected from the site of inoculation, there were 
few, if any, significant alterations of the primary CD4+ and CD8+ populations or their subsets (central and 
effector memory, naïve). Other immune cell populations, including CD20+ cells, monocytes and 
macrophage, dendritic cells and natural killer cells, also were largely unaffected in response to 
SIVsab92018 infection. Any significant changes were mostly transient.  
Immune cell populations were also surveyed through extensive IHC testing for expression of a 
number of different markers, including: Ki-67 (Figure 19), myeloperoxidase (Figure 20), MX1 (Figure 21), 
and active capase-3 (Figure 24). The relative levels of markers in each tissue (transverse colon, axillary LN, 
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and jejunum) were measured using quantitative image analysis (see 4.3.11). However, it was found that, as 
shown by flow cytometry, immune cell activation and proliferation (Ki-67) remained largely unchanged in 
response to infection, both in the lamina propria and the epithelium of the gut. Likewise, there was little to 
no increase in apoptosis (caspase-3) and any recruitment of neutrophils (MPO) in response to infection was 
only transient. There was also a transient, but significant, increase in the interferon-linked antiviral response 
(MX1) in both the gut and the lymph nodes, but only during the peak of viral replication. 
These trends were reflected by the gene expression patterns in the AGM gut. Transcriptomic 
analysis revealed few, if any, alterations to genes linked to immune response of CD4+ and CD8+ T cells or 
CD20+ B cells (Figure 22). Genes associated with the interferon response to viral infection, including MX1 
and the interferon-induced genes CXCL10 and CXCL11, were highly upregulated at the peak of viral 
replication (Figure 23). These increases in CXCL10//CXCL11 were also observed in the plasma at the peak 
of viral replication (Figure 17).  
7.3 SA3: Analyze the expression of inflammatory and anti-inflammatory genes following IR SIVsab 
challenge. 
During tissue collection, samples taken from the rectum and distal colon were preserved in 
RNAlater specifically to be used for RNAseq and transcriptomics.  The transcriptomics was performed in 
tandem with RMs that had been intrarectally infected with SIVmac251, which is pathogenic in RMs. This 
allowed for direct comparison between gene expression profiles in pathogenic and nonpathogenic 
infections. The initial analysis reveal that AGMs lacked up-regulation of genes associated with chronic 
inflammation (Figure 30C); they also expressed more of the anti-inflammatory cytokine IL-17B almost 
immediately postinfection (Figure 23). Additionally, the AGMs exhibited increased expression of a number 
of genes potentially related to the wound healing response.  
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 It is known that during acute HIV/SIV infection, viral replication within the GALT drives 
inflammation and damage of gut epithelium, leading to microbial translocation from the gut lumen. This, 
in turns, leads to establishment of chronic inflammation. By avoiding or repairing damage to the gut 
epithelium, AGMs would prevent both microbial translocation and the subsequent inflammation. 
 Indeed, when examined on a whole genome scale, a correlation was found in AGMs with late stage 
(noninflammatory) wound healing response (Figure 31A), while lacking any gene expression signatures 
associated with the presence of LPS at 3 dpi (i.e., microbial translocation) (Figure 32C). The AGMs were 
shown to have pattern of up-regulation of gene linked to wound healing very similar to those found in 
aquatic axolotl (Figures 33 & 34A). A primate species of salamander, the axolotl is able to conduct wound 
healing without inflammation or scar tissue formation. Like the axolotl, the AGMs appear to bypass the 
inflammatory stage of wound healing in the gut.  Doing so would not only enable them to repair virally 
induced damage to the epithelium, but also maintain lower levels of inflammation overall. Analysis of the 
protein interactions associated with specific gene pathways revealed that axolotl-like wound healing in 
AGMs was mediated by the ECM protein fibronectin (Figure 34B). 
IHC quantification of fibronectin in the rectum of the AGMs revealed that it was strongly localized 
to the ECM, a phenotype normally associated with wound healing (Figure 34C). Immunofluorescence 
staining for fibronectin and the macrophage marker HAM56 revealed that many macrophages in the rectal 
lamina propria of AGMs, but not RMs, were strongly positive for fibronectin (Figures 35 & 36). Deep 
mRNAseq showed that in AGMs, both M1 and M2 macrophages exhibited gene expression patterns 
associated with wound healing (Figure 37) 
The findings from the transcriptomics were confirmed by IHC staining for makers associated with 
loss of epithelial integrity (claudin-3, Figure 25), fibrosis (collagen, Figure 26) and microbial translocation 
(LPS-core and E. coli, Figures 27 & 28). By measuring the ratio of intact versus damaged gut epithelium 
stained for claudin-3 (see 4.3.11 & Appendix C), it was established that AGMs exhibit little to no loss of 
mucosal integrity in the gut following infection. They also exhibited no evidence for the fibrosis that would 
follow any significant damage to the gut. This lack of disruption to the gut epithelium was accompanied by 
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no significant alterations to LPS or E. coli levels, showing that no microbial translocation occurs following 
SIVsab infection. 
7.4 Final conclusion 
Taken together, we believe that these results have largely addressed the 3 original specific aims of 
this project. Therefore, we can confirm our original hypothesis, with a caveat. It was initially proposed that 
prevention of disease progression would hinge on: (i) lower availability of target cells at the mucosal site(s) 
of infection; (ii) lower levels of immune activation at the mucosal sites, which result in (iii) reduced 
recruitment of target cells to mucosal sites of infection and (iv) the establishment of an anti-inflammatory 
milieu that suppresses the virally induced proinflammatory response While we did demonstrate lower levels 
of immune activation at the mucosal sites following SIV-transmission and a lack of target-cell recruitment, 
we did not find a strong anti-inflammatory milieu following infection.  
Instead, our findings suggest prevention of inflammation in the gut may depend on preservation of 
gut integrity through a unique wound healing mechanism. It is probable that none of the elements are 
separate, with the low levels of immune activation and the anti-inflammatory response following infection 
limiting the rate of damage to the gut enough to allow for repair of the mucosal barrier, thereby preventing 
further disease progression in natural hosts. 
 However, more research is needed to better understand these protective responses in AGMs, 
particularly in regard to the macrophage-mediated wound healing response. Better understanding of these 
mechanisms could prove invaluable to the development of new strategies to reduce inflammation and 
preserve or restore the gut integrity in HIV+ individuals. Eventually, this could advance progress towards a 
functional cure to prevent progression to AIDS, potentially allowing cessation of ART treatment without 
the threat of disease progression. This research could also open up paths towards reducing the impact of the 
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comorbidities associated with the chronic systemic inflammation triggered by HIV/SIV infection, leading 
to a better quality of life and long-term pathogenic outcome for ART-treated HIV+ individuals.  
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Appendix A Reference Information 
Table 4: Chronically SIVmac-Infected RMs Reference Information 





55I SIVmac239 24 (249) 10.1371/journal.ppat.1001052  
83I SIVmac239 24 " " 
AD09 SIVmac239 23 " " 
AY25 SIVmac239 39 " " 
AY44 SIVmac239 39 " " 
AY99 SIVmac239 30 " " 
DBB8 SIVmac239 12 (370)  10.1093/infdis/jis643 
DBEH SIVmac239 12 “ " 
DBGE SIVmac239 12 “ " 
DEMD SIVmac239M 34 NA NA 
F57 SIVmac239 105 NA NA 
FZ2 SIVmac239 105 NA NA 
P383 SIVmac251 86 NA NA 
P436 SIVmac251 58 NA NA 
P735 SIVmac251 70 NA NA 
P787 SIVmac251 66 NA NA 
P857 SIVmac251 65 NA NA 
R268 SIVsmmE660 8 (249) 10.1371/journal.ppat.1001052  
R365 SIVmac251 8 NA NA 
R366 SIVmac251 8 NA NA 
R367 SIVmac251 8 NA NA 
R406 SIVmac251 8 NA NA 
R410 SIVmac251 8 NA NA 
R437 SIVsmmE660 26 (249) 10.1371/journal.ppat.1001052  
R443 SIVmac239 56 “ " 
R451 SIVmac239 21 “ " 
R453 SIVmac239 37 (157) 10.1128/JVI.02612-09 
R457 SIVmac239 57 (249) 10.1371/journal.ppat.1001052  
R462 SIVmac239 57 " " 
R475 SIVmac239 28 " " 
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      Table 4 (continued)   
R533 SIVmac251 8 NA NA 
R694 SIVmac251 8 NA NA 
R695 SIVmac251 8 NA NA 
R696 SIVmac251 8 NA NA 
RH594 SIVsmmE543 39 (93) 10.1182/blood-2012-06-437608 
RH767 SIVsmmE543 23 “   
RHk8 SIVmac239 50 “   
RJi9 SIVmac239 32 “   
ROu8 SIVmac239 Chronic (153) 10.4049/jimmunol.180.10.6798  




Table 5: Flow Cytometry Panels Showing Target Markers and Fluorochromes 















SS1 CD95 CCR5 CD8a/b CD28 CCR7 CD4  CD3 CCR7      
SS2 CD3 Beta 7 CD8a/b CXCR3   CD4   CCR4 CCR6       
SS3 CD38 CD25 CD8a/b 
HLA-
DR 
 CD4 CD69 CD3   
    
ICS1 Ki-67 CD95 CD8a/b CD28   CD4 CD20 CD3         
TruCount     CD20 CD4  CD3  CD45     
DC Surface CD95 Lineage   CD123   CD11C HLADR CD80 CD86 CD45     








    








    








 CD69 CD8a 
NK ICS2 Ki-67 NKP30 
  








Table 6: Product Information for Flow Cytometry Antibodies 
Antibody Clone 
Catalogue 
# Company Antibody Clone 
Catalogue 
# Company 
CD3e-FITC SP34 556611 BD Pharm CD16 APC-H7 3G8 560195 BD 
CD38-FITC AT-1 60131FI Stem Cell CD20-APC-H7 2H7 560853 BD Pharm 
CD95-FITC DX2 555673 BD Pharm CD4-APC L200 551980 BD Pharm 
Ki-67-FITC B56 556026 BD Pharm CD11c-APC S-HCL-3 340544 BD BioSci 
Perforin-FITC PF-344 3465-7 
Mabtech 
AB CD14-APC M5E2 555399 BD Pharm 
CD3-PE SP34-2 552127 BD Pharm NKG2A-APC Z199.1 A60797 
Beckman 
Coulter 
CD14-PE M5E2 555398 BD Pharm CD20-APC-Cy7 L27 335794 BD BioSci 
CD20-PE 2H7 556633 BD Pharm CD69-APC-Cy7 FN50 557756 BD Pharm 
CD25-PE 2A3 341009 BD Pharm HLA-DR-APC-Cy7 L243 335796 BD BioSci 
CD95-PE DX2 555674 BD Pharm CD3-V450 SP34-2 560351 BD Pharm 
CD163-PE GHI/61 556018 BD Pharm CD80-V450 L307.4 560442 BD Horizon 
CCR5-PE (CD195-PE) 3A9 556042 BD Pharm CCR4-V450 (CD194) 1G1 561123 BD Pharm 
Granzyme B-PE GB11 561142 BD Pharm Caspase-3-V450 C92-605 560627 BD Horizon 
Integrin b7-PE FIB504 555945 BD Pharm Streptavidin Q. Dot 565   Q10131MP Invitrogen 
NKp30-PE (CD337) Z25 IM3709 IOTest CD86-Biotin 
2331(FUN-
1) 555656 BD Pharm 
CD8 α/b -PE Texas Red 3B5 MHCD0817 Invitrogen CCR6-Biotin (CD196) 11A9 559561 BD Pharm 
CD28-PE-Cy7 CD28.2 560684 BD Pharm CCR7-Biotin 3D12 552174 eBioscience 
CD56-PE-Cy7 NCAM16.2 335791 BD BioSci CD45-PerCP D058-1283 558411 BD Pharm 
CD80-PE-Cy7 L307.4 561135 BD Pharm NKp46 Purified 9 E2 331901 Biolegend 
CD123-PE-Cy7 7G3 560826 BD Pharm         
HLA-DR-PE-Cy7 L243 335813 BD BioSci       
CXCR3-PE-Cy7 
(CD183) 1C6/CXCR3 560831 BD Pharm         
 
Table 7: Immunohistochemistry Antibodies Information 
Target 
Marker 









Dako MIB-1 M7240 




Dako polyclonal A0398 




Abcam polyclonal ab95926 




Abcam polyclonal ab2302 


















Dako polyclonal B0357 
1:500 2 min 
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Table 8: Reference Datasets for Biological Processes 
GSE  Description  Species  Tissue  n= PMID  
GSE23006  Wound healing  Mouse  Skin  24 20704739 
GSE23006  Wound healing  Mouse  Tongue  24 20704739 
GSE28914  Wound healing  Human  Skin  25 23082929 
GSE17698  Wound healing  Rat  Eardrum  40 21919009 
GSE35255  Wound healing  Axolotl, aquatic  Skin  16 22485136 
GSE35255  Wound healing  
Axolotl, 
terrestrial  Skin  16 22485136 
GSE9293  Colitis by TNBS  Rat  Colon  18 NA 
GSE9281 Colitis by DSS Rat  Colon  42 NA 
GSE35609  Colitis by TNBS  Mouse  Colon  34 23226271 
GSE19392  IFN-β stimulation  Human  
Airway epithelial 
cells  169 20064372 
GSE19182  
Cytokine 
stimulation  Human  HNEC cells  21 22005912 
GSE27870  
TNF-α a 
stimulation  Human  Endothelial cells  24 22121215 
GSE32513  
Microbial 
colonization  Mouse  Jejunum  48 22617837 
GSE32513  
Microbial 
colonization  Mouse  Ileum  48 22617837 
GSE32513  
Microbial 
colonization  Mouse  Colon  48 22617837 
GSE51269  TLR knock-out  Mouse  Colon  20 25210121 
GSE39582  Colon cancer  Human  Colon  585 23700391 
GSE26253  Colon cancer  Human  Colon  432 24598828 
GSE44076  Colon cancer  Human  Colon  246 25215506 
GSE17536  Colon cancer  Human  Colon  177 19914252 
GSE11223  Ulcerative colitis  Human  Colon  202 18523026 
GSE20881  Crohn’s disease  Human  Colon  172 20848455 




Appendix B : Methods 
 
Figure 38: Flow cytometry gating strategy for CD4+ and CD8+ populations. 
Gating strategy used to delineate primary T-cell populations (CD3+, CD4+, CD8+) and secondary T-cell populations 
(EM, CM and naïve). All gates were generated using Flowjo software version 10.1r5 (Tree Star Inc, Ashland, OR). 
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Figure 39: Method for quantification of positive DAB signal based on color deconvolution. 
To quantify the DAB stain, each raw image (A) was processed using the Color Deconvolution 1.7 plugin for FIJI 
v.1.0. The preset DAB settings were selected, and the software separated the image into 3 color channels, with the 
brown channel representing the positive DAB signal (B). A threshold was then manually applied to the brown channel 
image to remove background coloration (C). Finally, the area of each image representing the DAB signal above 
threshold was measured as a percentage of the total area of the image. All images were captured at 200X magnification 
using an AxioImager M1 brightfield microscope equipped with an AxioCam MRc5. All image manipulations and 




Figure 40: Method for quantification of tissue collagen based on color thresholds. 
To quantify the amount of collagen in each tissue, each raw image (A) was processed with the built-in Color Threshold 
function in FIJI v.1.0. Using this feature, first the collagen was isolated from the rest of the image by adjusting the 
Hue value of the Color Threshold function to only encompass the blue of the collagen (B). It should be noted that the 
blue dye was also partially taken up by the goblet cells in the mucosal epithelium. After setting the Color Threshold, 
all background colors were removed, and the image was transformed into black and white (C). This eliminates all area 
of the image that is not blue coloration, which then can be measured by setting an intensity threshold to select all black 
area in the image. All images were captured at 200X magnification using an AxioImager M1 brightfield microscope 
equipped with an AxioCam MRc5. All image manipulations and measurements were done with FIJI v.1.0. 
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Figure 41: Approximation of epithelial proliferation in colonic crypts. 
To generate an approximation of the levels of on-going proliferation in the gut epithelium, we captured images of 
individual crypts in tissue sections stained with Ki-67. As epithelial proliferation is localized to the base of the crypts, 
we measured both the total length of the crypt (total black line) and the length of the crypt with Ki-67+ epithelial cells 
(black line below the bisecting green arrow). Since increased levels of proliferation should result in an increase in the 
total number of Ki-67+ cells along the crypt, taking the ratio of the areas of the line allowed us to normalize 
proliferation across multiple crypts. All individual images were captured at 200X magnification using an AxioImager 
M1 brightfield microscope equipped with an AxioCam MRc5. All image manipulations and measurements were done 
with FIJI v.1.0. 
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Figure 42: Exclusion of epithelium to isolate cells in the lamina propria. 
To measure the Ki-67 expression by cells in the lamina propria, all the epithelial cells were manually removed from 
the images. By overlaying white coloration on the epithelial sections of the crypts, they were excluded from the 
thresholding for positive DAB signal (Figure 39). Then, a threshold could be applied to the area within the lamina 
propria alone and the total DAB signal measured as normal. All individual images were captured at 200X 
magnification using an AxioImager M1 brightfield microscope equipped with an AxioCam MRc5. All image 
manipulations and measurements were done with FIJI v.1.0. 
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Figure 43: Measurement of intact versus damaged transverse colon epithelium. 
To determine the relative proportion of intact colon mucosal epithelium compared to damaged epithelium, multiple 
contiguous images of a section of colonic mucosa were obtained. The length of the epithelium shown in the generated 
composite image was then traced using FIJI v.1.0; here, green lines represents intact, continuous epithelium, while 
red lines indicates broken, discontinuous epithelium. The lines were drawn freehand at a constant width of 10 pixels. 
Following tracing, the area of the line segments was measured with FIJI and these areas were used to establish a ratio 
representing of intact versus broken epithelium. All individual images were captured at 100X magnification using an 
AxioImager M1 brightfield microscope equipped with an AxioCam MRc5. After collection, the images were stitched 
together to form a composite using the Stitching plugin for FIJI version 1.0. 
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Appendix C : Supplemental data 
 
Figure 44: Immunohistochemistries (IHC) of the jejunum in SIVsab-infected African green monkeys 
(AGMs). 
DAB-based IHC for the same array of markers that were used for the colon and axillary LN. In all the images, positive 
DAB signal is shown in brown, with the remaining tissue counterstained blue. Below are shown quantifications of 
positive signal within the image. The quantification for each animal represents the average of the values from 9-12 
individual image quantifications. Villi enterocytes were included in all quantifications. The four different time groups 
are based on the days postinfection, with: BL (baseline, preinfection), RU (ramp-up, 4-6 dpi), PEAK (peak, 9-12dpi) 
and SP (set-point, 46-55 dpi). Each time group is assigned a corresponding color based on stage of viral replication: 
orange (baseline), blue (ramp-up), red (peak) and yellow (set-point). All quantifications were performed using FIJI 
version --1.0. Asterisks indicate statistical significance p<0.05. All images were captured at 200X magnification using 




Figure 45: Immunofluorescent (IF) staining for HAM56/FN in rectum lamina propria of African green 
monkeys (AGMs) with separate color channels. 
Rectum from AGMs were doubled stained for HAM56 (red) and FN (green), with a DAPI stain (blue) to visualize 
nuclei. Colocalization, if any, appears as yellow. From top to bottom are shown the composite images and then the 
DAPI, FN and HAM56 color channels. From left to right, representative images are shown from 0-6 days post 
infection. All images are at 200X magnification and were captured with an Olympus Fluoview 1000 Confocal 
Microscope housed at the Center for Biologic Imaging, Pittsburgh, PA. Each image represents a maximum intensity 
projection form a z-stack of 11-28 images at 1.78 m per step. The resolution of every image is 0.321 m/pixel. 
Maximum intensity projections were created with NIS Elements 5.20.00 (https://www.lim.cz/). All image editing was 
performed using FIJI version 2.0 (https://fiji.sc/). Editing includes adjustment of color channel brightness for clarity 
and application of the built-in FIJI Despeckle median filter to reduce noise. 
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Figure 46: Immunofluorescent (IF) staining for HAM56/FN in rectum lamina propria of rhesus macaques 
(RMs) with separate color channels. 
Rectum from RMs were doubled stained for HAM56 (red) and FN (green), with a DAPI stain (blue) to visualize 
nuclei. Colocalization, if any, appears as yellow. From top to bottom are shown the composite image and then the 
DAPI, FN and HAM56 color channels. From left to right, representative images are shown from 0-6 days post 
infection. All images are at 200X magnification and were captured with an Olympus Fluoview 1000 Confocal 
Microscope housed at the Center for Biologic Imaging, Pittsburgh, PA. Each image represents a maximum intensity 
projection form a z-stack of 11-28 images at 1.78 m per step. The resolution of every image is 0.321 m/pixel. 
Maximum intensity projections were created with NIS Elements 5.20.00 (https://www.lim.cz/). All image editing was 
performed using FIJI version 2.0 (https://fiji.sc/). Editing includes adjustment of color channel brightness for clarity 
and application of the built-in FIJI Despeckle median filter to reduce noise. 
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Figure 47: Example images for HAM56 immunohistochemistry and quantification. 
DAB-based IHC for HAM56 in the rectums of African green monkeys (AGMs) and rhesus macaques (RMs), from 0-
12 days post infection (A). In all images, positive DAB signal is shown in brown, with the remaining tissue 
counterstained blue. (B) The strategy to isolate the lamina propria for quantification is shown for the AGMs (left) and 
RMs (right). For each raw image (1), the luminal space and all surrounding tissue were manually excluded from the 
image (2), color deconvolution was used to separate the DAB coloration (3), and a threshold for color intensity was 
manually set to isolate the DAB signal (4). All image quantifications and editing were performed using FIJI version 
2.0 (https://fiji.sc/). All images were captured at either 200X or 100X (for whole lamina propria) magnification using 
a Zeiss AxioImager M1 bright-field microscope equipped with an AxioCam MRc5. 
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